Document:

EXHIBIT
      10.1

    

    SHARE
      EXCHANGE AGREEMENT

    

     

    SHENGTAI
      HOLDING, INC. 

     

    FOR
      THE EXCHANGE OF

     

    CAPITAL
      STOCK

    

    OF

    

    WEST
      COAST CAR COMPANY

    

    DATED
      AS OF May 15, 2007

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

     

    SHARE
      EXCHANGE AGREEMENT

    

    This
      SHARE EXCHANGE AGREEMENT, dated as of May 15, 2007 (the “Agreement”) by and
      among SHENGTAI HOLDING,
      INC.,
a
      newly-formed New Jersey corporation (“SHI”), WEST COAST CAR COMPANY, a Delaware
      corporation (“WCCC”), Tryant, LLC. (“Tryant”) and all of the shareholders of
      SHI, whose names are set forth on Exhibit A attached hereto (“SHAREHOLDERS”).

     

    WHEREAS,
      SHAREHOLDERS own 100% of the issued and outstanding shares of Common Stock
      of
      SHI (the "SHI
      Shares");

     

    WHEREAS,
      SHAREHOLDERS believe it is in their best interest to exchange the SHI Shares
      for
      shares of common stock of WCCC, par value $.001 per share (“WCCC
      Shares”),
      and
      WCCC believes it is in its best interests to acquire the SHI Shares in exchange
      for WCCC Shares, upon the terms and subject to the conditions set forth in
      this
      Agreement; and 

     

    WHEREAS,
      it is the intention of the parties that: (i) WCCC shall acquire 100% of the
      SHI
      Shares in exchange solely for the amount of WCCC Shares set forth herein; (ii)
      said exchange of shares shall qualify as a tax-free reorganization under Section
      368(a)(1)(B) of the Internal Revenue Code of 1986, as amended (the“Code”);
      and
      (iii) said exchange shall qualify as a transaction in securities exempt from
      registration or qualification under the Securities Act of 1933, as amended
      and
      in effect on the date of this Agreement (the “Securities
      Act”)

     

    NOW,
      THEREFORE, in consideration of the mutual terms, conditions and other agreements
      set forth herein, the parties hereto hereby agree as follows:

     

    ARTICLE
      I

     

    EXCHANGE
      OF SHARES FOR COMMON STOCK

     

    Section
      1.1 Agreement
      to Exchange SHI Shares for WCCC Shares.
      On the
      Closing Date (as hereinafter defined) and upon the terms and subject to the
      conditions set forth in this Agreement, SHAREHOLDERS shall sell, assign,
      transfer, convey and deliver the SHI Shares (representing 100 SHI Shares or
      100%
      of the issued and outstanding SHI Shares), to WCCC, and WCCC shall accept the
      SHI Shares from the SHAREHOLDERS in exchange for the issuance to the
      SHAREHOLDERS of the number of WCCC Shares set forth opposite the names of the
      SHAREHOLDERS on Exhibit A hereto.

    

    Section
      1.2 Capitalization.
      On the
      Closing Date, immediately before the transactions to be consummated pursuant
      to
      this Agreement, WCCC shall have authorized (a) 100,000,000 shares of Common
      Stock, par value $.001 per share, of which 1,000,000 shares shall be issued
      and
      outstanding, all of which are duly authorized, validly issued and fully paid
      and
      the detailed shareholdings of which are more particularly set out in Exhibit
      B
      hereto; and (b) 5,000,000 shares of Preferred Stock, $.001 par value, of which
      no shares are issued or outstanding. 

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    Section
      1.3 Closing.
      The
      closing of the exchange to be made pursuant to this Agreement (the "Closing")
      shall take place at 10:00 a.m. E.D.T. on the second business day after the
      conditions to closing set forth in Articles V and VI have been satisfied or
      waived, or at such other time and date as the parties hereto shall agree in
      writing but no later than May __, 2007(the "Closing Date"), at the offices
      of
      Guzov Ofsink, LLC, 600 Madison Avenue, 14th
      Floor,
      New York, New York 10022. At the Closing, SHAREHOLDERS shall (i) deliver to
      WCCC
      the stock certificates representing 100% of the SHI Shares, duly endorsed in
      blank for transfer or accompanied by appropriate stock powers duly executed
      in
      blank and (ii) pay or cause to be paid to [Names of Payees] the sum of $500,000
      (Five Hundred Thousand Dollars Only). In full consideration and exchange for
      the
      SHI Shares and payment, WCCC shall issue and exchange with SHAREHOLDERS
      9,125,000 WCCC Shares representing approximately 91,250 WCCC Shares for each
      SHI
      Share exchanged. 

     

    1.4
       Tax
      Treatment.
      The
      exchange described herein is intended to comply with Section 368(a)(1)(B) of
      the
      Code, and all applicable regulations thereunder. In order to ensure compliance
      with said provisions, the parties agree to take whatever steps may be necessary,
      including, but not limited to, the amendment of this Agreement.

    

    ARTICLE
      II

    

    REPRESENTATIONS
      AND WARRANTIES OF WCCC

    

    Each
      of
      WCCC and Tryant hereby, jointly and severally, represents, warrants and agrees
      as follows:

    

    Section
      2.1 Corporate
      Organization

    

    a. WCCC
      is a
      corporation duly organized, validly existing and in good standing under the
      laws
      of Delaware, and has all requisite corporate power and authority to own its
      properties and assets and to conduct its business as now conducted and is duly
      qualified to do business in good standing in each jurisdiction in which the
      nature of the business conducted by WCCC or the ownership or leasing of its
      properties makes such qualification and being in good standing necessary, except
      where the failure to be so qualified and in good standing will not have a
      material adverse effect on the business, operations, properties, assets,
      condition or results of operation of WCCC (a "WCCC
      Material Adverse Effect");
      

    

    b. Copies
      of
      the Articles of Incorporation and By-laws of WCCC as well as the Certificates
      of
      Designation of the Preferred Stock, with all amendments thereto to the date
      hereof, have been furnished to SHI and the SHAREHOLDERS, and such copies are
      accurate and complete as of the date hereof. The minute books of WCCC are
      current as required by law, contain the minutes of all meetings of the Board
      of
      Directors and shareholders of WCCC from its date of incorporation to the date
      of
      this Agreement, and adequately reflect all material actions taken by the Board
      of Directors and shareholders of WCCC.

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    Section
      2.2 Capitalization
      of WCCC.
      The
      authorized capital stock of WCCC consists of (a) 100,000,000 shares of Common
      Stock, par value $.001 per share, of which 1,000,000 shares are issued and
      outstanding, all of which are duly authorized, validly issued and fully paid
      and
      the detailed shareholdings of which are more particularly set out in Exhibit
      B
      hereto; and (b) 5,000,000 shares of Preferred Stock, $.001 par value, of which
      no shares are issued or outstanding. The parties agree that they have been
      informed of the issuances of these WCCC Shares, and that all such issuances
      of
      WCCC Shares pursuant to this Agreement will be in accordance with the provisions
      of this Agreement. All of the WCCC Shares to be issued pursuant to this
      Agreement have been duly authorized and will be validly issued, fully paid
      and
      non-assessable and no personal liability will attach to the ownership thereof
      and in each instance, have been issued in accordance with the registration
      requirements of applicable securities laws. As of the date of this Agreement
      there are and as of the Closing Date, there will be, no outstanding options,
      warrants, agreements, commitments, conversion rights, preemptive rights or
      other
      rights to subscribe for, purchase or otherwise acquire any shares of capital
      stock or any un-issued or treasury shares of capital stock of WCCC.

    

    Section
      2.3 Subsidiaries
      and Equity Investments.
      WCCC
      has no subsidiaries or equity interest in any corporation, partnership or joint
      venture. 

    

    Section
      2.4 Authorization
      and Validity of Agreements.
      WCCC
      has all corporate power and authority to execute and deliver this Agreement,
      to
      perform its obligations hereunder and to consummate the transactions
      contemplated hereby and upon the execution and delivery by SHI and the SHI
      Shareholders and the performance of their obligations herein, will constitute,
      a
      legal, valid and binding obligation of WCCC. The execution and delivery of
      this
      Agreement by WCCC and the consummation by WCCC of the transactions contemplated
      hereby have been duly authorized by all necessary corporate action of WCCC,
      and
      no other corporate proceedings on the part of WCCC are necessary to authorize
      this Agreement or to consummate the transactions contemplated
      hereby.

    

    Section 2.5 No
      Conflict or Violation.
      The
      execution, delivery and performance of this Agreement by WCCC do not and will
      not violate or conflict with any provision of its Articles of Incorporation
      or
      By-laws, and does not and will not violate any provision of law, or any order,
      judgment or decree of any court or other governmental or regulatory authority,
      nor violate or result in a breach of or constitute (with due notice or lapse
      of
      time or both) a default under, or give to any other entity any right of
      termination, amendment, acceleration or cancellation of, any contract, lease,
      loan agreement, mortgage, security agreement, trust indenture or other agreement
      or instrument to which WCCC is a party or by which it is bound or to which
      any
      of their respective properties or assets is subject, nor will it result in
      the
      creation or imposition of any lien, charge or encumbrance of any kind whatsoever
      upon any of the properties or assets of WCCC, nor will it result in the
      cancellation, modification, revocation or suspension of any of the licenses,
      franchises, permits to which WCCC is bound.

    

    Section
      2.6 Consents
      and Approvals.
      No
      consent, waiver, authorization or approval of any governmental or regulatory
      authority, domestic or foreign, or of any other person, firm or corporation,
      is
      required in connection with the execution and delivery of this Agreement by
      WCCC
      or the performance by WCCC of its obligations hereunder.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    Section
      2.7 Absence
      of Certain Changes or Events.
      Since
      its inception:

    

    a.  WCCC
      has
      operated in the ordinary course of business consistent with past practice and
      there has not been any material adverse change in the assets, properties,
      business, operations, prospects, net income or condition, financial or otherwise
      of WCCC. As of the date of this Agreement, WCCC does not know or have reason
      to
      know of any event, condition, circumstance or prospective development which
      threatens or may threaten to have a material adverse effect on the assets,
      properties, operations, prospects, net income or financial condition of
      WCCC;

    

    b.  there
      has
      not been any declaration, setting aside or payment of dividends or distributions
      with respect to shares of capital stock of WCCC or any redemption, purchase
      or
      other acquisition of any capital stock of WCCC or any other of WCCC’s
      securities; and

    

    c.  there
      has
      not been an increase in the compensation payable or to become payable to any
      director or officer of WCCC. 

    

    Section
      2.8 Disclosure.
      This
      Agreement and any certificate attached hereto or delivered in accordance with
      the terms hereby by or on behalf of WCCC in connection with the transactions
      contemplated by this Agreement, when taken together, do not contain any untrue
      statement of a material fact or omit any material fact necessary in order to
      make the statements contained herein and/or therein not misleading.

    

    Section
      2.9 Litigation.
      There
      is no action, suit, proceeding or investigation pending or threatened against
      the Company or any subsidiary that may affect the validity of this Agreement
      or
      the right of WCCC to enter into this Agreement or to consummate the transactions
      contemplated hereby.

    

    Section
      2.10 Securities
      Laws.
      WCCC
      has complied in all respects with applicable federal and state securities laws,
      rules and regulations, including the Sarbanes Oxley Act of 2002, as such laws,
      rules and regulations apply to WCCC and its securities; and (b) all shares
      of
      capital stock of the Company have been issued in accordance with applicable
      federal and state securities laws, rules and regulations. There are no stop
      orders in effect with respect to any of the Company’s securities.

    

    Section
      2.11 Tax
      Returns, Payments and Elections.
      WCCC
      has timely filed all tax returns, statements, reports, declarations and other
      forms and documents and has, to date, paid all taxes due.

    

    Section
      2.12 ’34
      Act Reports.
      None of
      WCCC’s filings with the SEC, contains any untrue statement of a material face or
      omits to state a material fact necessary to make the statements therein not
      misleading, in light of the circumstances in which they were made.

    

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    Section
      2.13  Market
      Makers.
      WCCC
      has at least four (4) market makers in its Common Stock.

    

    Section
      2.14 Survival.
      Each of
      the representations and warranties set forth in this Article II shall be deemed
      represented and made by WCCC at the Closing as if made at such time and shall
      survive the Closing for a period terminating on the second anniversary of the
      date of this Agreement.

    

    ARTICLE
      III

    

    REPRESENTATIONS
      AND WARRANTIES OF SHI AND SHAREHOLDERS

    

    SHI
      and
      each of the SHAREHOLDERS, severally, represent, warrant and agree as
      follows:

    

    Section
      3.1 Corporate
      Organization.

    

    a. SHI
      is a
      newly-formed corporation with no prior business activities. It is duly
      organized, validly existing and in good standing under the laws of the state
      of
      New Jersey and has all requisite corporate power and authority to own its
      properties and assets and to conduct its business as now conducted and is duly
      qualified to do business, is in good standing in each jurisdiction wherein
      the
      nature of the business conducted by SHI or the ownership or leasing of its
      properties makes such qualification and being in good standing necessary, except
      where the failure to be so qualified and in good standing will not have a
      material adverse effect on the business, operations, properties, assets,
      condition or results of operation of SHI (a "SHI
      Material Adverse Effect").
      As of
      the date of this Agreement, SHI owns all of the issued and outstanding equity
      or
      voting interests in Weifang Shengtai Pharmaceutical Co., Ltd (“Shengtai”).
      Shengtai is duly organized, validly existing and in good standing under the
      laws
      of the Peoples’ Republic of China (“PRC”) and has all requisite corporate power
      and authority to own its properties and assets and to conduct its business
      as
      now conducted and is duly qualified to do business, is in good standing in
      each
      jurisdiction wherein the nature of the business conducted by Shengtai or the
      ownership or leasing of its properties makes such qualification and being in
      good standing necessary, except where the failure to be so qualified and in
      good
      standing will not have a material adverse effect on the business, operations,
      properties, assets, condition or results of operation of Shengtai (a
"Shengtai
      Material Adverse Effect")

    

    b. Copies
      of
      the Certificate of Incorporation and By-laws of SHI and Shengtai, with all
      amendments thereto to the date hereof, have been furnished to WCCC, and such
      copies are accurate and complete as of the date hereof. The minute books of
      SHI
      are current as required by law, contain the minutes of all meetings of the
      Board
      of Directors and shareholders of SHI, and committees of the Board of Directors
      of SHI from the date of incorporation to the date of this Agreement, and
      adequately reflect all material actions taken by the Board of Directors,
      shareholders and committees of the Board of Directors of SHI.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    Section
      3.2 Capitalization
      of SHI; Title to the SHI Shares.
      On the
      Closing Date, immediately before the transactions to be consummated pursuant
      to
      this Agreement, SHI shall have authorized One Hundred Thousand (100,000) SHI
      Shares, of which 100 SHI Shares will be issued and outstanding. The SHI Shares
      are the sole outstanding shares of capital stock of SHI, and there are no
      outstanding options, warrants, agreements, commitments, conversion rights,
      preemptive rights or other rights to subscribe for, purchase or otherwise
      acquire any shares of capital stock or other equity or voting interest or any
      unissued or treasury shares of capital stock of SHI. As of the date hereof
      and
      on the Closing Date, each SHAREHOLDER owns and will own the SHI Shares free
      and
      clear of any liens, claims or encumbrances and has and will have the right
      to
      transfer the SHI Shares without consent of any other person or entity.

    

    Section
      3.3 Subsidiaries
      and Equity Investments; Assets.
      As of
      the date hereof and on the Closing Date, SHI owns and will own all of the equity
      or voting interests in Shengtai. SHI does not and will not directly or
      indirectly, own any other shares of capital stock or any other equity interest
      in any entity or any right to acquire any shares or other equity interest in
      any
      entity and SHI does not and will not have any assets or liabilities. As of
      the
      date hereof and on Closing Date, Shengtai does not and will not directly or
      indirectly, own any shares of capital stock or any other equity interest in
      any
      entity or any right to acquire any shares or other equity interest in any
      entity. As of the date hereof and on the Closing Date, there are and will be
      no
      outstanding options, warrants, agreements, commitments, conversion rights,
      preemptive rights or other rights to subscribe for, purchase or otherwise
      acquire any shares of capital stock or other equity or voting interest in
      Shengtai. 

    

    Section
      3.4 Authorization
      and Validity of Agreements.
      SHI has
      all corporate power and authority to execute and deliver this Agreement, to
      perform its obligations hereunder and to consummate the transactions
      contemplated hereby. The execution and delivery of this Agreement by SHI and
      the
      consummation of the transactions contemplated hereby have been duly authorized
      by all necessary corporate action and no other corporate proceedings on the
      part
      of SHI are necessary to authorize this Agreement or to consummate the
      transactions contemplated hereby. The SHAREHOLDERS have approved this Agreement
      on behalf of SHI and no other stockholder approvals are required to consummate
      the transactions contemplated hereby. Each SHAREHOLDER who is a natural person
      is over the age of 21, is competent to execute this Agreement, and has the
      power
      to execute and perform this Agreement. The execution and delivery of this
      Agreement by each SHAREHOLDER which is not a natural person (“Entity
      Shareholder”) and the consummation of the transactions contemplated hereby by
      each Entity Shareholder have been duly authorized by all necessary action by
      the
      Entity Shareholder and no other proceedings on the part of SHI or any
      SHAREHOLDER are necessary to authorize this Agreement or to consummate the
      transactions contemplated hereby. 

    

    Section
      3.5 No
      Conflict or Violation.
      The
      execution, delivery and performance of this Agreement by SHI or any SHAREHOLDER
      does not and will not violate or conflict with any provision of the constituent
      documents of SHI, and does not and will not violate any provision of law, or
      any
      order, judgment or decree of any court or other governmental or regulatory
      authority, nor violate, result in a breach of or constitute (with due notice
      or
      lapse of time or both) a default under or give to any other entity any right
      of
      termination, amendment, acceleration or cancellation of any contract, lease,
      loan agreement, mortgage, security agreement, trust indenture or other agreement
      or instrument to which SHI or any SHAREHOLDER is a party or by which it is
      bound
      or to which any of its respective properties or assets is subject, nor result
      in
      the creation or imposition of any lien, charge or encumbrance of any kind
      whatsoever upon any of the properties or assets of SHI or any SHAREHOLDER,
      nor
      result in the cancellation, modification, revocation or suspension of any of
      the
      licenses, franchises, permits to which SHI or any SHAREHOLDER is
      bound.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    Section
      3.6 Investment
      Representations.
      (a) The
      WCCC Shares will be acquired hereunder solely for the account of the
      SHAREHOLDERS, for investment, and not with a view to the resale or distribution
      thereof. Each SHAREHOLDER understands and is able to bear any economic risks
      associated with such SHAREHOLDER’S investment in the WCCC Shares. Each
      SHAREHOLDER has had full access to all the information such SHAREHOLDER
      considers necessary or appropriate to make an informed investment decision
      with
      respect to the WCCC Shares to be acquired under this Agreement. Each SHAREHOLDER
      further has had an opportunity to ask questions and receive answers from WCCC’s
      directors regarding WCCC and to obtain additional information (to the extent
      WCCC’s directors possessed such information or could acquire it without
      unreasonable effort or expense) necessary to verify any information furnished
      to
      such SHAREHOLDER or to which such SHAREHOLDER had access. Each SHAREHOLDER
      is at
      the time of the offer and execution of this Agreement, domiciled and resident
      outside the United States (a “PRC
      Shareholder”)
      and is
      an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D
      promulgated by the Securities and Exchange Commission under the Securities
      Act).

    

    (b)
      No
      PRC Shareholder, nor any affiliate of any PRC Shareholder, nor any person acting
      on behalf of any PRC Shareholder or any behalf of any such affiliate, has
      engaged or will engage in any activity undertaken for the purpose of, or that
      reasonably could be expected to have the effect of, conditioning the markets
      in
      the United States for the WCCC Shares, including, but not limited to, effecting
      any sale or short sale of securities through any PRC Shareholder or any of
      affiliate of any PRC Shareholder prior to the expiration of any restricted
      period contained in Regulation S promulgated under the Securities Act (any
      such
      activity being defined herein as a “Directed Selling Effort”). To the best
      knowledge of each of the PRC Shareholders, this Agreement and the transactions
      contemplated herein are not part of a plan or scheme to evade the registration
      provisions of the Securities Act, and the WCCC Shares are being acquired for
      investment purposes by the PRC Shareholders. Each PRC Shareholder agrees that
      all offers and sales of WCCC Shares from the date hereof and through the
      expiration of the any restricted period set forth in Rule 903 of Regulation
      S
      (as the same may be amended from time to time hereafter) shall not be made
      to
      U.S. Persons or for the account or benefit of U.S. Persons and shall otherwise
      be made in compliance with the provisions of Regulation S and any other
      applicable provisions of the Securities Act. Neither any PRC Shareholder nor
      the
      representatives of any PRC Shareholder have conducted any Directed Selling
      Effort as that term is used and defined in Rule 902 of Regulation S and no
      PRC
      Shareholder nor any representative of any PRC Shareholder will engage in any
      such Directed Selling Effort within the United States through the expiration
      of
      any restricted period set forth in Rule 903 of Regulation S.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    Section
      3.7 Brokers’
      Fees. No
      SHAREHOLDER has any liability to pay any fees or commissions or other
      consideration to any broker, finder, or agent with respect to the transactions
      contemplated by this Agreement. 

    

    Section
      3.8 Disclosure.
      This
      Agreement, the schedules hereto and any certificate attached hereto or delivered
      in accordance with the terms hereby by or on behalf of SHI or the SHAREHOLDERS
      in connection with the transactions contemplated by this Agreement, when taken
      together, do not contain any untrue statement of a material fact or omit any
      material fact necessary in order to make the statements contained herein and/or
      therein not misleading. 

    

    Section
      3.9 Survival.
      Each of
      the representations and warranties set forth in this Article III shall be deemed
      represented and made by SHI and the SHAREHOLDERS at the Closing as if made
      at
      such time and shall survive the Closing for a period terminating on the second
      anniversary of the date of this Agreement.

     

    ARTICLE
      IV

    

    COVENANTS

    

    Section
      4.1 Certain
      Changes and Conduct of Business.

    

    a. From
      and
      after the date of this Agreement and until the Closing Date, WCCC shall conduct
      its business solely in the ordinary course consistent with past practices and,
      in a manner consistent with all representations, warranties or covenants of
      WCCC, and without the prior written consent of SHI will not, except as required
      or permitted pursuant to the terms hereof:

    

    	i.  	
            make
              any material change in the conduct of its businesses and/or operations
              or
              enter into any transaction other than in the ordinary course of business
              consistent with past practices;

          

    

    	ii.  	
            make
              any change in its Articles of Incorporation or By-laws; issue any
              additional shares of capital stock or equity securities or grant any
              option, warrant or right to acquire any capital stock or equity securities
              or issue any security convertible into or exchangeable for its capital
              stock or alter in any material term of any of its outstanding securities
              or make any change in its outstanding shares of capital stock or its
              capitalization, whether by reason of a reclassification, recapitalization,
              stock split or combination, exchange or readjustment of shares, stock
              dividend or otherwise;

          

    

    	iii.  	
            A.       
              incur,
              assume or guarantee any indebtedness for borrowed money, issue any
              notes,
              bonds, debentures or other corporate securities or grant any option,
              warrant or right to purchase any thereof, except pursuant to transactions
              in the ordinary course of business consistent with past practices;
              or

          

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    
      	 	
              B.

            	
              issue
                any securities convertible or exchangeable for debt or equity securities
                of WCCC;

            

    

    

    	iv.  	
            make
              any sale, assignment, transfer, abandonment or other conveyance of
              any of
              its assets or any part thereof, except pursuant to transactions in
              the
              ordinary course of business consistent with past
              practice;

          

    

    	v.  	
            subject
              any of its assets, or any part thereof, to any lien or suffer such
              to be
              imposed other than such liens as may arise in the ordinary course of
              business consistent with past practices by operation of law which will
              not
              have an WCCC Material Adverse Effect;

          

    

    	vi.  	
            acquire
              any assets, raw materials or properties, or enter into any other
              transaction, other than in the ordinary course of business consistent
              with
              past practices;

          

    

    	vii.  	
            enter
              into any new (or amend any existing) employee benefit plan, program
              or
              arrangement or any new (or amend any existing) employment, severance
              or
              consulting agreement, grant any general increase in the compensation
              of
              officers or employees (including any such increase pursuant to any
              bonus,
              pension, profit-sharing or other plan or commitment) or grant any increase
              in the compensation payable or to become payable to any employee, except
              in accordance with pre-existing contractual provisions or consistent
              with
              past practices;

          

    

    	viii.  	
            make
              or commit to make any material capital
              expenditures;

          

    

    	ix.  	
            pay,
              loan or advance any amount to, or sell, transfer or lease any properties
              or assets to, or enter into any agreement or arrangement with, any
              of its
              affiliates;

          

    

    	x.  	
            guarantee
              any indebtedness for borrowed money or any other obligation of any
              other
              person;

          

    

    	xi.  	
            fail
              to keep in full force and effect insurance comparable in amount and
              scope
              to coverage maintained by it (or on behalf of it) on the date
              hereof;

          

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    	xii.  	
            take
              any other action that would cause any of the representations and
              warranties made by it in this Agreement not to remain true and correct
              in
              all material aspect;

          

    

    	xiii.  	
            make
              any material loan, advance or capital contribution to or investment
              in any
              person;

          

    

    	xiv.  	
            make
              any material change in any method of accounting or accounting principle,
              method, estimate or practice;

          

    

    	xv.  	
            settle,
              release or forgive any claim or litigation or waive any
              right;

          

    

    	xvi.  	
            commit
              itself to do any of the foregoing.

          

    

    b. From
      and
      after the date of this Agreement, SHI will and SHI will cause Shengtai to:
      

    

    	1.  	
            continue
              to maintain, in all material respects, its properties in accordance
              with
              present practices in a condition suitable for its current
              use;

          

    

    	2.  	
            file,
              when due or required, federal, state, foreign and other tax returns
              and
              other reports required to be filed and pay when due all taxes,
              assessments, fees and other charges lawfully levied or assessed against
              it, unless the validity thereof is contested in good faith and by
              appropriate proceedings diligently
              conducted;

          

    

    	3.  	
            continue
              to conduct its business in the ordinary course consistent with past
              practices;

          

    

    	4.  	
            keep
              its books of account, records and files in the ordinary course and
              in
              accordance with existing practices; and

          

    

    5. continue
      to maintain existing business relationships with suppliers. 

    

    c. From
      and
      after the date of this Agreement, SHI will not and will ensure that Shengtai
      does not:

    

    	xvii.  	
            make
              any material change in the conduct of its businesses and/or operations
              or
              enter into any transaction other than in the ordinary course of business
              consistent with past practices;

          

    

    	xviii.  	
            make
              any change in its Business License, Bylaws or other governing documents;
              issue any additional shares of capital stock or equity securities or
              grant
              any option, warrant or right to acquire any capital stock or equity
              securities or issue any security convertible into or exchangeable for
              its
              capital stock or alter in any material term of any of its outstanding
              securities or make any change in its outstanding shares of capital
              stock
              or its capitalization, whether by reason of a reclassification,
              recapitalization, stock split or combination, exchange or readjustment
              of
              shares, stock dividend or otherwise;

          

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    	xix.  	
            A.       
              incur,
              assume or guarantee any indebtedness for borrowed money, issue any
              notes,
              bonds, debentures or other corporate securities or grant any option,
              warrant or right to purchase any thereof, except pursuant to transactions
              in the ordinary course of business consistent with past practices;
              or

          

    

    
      	 	
              B.

            	
              issue
                any securities convertible or exchangeable for debt or equity securities
                of SHI or Shengtai;

            

    

    

    	xx.  	
            make
              any sale, assignment, transfer, abandonment or other conveyance of
              any of
              its assets or any part thereof, except pursuant to transactions in
              the
              ordinary course of business consistent with past
              practice;

          

    

    	xxi.  	
            subject
              any of its assets, or any part thereof, to any lien or suffer such
              to be
              imposed other than such liens as may arise in the ordinary course of
              business consistent with past practices by operation of law which will
              not
              have an SHI Material Adverse Effect;

          

    

    	xxii.  	
            acquire
              any assets, raw materials or properties, or enter into any other
              transaction, other than in the ordinary course of business consistent
              with
              past practices;

          

    

    	xxiii.  	
            enter
              into any new (or amend any existing) employee benefit plan, program
              or
              arrangement or any new (or amend any existing) employment, severance
              or
              consulting agreement, grant any general increase in the compensation
              of
              officers or employees (including any such increase pursuant to any
              bonus,
              pension, profit-sharing or other plan or commitment) or grant any increase
              in the compensation payable or to become payable to any employee, except
              in accordance with pre-existing contractual provisions or consistent
              with
              past practices;

          

    

    	xxiv.  	
            make
              or commit to make any material capital
              expenditures;

          

    

    	xxv.  	
            pay,
              loan or advance any amount to, or sell, transfer or lease any properties
              or assets to, or enter into any agreement or arrangement with, any
              of its
              affiliates;

          

     

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

     

    	xxvi.  	
            guarantee
              any indebtedness for borrowed money or any other obligation of any
              other
              person;

          

    

    	xxvii.  	
            fail
              to keep in full force and effect insurance comparable in amount and
              scope
              to coverage maintained by it (or on behalf of it) on the date
              hereof;

          

    

    	xxviii.  	
            take
              any other action that would cause any of the representations and
              warranties made by it in this Agreement not to remain true and correct
              in
              all material aspect;

          

    

    	xxix.  	
            make
              any material loan, advance or capital contribution to or investment
              in any
              person;

          

    

    	xxx.  	
            make
              any material change in any method of accounting or accounting principle,
              method, estimate or practice;

          

    

    	xxxi.  	
            settle,
              release or forgive any claim or litigation or waive any
              right;

          

    

    	xxxii.  	
            commit
              itself to do any of the foregoing.

          

     

    Section
      4.2 Access
      to Properties and Records.
      SHI
      shall afford WCCC’s accountants, counsel and authorized representatives, and
      WCCC shall afford to SHI's accountants, counsel and authorized representatives
      full access during normal business hours throughout the period prior to the
      Closing Date (or the earlier termination of this Agreement) to all of such
      parties’ properties, books, contracts, commitments and records and, during such
      period, shall furnish promptly to the requesting party all other information
      concerning the other party's business, properties and personnel as the
      requesting party may reasonably request, provided that no investigation or
      receipt of information pursuant to this Section 4.2 shall affect any
      representation or warranty of or the conditions to the obligations of any party.
      

    

    
      
         

      

      
        13

        
          

        

      

      
         

      

    

    Section
      4.3 Negotiations.
      From
      and after the date hereof until the earlier of the Closing or the termination
      of
      this Agreement, no party to this Agreement nor its officers or directors
      (subject to such director's fiduciary duties) nor anyone acting on behalf of
      any
      party or other persons shall, directly or indirectly, encourage, solicit, engage
      in discussions or negotiations with, or provide any information to, any person,
      firm, or other entity or group concerning any merger, sale of substantial
      assets, purchase or sale of shares of capital stock or similar transaction
      involving any party. A party shall promptly communicate to any other party
      any
      inquiries or communications concerning any such transaction which they may
      receive or of which they may become aware of.

    

    Section
      4.4 Consents
      and Approvals.
      The
      parties shall:

    

    	i.  	
            use
              their reasonable commercial efforts to obtain all necessary consents,
              waivers, authorizations and approvals of all governmental and regulatory
              authorities, domestic and foreign, and of all other persons, firms
              or
              corporations required in connection with the execution, delivery and
              performance by them of this Agreement; and

          

    

    	ii.  	
            diligently
              assist and cooperate with each party in preparing and filing all documents
              required to be submitted by a party to any governmental or regulatory
              authority, domestic or foreign, in connection with such transactions
              and
              in obtaining any governmental consents, waivers, authorizations or
              approvals which may be required to be obtained connection in with such
              transactions.

          

    

    Section
      4.5 Public
      Announcement.
      Unless
      otherwise required by applicable law, the parties hereto shall consult with
      each
      other before issuing any press release or otherwise making any public statements
      with respect to this Agreement and shall not issue any such press release or
      make any such public statement prior to such consultation.

    

    Section
      4.6 Stock
      Issuance.
      From
      and after the date of this Agreement until the Closing Date, none of WCCC,
      SHI
      nor Shengtai shall issue any additional shares of its capital stock.

    

    Section
      4.7 Notwithstanding
      anything to the contrary contained herein, it is herewith understood and agreed
      that both SHI and WCCC may enter into and conclude agreements and/or financing
      transactions as same relate to and/or are contemplated by any separate written
      agreements either: (a) annexed hereto as exhibits; or (b) entered into by WCCC
      with SHI executed by both parties subsequent to the date hereof. These
      Agreements shall become, immediately upon execution, part of this Agreement
      and
      subject to all warranties, representations and conditions contained
      herein.

    

    
      
         

      

      
        14

        
          

        

      

      
         

      

    

    

    ARTICLE
      V

    

    CONDITIONS
      TO OBLIGATIONS OF SHI AND SHAREHOLDERS

    

    The
      obligations of SHI and the SHAREHOLDERS to consummate the transactions
      contemplated by this Agreement are subject to the fulfillment, at or before
      the
      Closing Date, of the following conditions, any one or more of which may be
      waived by both SHI and the SHAREHOLDERS in their sole discretion:

    

    Section
      5.1 Representations
      and Warranties of WCCC and Tryant.
      All
      representations and warranties made by WCCC and Tryant in this Agreement shall
      be true and correct on and as of the Closing Date as if again made by WCCC
      as of
      such date. 

    

    Section
      5.2 Agreements
      and Covenants.
      WCCC
      shall have performed and complied in all material respects to all agreements
      and
      covenants required by this Agreement to be performed or complied with by it
      on
      or prior to the Closing Date. 

    

    Section
      5.3 Consents
      and Approvals.
      Consents, waivers, authorizations and approvals of any governmental or
      regulatory authority, domestic or foreign, and of any other person, firm or
      corporation, required in connection with the execution, delivery and performance
      of this Agreement shall be in full force and effect on the Closing
      Date.

    

    Section
      5.4 No
      Violation of Orders.
      No
      preliminary or permanent injunction or other order issued by any court or
      governmental or regulatory authority, domestic or foreign, nor any statute,
      rule, regulation, decree or executive order promulgated or enacted by any
      government or governmental or regulatory authority, which declares this
      Agreement invalid in any respect or prevents the consummation of the
      transactions contemplated hereby, or which materially and adversely affects
      the
      assets, properties, operations, prospects, net income or financial condition
      of
      WCCC shall be in effect; and no action or proceeding before any court or
      governmental or regulatory authority, domestic or foreign, shall have been
      instituted or threatened by any government or governmental or regulatory
      authority, domestic or foreign, or by any other person, or entity which seeks
      to
      prevent or delay the consummation of the transactions contemplated by this
      Agreement or which challenges the validity or enforceability of this
      Agreement.

    

    Section
      5.5 Other
      Closing Documents.
      SHI
      shall have received such other certificates, instruments and documents in
      confirmation of the representations and warranties of WCCC and Tryant or in
      furtherance of the transactions contemplated by this Agreement as SHI or its
      counsel may reasonably request.

    

    Section
      5.6 Additional
      Funding.
      SHI
      shall have obtained written commitments to invest a minimum of $15,000,000
      in
      the aggregate from third party investor(s) to further the business objectives
      of
      Shengtai, which commitment may close either before or after Closing
      Date.

     

    Section
      5.7 WCCC
      Shareholding.
      Chinamerica Fund, LP and/or its designees shall have consummated the sale and
      purchase of and be the beneficial shareholder of 600,000 shares of common stock
      of WCCC.

    

    
      
         

      

      
        15

        
          

        

      

      
         

      

    

     

    ARTICLE
      VI

     

    CONDITIONS
      TO OBLIGATIONS OF WCCC

    

    The
      obligations of WCCC to consummate the transactions contemplated by this
      Agreement are subject to the fulfillment, at or before the Closing Date, of
      the
      following conditions, any one or more of which may be waived by WCCC in its
      sole
      discretion:

    

    Section
      6.1 Representations
      and Warranties of SHI and SHAREHOLDERS.
      All
      representations and warranties made by SHI and SHAREHOLDERS in this Agreement
      shall be true and correct on and as of the Closing Date as if again made by
      SHI
      on and as of such date. 

    

    Section
      6.2 Agreements
      and Covenants.
      SHI and
      SHAREHOLDERS shall have performed and complied in all material respects to
      all
      agreements and covenants required by this Agreement to be performed or complied
      with by it on or prior to the Closing Date. 

    

    Section
      6.3 Consents
      and Approvals.
      All
      consents, waivers, authorizations and approvals of any governmental or
      regulatory authority, domestic or foreign, and of any other person, firm or
      corporation, required in connection with the execution, delivery and performance
      of this Agreement, shall have been duly obtained and shall be in full force
      and
      effect on the Closing Date. 

    

    Section
      6.4 No
      Violation of Orders.
      No
      preliminary or permanent injunction or other order issued by any court or other
      governmental or regulatory authority, domestic or foreign, nor any statute,
      rule, regulation, decree or executive order promulgated or enacted by any
      government or governmental or regulatory authority, domestic or foreign, that
      declares this Agreement invalid or unenforceable in any respect or which
      prevents the consummation of the transactions contemplated hereby, or which
      materially and adversely affects the assets, properties, operations, prospects,
      net income or financial condition of SHI or Shengtai, taken as a whole, shall
      be
      in effect; and no action or proceeding before any court or government or
      regulatory authority, domestic or foreign, shall have been instituted or
      threatened by any government or governmental or regulatory authority, domestic
      or foreign, or by any other person, or entity which seeks to prevent or delay
      the consummation of the transactions contemplated by this Agreement or which
      challenges the validity or enforceability of this Agreement.

    

    Section
      6.5. Other
      Closing Documents.
      WCCC
      shall have received such other certificates, instruments and documents in
      confirmation of the representations and warranties of SHI or in furtherance
      of
      the transactions contemplated by this Agreement as WCCC or its counsel may
      reasonably request.

    

    
      
         

      

      
        16

        
          

        

      

      
         

      

    

     

    ARTICLE
      VII

     

    TERMINATION
      AND ABANDONMENT

    

    SECTION
      7.1 Methods
      of Termination.
      This
      Agreement may be terminated and the transactions contemplated hereby may be
      abandoned at any time before the Closing:

    

    a. By
      the
      mutual written consent of SHAREHOLDERS, SHI, Tryant and WCCC;

    

    b.  By
      WCCC,
      upon a material breach of any representation, warranty, covenant or agreement
      on
      the part of SHI or the SHAREHOLDERS set forth in this Agreement, or if any
      representation or warranty of SHI or the SHAREHOLDERS shall become untrue,
      in
      either case such that any of the conditions set forth in Article VI hereof
      would
      not be satisfied (a "SHI
      Breach"),
      and
      such breach shall, if capable of cure, has not been cured within ten (10) days
      after receipt by the party in breach of a notice from the non-breaching party
      setting forth in detail the nature of such breach;

    

    c.  By
      SHI,
      upon a material breach of any representation, warranty, covenant or agreement
      on
      the part of WCCC set forth in this Agreement, or, if any representation or
      warranty of WCCC shall become untrue, in either case such that any of the
      conditions set forth in Article V hereof would not be satisfied (a "WCCC
      Breach"),
      and
      such breach shall, if capable of cure, not have been cured within ten (10)
      days
      after receipt by the party in breach of a written notice from the non-breaching
      party setting forth in detail the nature of such breach;

    

    d.  By
      either
      WCCC or SHI, if the Closing shall not have consummated before ninety (90) days
      after the date hereof; provided, however, that this Agreement may be extended
      by
      written notice of either SHI or WCCC, if the Closing shall not have been
      consummated as a result of WCCC or SHI having failed to receive all required
      regulatory approvals or consents with respect to this transaction or as the
      result of the entering of an order as described in this Agreement; and further
      provided, however, that the right to terminate this Agreement under this Section
      7.1(d) shall not be available to any party whose failure to fulfill any
      obligations under this Agreement has been the cause of, or resulted in, the
      failure of the Closing to occur on or before this date.

    

    e.  By
      either
      SHI or WCCC if a court of competent jurisdiction or governmental, regulatory
      or
      administrative agency or commission shall have issued an order, decree or ruling
      or taken any other action (which order, decree or ruling the parties hereto
      shall use its best efforts to lift), which permanently restrains, enjoins or
      otherwise prohibits the transactions contemplated by this
      Agreement.

     

    
      
         

      

      
        17

        
          

        

      

      
         

      

    

     

    Section
      7.2 Procedure
      Upon Termination.
      In the
      event of termination and abandonment of this Agreement by SHI or WCCC pursuant
      to Section 7.1, written notice thereof shall forthwith be given to the other
      parties and this Agreement shall terminate and the transactions contemplated
      hereby shall be abandoned, without further action. If this Agreement is
      terminated as provided herein, no party to this Agreement shall have any
      liability or further obligation to any other party to this Agreement; provided,
      however, that no termination of this Agreement pursuant to this Article VII
      shall relieve any party of liability for a breach of any provision of this
      Agreement occurring before such termination.

     

    ARTICLE
      VIII

    

    POST-CLOSING
      AGREEMENTS

    

    Section
      8.1 Consistency
      in Reporting.
      Each
      party hereto agrees that if the characterization of any transaction contemplated
      in this agreement or any ancillary or collateral transaction is challenged,
      each
      party hereto will testify, affirm and ratify that the characterization
      contemplated in such agreement was the characterization intended by the party;
      provided, however, that nothing herein shall be construed as giving rise to
      any
      obligation if the reporting position is determined to be incorrect by final
      decision of a court of competent jurisdiction.

     

    ARTICLE
      IX

    

    MISCELLANEOUS
      PROVISIONS

    

    Section
      9.1 Survival
      of Provisions.
      The
      respective representations, warranties, covenants and agreements of each of
      the
      parties to this Agreement (except covenants and agreements which are expressly
      required to be performed and are performed in full on or before the Closing
      Date) shall survive the Closing Date and the consummation of the transactions
      contemplated by this Agreement, subject to Sections 2.14, 3.9 and 9.1. In the
      event of a breach of any of such representations, warranties or covenants,
      the
      party to whom such representations, warranties or covenants have been made
      shall
      have all rights and remedies for such breach available to it under the
      provisions of this Agreement or otherwise, whether at law or in equity,
      regardless of any disclosure to, or investigation made by or on behalf of such
      party on or before the Closing Date. Notwithstanding the foregoing, each party’s
      liability to the other for breach of any representation, warranty or covenant
      shall not exceed, in the aggregate, $500,000.

    

    Section
      9.2 Publicity.
      No
      party shall cause the publication of any press release or other announcement
      with respect to this Agreement or the transactions contemplated hereby without
      the consent of the other parties, unless a press release or announcement is
      required by law. If any such announcement or other disclosure is required by
      law, the disclosing party agrees to give the non-disclosing parties prior notice
      and an opportunity to comment on the proposed disclosure.

     

    
      
         

      

      
        18

        
          

        

      

      
         

      

    

     

    Section
      9.3 Successors
      and Assigns.
      This
      Agreement shall inure to the benefit of, and be binding upon, the parties hereto
      and their respective successors and assigns; provided, however, that no party
      shall assign or delegate any of the obligations created under this Agreement
      without the prior written consent of the other parties. 

    

    Section
      9.4 Fees
      and Expenses.
      Except
      as otherwise expressly provided in this Agreement, all legal and other fees,
      costs and expenses incurred in connection with this Agreement and the
      transactions contemplated hereby shall be paid by the party incurring such
      fees,
      costs or expenses. 

    

    Section
      9.5 Notices.
      All
      notices and other communications given or made pursuant hereto shall be in
      writing and shall be deemed to have been given or made if in writing and
      delivered personally or sent by registered or certified mail (postage prepaid,
      return receipt requested) to the parties at the following addresses:

    

    If
      to SHI
      or the SHAREHOLDERS, to:

    

    Shengtai
      Holding Inc.

    45
      Old
      Millstone Drive, Unit 6,

    East
      Windsor, NJ 08520

    Attn:
      Mr.
      Qingtai Liu/ Mr. Chenghai Du

    

    with
      a
      copy to:

    

    Guzov
      Ofsink, LLC

    600
      Madison Avenue, 14th
      Floor

    New
      York,
      New York 10022

    Attn:
      Darren Ofsink, Esq.

    Fax:
      212-688-7273

    

    If
      to
      WCCC, to:

    

    1608
      West
      2225 South 

    Woods
      Cross, UT 84087

    Attn:
       Daniel
      D.
      Drummond

    Fax: (760)
      454-1643

    

    with
      a
      copy to:

    

    Cletha
      Walstrand, Esquire

    1322
      West
      Pachua Circle

    Ivins,
      UT
      84738

    Fax: (435)
      688-7318 

     

    
      
         

      

      
        19

        
          

        

      

      
         

      

    

     

    If
      to
      Tryant, to:

    

    1608
      West
      2225 South

    Woods
      Cross, UT 84087 

    Attn:
       Alexander
      S. Ferries 

    Fax:
       (760)
      454-1643

    

    or
      to
      such other persons or at such other addresses as shall be furnished by any
      party
      by like notice to the others, and such notice or communication shall be deemed
      to have been given or made as of the date so delivered or mailed. No change
      in
      any of such addresses shall be effective insofar as notices under this Section
      9.5 are concerned unless such changed address is located in the United States
      of
      America and notice of such change shall have been given to such other party
      hereto as provided in this Section 9.5

    

    Section
      9.6 Entire
      Agreement.
      This
      Agreement, together with the exhibits hereto, represents the entire agreement
      and understanding of the parties with reference to the transactions set forth
      herein and no representations or warranties have been made in connection with
      this Agreement other than those expressly set forth herein or in the exhibits,
      certificates and other documents delivered in accordance herewith. This
      Agreement supersedes all prior negotiations, discussions, correspondence,
      communications, understandings and agreements between the parties relating
      to
      the subject matter of this Agreement and all prior drafts of this Agreement,
      all
      of which are merged into this Agreement. No prior drafts of this Agreement
      and
      no words or phrases from any such prior drafts shall be admissible into evidence
      in any action or suit involving this Agreement.

    

    Section
      9.7 Severability.
      This
      Agreement shall be deemed severable, and the invalidity or unenforceability
      of
      any term or provision hereof shall not affect the validity or enforceability
      of
      this Agreement or of any other term or provision hereof. Furthermore, in lieu
      of
      any such invalid or unenforceable term or provision, the parties hereto intend
      that there shall be added as a part of this Agreement a provision as similar
      in
      terms to such invalid or unenforceable provision as may be possible so as to
      be
      valid and enforceable.

    

    Section
      9.8 Titles
      and Headings.
      The
      Article and Section headings contained in this Agreement are solely for
      convenience of reference and shall not affect the meaning or interpretation
      of
      this Agreement or of any term or provision hereof.

    

    Section
      9.9 Counterparts. This
      Agreement may be executed in two or more counterparts, each of which shall
      be
      deemed an original and all of which together shall be considered one and the
      same agreement.

    

    Section
      9.10 Convenience
      of Forum; Consent to Jurisdiction.
      The
      parties to this Agreement, acting for themselves and for their respective
      successors and assigns, without regard to domicile, citizenship or residence,
      hereby expressly and irrevocably elect as the sole judicial forum for the
      adjudication of any matters arising under or in connection with this Agreement,
      and consent and subject themselves to the jurisdiction of, the courts of the
      State of New York located in County of New York, and/or the United States
      District Court for the Southern District of New York, in respect of any matter
      arising under this Agreement. Service of process, notices and demands of such
      courts may be made upon any party to this Agreement by personal service at
      any
      place where it may be found or giving notice to such party as provided in
      Section 9.5.

     

    
      
         

      

      
        20

        
          

        

      

      
         

      

    

     

    Section
      9.11 Enforcement
      of the Agreement.
      The
      parties hereto agree that irreparable damage would occur if any of the
      provisions of this Agreement were not performed in accordance with their
      specific terms or were otherwise breached. It is accordingly agreed that the
      parties shall be entitled to an injunction or injunctions to prevent breaches
      of
      this Agreement and to enforce specifically the terms and provisions hereto,
      this
      being in addition to any other remedy to which they are entitled at law or
      in
      equity.

    

    Section
      9.12 Governing
      Law.
      This
      Agreement shall be governed by and interpreted and enforced in accordance with
      the laws of the State of New York without giving effect to the choice of law
      provisions thereof.

    

    Section
      9.13 Amendments
      and Waivers.
      No
      amendment of any provision of this Agreement shall be valid unless the same
      shall be in writing and signed by all of the parties hereto.. No waiver by
      any
      party of any default, misrepresentation, or breach of warranty or covenant
      hereunder, whether intentional or not, shall be deemed to extend to any prior
      or
      subsequent default, misrepresentation, or breach of warranty or covenant
      hereunder or affect in any way any rights arising by virtue of any prior or
      subsequent such occurrence.

     

    IN
      WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
      date
      first above written.

    
      	 	 	 	 	 
	
              SHENGTAI
                HOLDING, INC. 

            	 	 	 
	 	 	 	 	 
	By: 	/s/
              Qingtai
              Liu	 	 	
            
	 	
              

              Qingtai
                Liu

            	 	 	
            
	Title:  	
              Chief
                Executive Officer

            	 	 	
            

      	 	 	 	 	 
	
              WEST
                COAST CAR COMPANY 

            	 	 	 
	 	 	 	 	 
	By: 	 /s/
              Daniel Drummond	 	 	
            
	
              Title:

            	
              
 Acting
              President	 	 	
            

    

     

    
      
         

      

      
        21

        
          

        

      

      
         

      

    

     

    
      	 	 	 	 
	
              SHAREHOLDERS: 

            	 	 	 
	 	 	 	 
	/s/
              Qingtai Liu	 	 	
            
	
              
Qingtai
              Liu	 	 	
            

    

    
      	 	 	 	 
	/s/
              Chenghai
              Du	 	 	
            
	
              

              Chenghai
                Du

            	 	 	
            

    

    
      	 	 	 	 	 
	TRYANT,
              LLC 	 	 	 
	 	 	 	 	 
	By: 	 /s/
              Jeff Jenson	 	 	
            
	 	
              

            	 	 	
            
	Title:	
            	 	 	
            
	 	
              
 	 	 	 

    

     

    
      
         

      

      
        22

        
          

        

      

      
         

      

    

     

    EXHIBIT
      A

    

      
        	
                Name

              	 	
                Number
                  of SHI Shares

              	 	
                Number
                  of WCCC Shares

              
	
                of
                  SHAREHOLDER

              	 	
                Being
                  Exchanged

              	 	
                to
                  be Received

              
	 	 	 	 	 
	 	 	 	 	 
	
                Qingtai
                  Liu

              	 	
                90

              	 	
                8,212,570

              
	 	 	 	 	 
	
                Chenghai
                  Du

              	 	
                10

              	 	
                912,530

              

      

    

    

    
      
         

      

      
        23

        
          

        

      

      
         

      

    

     

    Exhibit
      B

    

      
        	
                WCCC
                  Shareholders

              	 	
                
                  Number
                    of Shares of

                  Common
                    Stock

                

              	 
	 	 	 	 
	
                Tryant
                  LLC and remaining shareholders

              	 	 	
                400,000

              	 
	 	 	 	 	 
	
                Chinamerica
                  Fund LP

              	 	 	
                600,000

              	 

      

    

     

    
      
         

      

      
        24EXHIBIT
      10.2

    

    STOCK
      PURCHASE AGREEMENT

    

    West
      Coast Car Company

    c/o
      Weifang Shengtai Pharmaceutical Co., Ltd. 

    Hi-Tech
      Industrial Park of Changle County,

    Shandong
      Province,

    People’s
      Republic of China 262400

    

    Ladies
      and Gentlemen: 

    

    The
      undersigned (the “Investor”) hereby confirms its agreement with you, in
      accordance with and pursuant to the Terms and Conditions for Purchase of
      Securities (the “Terms and Conditions”) set forth in Annex I, together with the
      Exhibits thereto, and the Investor Questionnaire as set forth in Annex II,
      each
      of which is attached hereto and incorporated herein by reference, as
      follows:

    

    1. This
      Stock Purchase Agreement (the “Stock Purchase Agreement”) is made as of the date
      set forth below among West Coast Car Company, a Delaware corporation (the
“Company”), and the Investor.

     

    2. The
      Company has authorized the sale and issuance of up to 8,750,000 shares (the
      “Securities”) of common stock of the Company, par value US$0.001 per share (the
“Common Stock”) with .5 attached warrants to purchase Common Stock per share of
      Common Stock which are exercisable at $2.60 per share for a period of five
      years
      (each full warrant a “Warrant”), in a private placement (the “Offering”) to
      certain accredited investors in the United States and elsewhere in reliance
      upon
      available exemptions from the U.S. Securities Act of 1933, as amended (the
      “Securities Act”).

     

    3. The
      Company and the Investor agree that the Investor will purchase from the Company
      the following number of shares of Common Stock, for a purchase price of US$2.00
      per share and attached .5 Warrants (the “Purchase Price”), pursuant to the Terms
      and Conditions. Unless otherwise requested by the Investor, certificates
      representing the Securities purchased by the Investor will be registered in
      the
      Investor’s name and address as set forth below.

    

    Number
      of
      Shares:____________________________

    

    Number
      of
      Warrants (number of shares multiplied by
      50%):____________________________

    

    Purchase
      Price (number of Shares multiplied by
      US$2.00):_____________________________

    

    Please
      initial below to indicate agreement to purchase the number of shares and
      Warrants:

     

    ____________________

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    4. The
      Investor represents that, except as set forth below, (a) it has had no position,
      office or other material relationship within the past three years with the
      Company or persons known to it to be affiliates of the Company, (b) neither
      it,
      nor any group of which it is a member or to which it is related, beneficially
      owns (including the right to acquire or vote) any securities of the Company
      and
      (c) it is not a Registered Representative at a NASD member firm and has no
      direct or indirect affiliation or association with any NASD member firm as
      of
      the date hereof. Exceptions:

    

    ______________________________________________________________________________

    ______________________________________________________________________________

    

    (If
      no
      exceptions, write “none.” If left blank, response will be deemed to be
“none.”)

    

    Please
      confirm that the foregoing correctly sets forth the agreement between us by
      signing in the space provided below for that purpose. By executing this
      Agreement, you acknowledge that the Company may use the information in
      paragraphs 3 and 4 above and the name and address information below in
      preparation of the Registration Statement (as defined in Annex I).

    

    Dated
      as
      of May 15, 2007

    

    AGREED
      AND ACCEPTED: 

    

    
      	
              West
                Coast Car Company

            	
              Investor:
                _____________________________

            
	 	 
	 	
              By:
                __________________________________

            
	 	 
	
              /s/Qingtai
                Liu

            	
              Print
                Name: ___________________________

            
	
              
                

              

              By:
                Qingtai Liu

            	 
	
              Title:
                President and CEO

            	
              Title:
                ________________________________

            
	 	 
	 	
              Address:
                ______________________________

            
	 	 
	 	
              _____________________________________

            
	 	 
	 	
              Tax
                ID No. ___________________________

            
	 	 
	 	
              Contact
                name: _________________________

            
	 	 
	 	
              Telephone:
                ____________________________

            
	 	 
	 	
              Name
                in which shares should be registered (if different):

            
	 	 
	 	
              _____________________________________

            

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    ANNEX
      I

    

    TERMS
      AND CONDITIONS FOR PURCHASE OF SECURITIES

    

    1. Authorization
      and Sale of the Securities.
      Subject
      to these Terms and Conditions, the Company has authorized the issuance and
      sale
      of up to 8,750,000 shares
      of
      its Common Stock and up to 4,375,000 Warrants (collectively, the “Securities”)
      in the Offering. 

    

    2. Agreement
      to Sell and Purchase the Securities; Subscription Date.

    

    2.1 At
      the
      Closing (as defined in Section 3), the Company will issue and sell to the
      Investor, and the Investor will purchase from the Company upon the terms and
      conditions hereinafter set forth, the number of Securities set forth in
      paragraph 3 of the Stock Purchase Agreement to which these Terms and Conditions
      are attached at the purchase price set forth thereon (collectively, the
“Agreement”).

    

    2.2 As
      part
      of the Offering, the Company may enter into the same form of Stock Purchase
      Agreement, including these Terms and Conditions, with certain other investors
      (the “Other Investors”) and complete sales of Securities to them. The Investor
      and the Other Investors are hereinafter sometimes collectively referred to
      as
      the “Investors,” and this Agreement and the Stock Purchase Agreements (including
      the Terms and Conditions) executed by the Other Investors are hereinafter
      sometimes collectively referred to as the “Agreements.” The Company may accept
      executed Agreements from Investors for the purchase of Securities until the
      date
      (the “Subscription Date”) on which the Company has (i) executed Agreements
      with Investors for the purchase all of the Securities, and (ii) notified
      Hickey Freihofner Capital, a division of Brill Securities, Inc, Member
      NASD/MSRB/SIPC, in its capacity as U.S. placement agent for the Offering (the
      “U.S. Placement Agent”), in writing, that it will no longer accept Agreements
      from Investors for the purchase of Securities in the Offering, but in no event
      shall the Subscription Date be later than May 7, 2007, or such earlier date
      as
      the Company has received $15 million in escrow. Each Investor must complete
      a
      Stock Purchase Agreement and an Investor Questionnaire (in the form attached
      as
      Annex II to the Stock Purchase Agreement) in order to purchase Securities in
      the
      Offering.

     

    2.3 The
      Investor acknowledges that the Company intends to pay through Brill Securities,
      Inc. to the placement agents in the Offering as follows: Brill Securities,
      Inc.,
      and the Company’s foreign finder, shall each receive 5% of the gross proceeds of
      the Offering, an additional 1% for non-accountable expenses and a number of
      Warrants equal to 1.25% of the number of shares of Common Stock sold in the
      Offering. 

     

    3. Delivery
      of the Securities at Closing.

     

    3.1 The
      completion of the purchase and sale of the Securities (the “Closing”) shall
      occur (the “Closing Date”) on or about May 7, 2007, or such earlier date as the
      Company has received $15 million in escrow, at the offices of the Company’s
      counsel. At the Closing, the Company shall deliver to the Investor, or make
      arrangements to deposit with an overnight courier for next day delivery to
      the
      Investor, one or more stock and Warrant certificates (in the form of Exhibit
      G
      annexed hereto) representing the number of Securities set forth in paragraph
      4
      of the Stock Purchase Agreement, each such certificate to be registered in
      the
      name of the Investor or, if so indicated on the signature page of the Stock
      Purchase Agreement, in the name of a nominee designated by the Investor.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    3.2 The
      obligation of the Company to issue the Securities to the Investor shall be
      subject to the following conditions, any one or more of which may be waived
      by
      the Company: (a) receipt by the Company of a certified or official bank check
      or
      wire transfer of funds in the full amount of the purchase price for the
      Securities being purchased hereunder as set forth in paragraph 3 of the Stock
      Purchase Agreement; (b) receipt of executed Agreements from Investors
      purchasing an aggregate investment in the Common Stock of no less than US$15
      million, (c) completion of the purchases and sales under the Agreements with
      the
      Other Investors; (d) the accuracy of the representations and warranties made
      by
      the Investors and the fulfillment of those undertakings of the Investors to
      be
      fulfilled prior to the Closing; and (e) the absence of any threat of or pending
      legal action, suit or proceeding which seeks to restrain or prohibit the
      transactions contemplated by the Agreements.

    

    3.3 The
      Investor’s obligation to purchase the Securities shall be subject to the
      following conditions, any one or more of which may be waived by the Investor:
      (a) Investors shall have executed Agreements for the purchase of Securities
      so
      as to constitute an aggregate investment in the Common Stock of no less than
      US$15 million; (b) the representations and warranties of the Company set forth
      herein shall be true and correct as of the Closing Date in all material respects
      (except for representations and warranties that speak as of a specific date,
      which representations and warranties shall be true and correct as of such date);
      (c) the Investor shall have received such documents as such Investor shall
      reasonably have requested, including, a standard opinion of Company Counsel
      as
      to the matters set forth in Section 4.2 and as to exemption from the
      registration requirements of the Securities Act of 1933, as amended (the
“Securities Act”), of the offer and sale of the Securities; (d) the absence of
      any threat of or pending legal action, suit or proceeding which seeks to
      restrain or prohibit the transactions contemplated by the Agreements; (e) the
      U.S. Placement Agent shall agree to refrain from selling or transferring shares
      beneficially owned by it prior to the date of this Agreement or received as
      compensation in accordance with Section 2.3 hereof for such period and in such
      form as may be agreed with the Company; (f) the Limited Standstill Agreements,
      substantially in the form attached hereto as Exhibit B, shall be executed and
      delivered by each of the Company’s directors and executive officers; (g) the
      Company shall have consummated a share exchange with Shengtai Holding, Inc.
      pursuant to which it has acquired all the issued and outstanding shares of
      common stock of Shengtai Holding, Inc. making is a wholly owned subsidiary
      of
      the Company , and Shengtai Holding, Inc. shall have no other securities issued
      and outstanding and shall have no obligation or agreement to issue securities
      other than to the Company; and (h) as of the Closing Date, Shengtai Holding,
      Inc. shall own all of the issued and outstanding shares of common stock or
      other
      equity interest in Weifang Shengtai Pharmaceutical Co., Ltd., also known as
      Weifang Shengtai Medicine Co., Ltd.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4. Representations,
      Warranties and Covenants of the Company.
      The
      Company hereby represents and warrants to, and covenants with, the Investor,
      as
      follows:

     

    4.1 Organization.
      The
      Company is duly organized and validly existing in good standing under the laws
      of the jurisdiction of its organization. Each of the Company and its
      Subsidiaries (as defined in Rule 405 under the Securities Act) has full
      power and authority to own, operate and occupy its properties and to conduct
      its
      business as presently conducted and as described in the documents filed by
      the
      Company under the Securities Exchange Act of 1934, as amended (the “Exchange
      Act”), (the “Exchange Act Documents”), and is registered or qualified to do
      business and in good standing in each jurisdiction in which the nature of the
      business conducted by it or the location of the properties owned or leased
      by it
      requires such qualification and where the failure to be so qualified would
      have
      a material adverse effect upon the condition (financial or otherwise), earnings,
      business or business prospects, properties or operations of the Company and
      its
      Subsidiaries, considered as one enterprise (a “Material Adverse Effect”), and no
      proceeding has been instituted in any such jurisdiction, revoking, limiting
      or
      curtailing, or seeking to revoke, limit or curtail, such power and authority
      or
      qualification. 

     

    4.2 Due
      Authorization and Valid Issuance.
      The
      Company has all requisite power and authority to execute, deliver and perform
      its obligations under the Agreements, and the Agreements have been duly
      authorized and validly executed and delivered by the Company and, assuming
      due
      authorization, execution and delivery by the Investors, constitute legal, valid
      and binding agreements of the Company enforceable against the Company in
      accordance with their terms, except as rights to indemnity and contribution
      may
      be limited by state or federal securities laws or the public policy underlying
      such laws, except as enforceability may be limited by applicable bankruptcy,
      insolvency, reorganization, moratorium or similar laws affecting creditors’ and
      contracting parties’ rights generally and except as enforceability may be
      subject to general principles of equity (regardless of whether such
      enforceability is considered in a proceeding in equity or at law). The
      Securities being purchased by the Investor hereunder, upon issuance and payment
      therefor pursuant to this Agreement, will be duly authorized, validly issued,
      fully-paid and non-assessable. 

     

    4.3 Non-Contravention.
      The
      execution and delivery of the Agreements, the issuance and sale of the
      Securities under the Agreements, the fulfillment of the terms of the Agreements
      and the consummation of the transactions contemplated thereby will not
      (A) conflict with or constitute a violation of, or default (with the
      passage of time or otherwise) under, (i) any material bond, debenture, note
      or other evidence of indebtedness, lease, contract, indenture, mortgage, deed
      of
      trust, loan agreement, joint venture or other agreement or instrument to which
      the Company or any Subsidiary is a party or by which it or any of its
      Subsidiaries or their respective properties are bound, (ii) the charter,
      by-laws or other organizational documents of the Company or any Subsidiary,
      or
      (iii) any law, administrative regulation, ordinance or order of any court
      or governmental agency, arbitration panel or authority applicable to the Company
      or any Subsidiary or their respective properties, except in the case of
      clauses (i) and (iii) for any such conflicts, violations or defaults which
      are not reasonably likely to have a Material Adverse Effect or (B) result
      in the creation or imposition of any lien, encumbrance, claim, security interest
      or restriction whatsoever upon any of the material properties or assets of
      the
      Company or any Subsidiary or an acceleration of indebtedness pursuant to any
      obligation, agreement or condition contained in any material bond, debenture,
      note or any other evidence of indebtedness or any material indenture, mortgage,
      deed of trust or any other agreement or instrument to which the Company or
      any
      Subsidiary is a party or by which any of them is bound or to which any of the
      material property or assets of the Company or any Subsidiary is subject. No
      consent, approval, authorization or other order of, or registration,
      qualification or filing with, any regulatory body, administrative agency, or
      other governmental body in the United States or any other person is required
      for
      the execution and delivery of the Agreements and the valid issuance and sale
      of
      the Securities to be sold pursuant to the Agreements, other than such as have
      been made or obtained, and except for any post-closing securities filings or
      notifications required to be made under federal or state securities
      laws.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.4 Capitalization.
      The
      Company is authorized to issue 100,000,000 shares of Common Stock, $.001 par
      value, and 5,000,000 shares of preferred stock, $.001 par value. On Closing
      Date, the Company shall have 1,000,000 shares of Common Stock issued and
      outstanding, shall have no other securities issued and outstanding and shall
      have no obligation or agreement to issue securities other than to Investors
      under the Stock Purchase Agreements for the purchase of Common Stock not
      exceeding 8,750,000 shares. The outstanding shares of capital stock of the
      Company have been duly and validly issued and are fully paid and nonassessable,
      have been issued in compliance with all federal and state securities laws,
      and
      were not issued in violation of any preemptive rights or similar rights to
      subscribe for or purchase securities. There are no outstanding rights
      (including, without limitation, preemptive rights), warrants or options to
      acquire, or instruments convertible into or exchangeable for, any unissued
      shares of capital stock or other equity interest in the Company or any
      Subsidiary, or any contract, commitment, agreement, understanding or arrangement
      of any kind to which the Company is a party or of which the Company has
      knowledge and relating to the issuance or sale of any capital stock of the
      Company or any Subsidiary, any such convertible or exchangeable securities
      or
      any such rights, warrants or options. The issue and sale of the Securities
      will
      not obligate the Company to issue shares of Common Stock or other securities
      to
      any person and will not result in a right of any holder of the Company’s
      securities to adjust the exercise, conversion, exchange or reset price under
      such securities. Without limiting the foregoing, no preemptive right, co-sale
      right, right of first refusal, registration right, or other similar right exists
      with respect to the Securities or the issuance and sale thereof. No further
      approval or authorization of any stockholder, the Board of Directors of the
      Company or others is required for the issuance and sale of the Securities.
      The
      Company owns the entire equity interest in each of its Subsidiaries, free and
      clear of any pledge, lien, security interest, encumbrance, claim or equitable
      interest. There are no stockholders agreements, voting agreements or other
      similar agreements with respect to the Common Stock to which the Company is
      a
      party or, to the knowledge of the Company, between or among any of the Company’s
      stockholders. 

     

    4.5 Legal
      Proceedings.
      There
      is no material legal or governmental proceeding pending or, to the knowledge
      of
      the Company, threatened to which the Company or any Subsidiary, or Shengtai
      Holdings, Inc. or Weifang Shengtai Pharmaceutical Co., Ltd. (collectively
“Shengtai”), is or may be a party or of which the business or property of the
      Company or any Subsidiary or Shengtai is subject that is not disclosed in the
      Exchange Act Documents.

     

    4.6 Financial
      Statements.
      The
      financial statements of the Weifang Shengtai Pharmaceutical Co., Ltd and its
      related notes attached hereto as Exhibit E (the “Financial Statements”) present
      fairly, in accordance with generally accepted accounting principles, the
      financial position of Weifang Shengtai Pharmaceutical Co., Ltd as of the dates
      indicated, and the results of its operations and cash flows for the periods
      therein specified consistent with its books and records. Such financial
      statements (including the related notes) have been prepared in accordance with
      generally accepted accounting principles applied on a consistent basis
      throughout the periods therein specified, except as may be disclosed in
      the
      notes to such financial statements, or in the case of unaudited statements,
      as
      may be permitted by the Securities and Exchange Commission (the “SEC”). The
      other financial information pertaining to Weifang Shengtai Pharmaceutical Co.,
      Ltd. has been prepared on a basis consistent with its financial
      statements.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.7 No
      Material Adverse Change.
      Except
      as disclosed in the Financial Statements, as of December 31, 2006, there has
      not
      been (i) any material adverse change in the financial condition or earnings
      of Weifang Shengtai Pharmaceutical Co., Ltd., (ii) any material adverse
      event affecting Weifang Shengtai Pharmaceutical Co., Ltd., (iii) any
      obligation, direct or contingent, that is material to Weifang Shengtai
      Pharmaceutical Co., Ltd, incurred by it, except obligations incurred in the
      ordinary course of business, (iv) any dividend or distribution of any kind
      declared, paid or made on the capital stock of Weifang Shengtai Pharmaceutical
      Co., Ltd, or (v) any loss or damage (whether or not insured) to the
      physical property of Weifang Shengtai Pharmaceutical Co., Ltd which has been
      sustained which has a Material Adverse Effect. As of December 31, 2006, there
      has not been (i) any material adverse change in the financial condition or
      earnings of Shengtai Holding, Inc., (ii) any material adverse event
      affecting Shengtai Holding, Inc., Ltd., (iii) any obligation, direct or
      contingent, that is material to Shengtai Holding, Inc., incurred by it, except
      obligations incurred in the ordinary course of business, (iv) any dividend
      or distribution of any kind declared, paid or made on the capital stock of
      Shengtai Holding, Inc., or (v) any loss or damage (whether or not insured)
      to the physical property of Shengtai Holding, Inc. which has been sustained
      which has a Material Adverse Effect.

     

    4.8 Reporting
      Status; Disclosure.
      The
      Company has filed in a timely manner all documents and reports that the Company
      was required to file under the Exchange Act during the twelve months preceding
      the date of this Agreement or has received a valid extension of such time of
      filing and has filed any such documents and reports prior to the expiration
      of
      any such extension. The Exchange Act Documents complied in all material respects
      with the applicable requirements of the SEC, including the rules and regulations
      promulgated under the Securities Act and the Exchange Act as required as of
      their respective filing dates and the information contained therein was
      accurate, true and complete in all material respects as of such filing date.
      The
      representations and warranties of the Company contained in this Section 4
      as of the date hereof and as of the Closing Date are accurate, true and complete
      in all material respects.

     

    4.9 No
      Manipulation of Stock.
      The
      Company has not taken and will not take any action designed to or that might
      reasonably be expected to cause or result in stabilization or manipulation
      of
      the price of the Common Stock to facilitate the sale or resale of the
      Securities.

     

    4.10 Company
      not an “Investment Company”.
      The
      Company is not, and as a result of the transactions contemplated by this
      Agreement will not be, an “investment company” or an entity “controlled” by an
“investment company” within the meaning of the Investment Company
      Act.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.11 Transactions
      with Affiliates and Employees.
      Except
      as set forth in the Exchange Act Documents, none of the officers or directors
      of
      the Company is a party to any transaction with the Company (other than for
      services as officers and directors), since the beginning of the current fiscal
      year in excess of $120,000 other than (a) payment of salary or consulting fees
      for services rendered, (b) reimbursement for expenses incurred or advances
      made
      on behalf of the Company, (c) interests arising solely as a shareholder of
      the
      Company or its subsidiaries, and (d) employee benefits, including stock option
      agreements under any stock option plan of the Company.

     

    None
      of
      the officers or directors of the Weifang Shengtai Pharmaceutical Co., Ltd.
      is a
      party to any transaction with the Weifang Shengtai Pharmaceutical Co., Ltd.
      (other than for services as officers and directors), since the beginning of
      the
      current fiscal year in excess of $120,000 other than (a) payment of salary
      or
      consulting fees for services rendered, (b) reimbursement for expenses incurred
      or advances made on behalf of the Weifang Shengtai Pharmaceutical Co., Ltd.,
      (c)
      interests arising solely as a shareholder of the Weifang Shengtai Pharmaceutical
      Co., Ltd. or its subsidiaries, and (d) employee benefits, including stock option
      agreements under any stock option plan of the Weifang Shengtai Pharmaceutical
      Co., Ltd.

     

    None
      of
      the officers or directors of the Shengtai Holding, Inc. is a party to any
      transaction with the Shengtai Holding, Inc. (other than for services as officers
      and directors), since the beginning of the current fiscal year in excess of
      $120,000 other than (a) payment of salary or consulting fees for services
      rendered, (b) reimbursement for expenses incurred or advances made on behalf
      of
      the Shengtai Holding, Inc., (c) interests arising solely as a shareholder of
      the
      Shengtai Holding, Inc. or its subsidiaries, and (d) employee benefits, including
      stock option agreements under any stock option plan of the Shengtai Holding,
      Inc.

    

    4.12 Accountants.
      To the
      Company’s knowledge, Moore Stephens Wurth Frazer and Torbet, LP are independent
      accountants as required by the Securities Act and the rules and regulations
      promulgated thereunder.

     

    4.13
      Taxes.
      The
      Company has filed all necessary federal, state and foreign income and franchise
      tax returns and has paid or accrued all taxes shown as due thereon, and the
      Company has no knowledge of a tax deficiency which has been or might be asserted
      or threatened against it which would have a Material Adverse Effect.

     

    4.14 Transfer
      Taxes.
      On the
      Closing Date, all stock transfer or other taxes (other than income taxes) which
      are required to be paid in connection with the sale and transfer of the
      Securities to be sold to the Investor hereunder will be, or will have been,
      fully paid or provided for by the Company and all laws imposing such taxes
      will
      be or will have been fully complied with.

     

    4.15 Private
      Offering.
      The
      Company has not distributed and will not distribute prior to the Closing Date
      any offering material in connection with this Offering and sale of the
      Securities other than the exhibits attached hereto and the corporate
      presentation containing certain financial projections which constitute material
      non-public information (the “Corporate Presentation”). The Company has not in
      the past nor will it hereafter take any action to sell, offer for sale or
      solicit offers to buy any securities of the Company which would bring the offer,
      issuance or sale of the Securities as contemplated by this Agreement, within
      the
      provisions of Section 5 of the Securities Act, unless such offer, issuance
      or
      sale was or shall be within the exemptions of Section 4 of the Securities Act
      and Regulation S promulgated thereunder. However, the Company shall not be
      restricted from the issuance of (i) equity securities issued or sold in
      connection with commercial or strategic partnership arrangements entered into
      for primarily non-equity financing purposes, (ii) equity securities issued
      on a
      pro rata basis to all holders of a class of outstanding equity securities of
      the
      Company as a result of a stock split or stock dividend, (iii) equity securities
      or options to acquire equity securities issued pursuant to employee stock
      option, purchase or similar equity-based stock incentive plans in effect as
      of
      the date of this Agreement, (iv) equity securities sold or otherwise disposed
      of
      pursuant to plans adopted in compliance with Rule 10b5-1 under the Exchange
      Act,
      and (v) equity securities issued in connection with acquisitions where such
      equity securities are issued by the Company as consideration to the purchaser
      in
      such acquisition. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.16 Limited
      Standstill.
      The
      Company will make available to the Investors on the Closing Date copies of
      the
      Limited Standstill Agreements, substantially in the form attached hereto as
      Exhibit B, executed by each of the Company’s directors, the Company’s President
      and the Company’s Chief Financial Officer (if applicable). The Company
      represents and warrants to the Investors that, as of the date of the Agreements,
      no other member of the Company’s management owns equity securities or securities
      or instruments convertible into or exchangeable for equity securities of the
      Company.

     

    4.17 Foreign
      Corrupt Practices; Anti Money Laundering.
      Neither
      the Company and its subsidiaries, nor to the knowledge of the Company or its
      subsidiaries as the case may be, any agent or other person acting on behalf
      of
      the Company or its subsidiaries, has violated in any material respect any
      provision of the Foreign Corrupt Practices Act of 1977, as amended, at any
      time
      the Company has been subject thereto. The operations of the Company and its
      subsidiaries are and have been conducted at all times in compliance with the
      money laundering statutes of applicable jurisdictions, the rules and regulations
      thereunder and any related or similar rules, regulations or guidelines, issued,
      administered or enforced by any applicable governmental authority (collectively,
      the “Money Laundering Laws”) and no action, suit or proceeding by or before any
      court or governmental authority or arbitrator involving the Company or its
      subsidiaries with respect to the Money Laundering Laws is pending or, to the
      Company’s knowledge, threatened.

    

    4.18 Acknowledgement
      Regarding Investors’ Purchase of Securities.
      The
      Company acknowledges and agrees that each of the Investors is acting solely
      in
      the capacity of an arm’s length purchaser with respect to the Agreements and the
      transactions contemplated thereby. The Company further represents to each
      Investor that the Company’s decision to enter into this Agreement has been based
      solely on the independent evaluation of the transactions contemplated hereby
      by
      the Company and its representations.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.19 Disclosure.
      Following the issuance of the press release and Current Report on Form 8-K
      in
      accordance with Section 10 hereof, the Investors will not, to the Company’s
      knowledge, possess any material non-public information concerning the Company.
      The Company acknowledges that the Investor is relying on the representations,
      acknowledgements and agreements made by the Company in this Section 4 and
      elsewhere in this Agreement in making decisions concerning an investment in
      the
      Company’s securities.

     

    5. Additional
      Covenants of the Company.

     

    5.1 Make
      Good Shares.
      The
      Company agrees cause Mr. Qingtai Liu to escrow with the Company’s transfer agent
      (or other escrow agent agreed to by the parties) to reserve for issuance on
      the
      Closing Date an aggregate of 5,000,000 shares of Common Stock then held by
      Mr.
      Liu or other members of management (the “Make Good Shares”) for issuance to
      Investors in accordance with the following:

     

    (a) If
      the
      Company’s net income for the fiscal year ending June 30, 2007, is less than US$7
      million, as set forth in the Company’s audited financial statements as filed
      with the SEC in the Company’s Annual Report on Form 10-K for the fiscal year
      ended June 30, 2007 (and any amendments thereto) or if such Annual Report is
      not
      prepared or filed with the SEC by the last date permissible under the Exchange
      Act and any applicable grace period under the rules of any exchange or
      inter-dealer quotation system on which the Company’s Common Stock is being
      traded or quoted (the “Penalty Date”), then the Company and Mr. Qingtai Liu
      shall provide to the Company’s Transfer Agent an instruction notice
      substantially in the form attached hereto as Exhibit A, with a copy to
      Investors, to transfer 2,500,000 Make Good Shares from escrow to the Investors
      on a pro-rata basis; provided, however, that if no Make Good Shares are to
      be
      transferred pursuant to this Section 5.1(a), then such shares shall continue
      to
      be held in escrow , if required, in accordance with Section 5.1(b)
      below;

     

    (b) If
      the
      Company’s net income for the fiscal year ending June 30, 2008, is less than US$9
      million, as set forth in the Company’s audited financial statements as filed
      with the SEC in the Company’s Annual Report on Form 10-K for the fiscal year
      ended June 30, 2008 (and any amendments thereto) or if such Annual Report is
      not
      prepared or filed with the SEC by the Penalty Date, then the Company and Mr.
      Qingtai Liu shall provide to the Company’s Transfer Agent an instruction notice
      substantially in the form attached hereto as Exhibit A, with a copy to
      Investors, to transfer 2,500,000 Make Good Shares to the Investors on a pro-rata
      basis.

     

    (c) In
      the
      event that liquidated damages are required to be paid to Investors as set forth
      in Section 8.1 below in connection with a Registration Default (as defined
      below), then, prior to the determination required under Section 5.1(a) and
      (b)
      above, the amount of any such liquidated damages required to be paid pursuant
      to
      Section 8.1 shall be deducted from the required net income amount set forth
      in
      Section 5.1 (a) and (b) above with respect to the fiscal year in which such
      liquidated damages are paid. 

     

    (d) No
      portion of the Make Good Shares may be transferred to Investors or registered
      for resale prior to the Penalty Date for fiscal year ended June 30, 2007 or,
      if
      later, thirty (30) days after the effective date of the Registration Statement
      for the Securities sold in the Offering, provided that, if the Registration
      Statement has not been declared effective by the Relevant Effective Date defined
      in Section 8.1, all Make Goods Shares required to be transferred to Investors
      as
      of that date shall be transferred to the Investors on such date.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (e) Each
      certificate evidencing a Make Good Share shall be dated June 30 of the relevant
      year and shall be deemed transferred to the appropriate Investor as of such
      date. 

     

    5.2 Right
      of First Refusal.
      From
      the Closing Date and continuing for the longer of (a) a period of one (1) year
      following the effective date of the Initial Registration Statement (as defined
      in Section 8.1 below) covering the resale of the Securities, or (b) two years
      following the Closing Date, the Company shall give the Investors the right
      of
      first refusal on any future placement or offering of any debt or equity
      securities (the “Future Securities”) to a proposed third party purchaser.

    

    The
      Company shall, not less than fifteen (15) business days prior to the
      consummation of such issuance or sale, offer such Future Securities to the
      Investors by sending written notice (an “Issuance Notice”) to the Investors,
      which shall state (a)
      the
      identity of the proposed third party purchaser, (b) a description of the Future
      Securities to be issued or sold, including detailed terms of such securities,
      (c) the amount of the Future Securities proposed to be issued to the proposed
      third party purchaser (the “Offered New Securities”); (d) the proposed purchase
      price for the Offered Securities (the “Issuance Price”); and (e) the terms and
      conditions of such proposed sale. 

     

    The
      Issuance Notice shall also certify that the Company has received a firm offer
      from the proposed third party purchaser and in good faith believes a binding
      agreement for the Offered New Securities is obtainable on the terms set forth
      in
      the Issuance Notice. The Issuance Notice shall also include a copy of any
      written proposal, term sheet or letter of intent or other agreement or
      understanding relating to the Offered New Securities and proof satisfactory
      to
      the Company that the Offered New Securities will not violate any applicable
      securities laws. Upon delivery of the Issuance Notice, such offer shall be
      irrevocable unless and until the rights of first refusal provided for herein
      shall have been waived or shall have expired. 

     

    By
      notification to the Company within ten (10) business days after the Issuance
      Notice is given, the Investor may elect to purchase or otherwise acquire, at
      the
      price and on the terms specified in the Issuance Notice, up to all of the
      Offered New Securities.
      The
      closing of any sale pursuant to this Section 5.2 shall occur within thirty
      (30)
      days after the date on which such notification is given by the
      Investor.
      If the
      Investors elect to acquire more than all the Offered New Securities, then such
      Offered New Securities shall be pro-rated to such Investors in accordance with
      their respective shareholdings in the Company. If
      less
      than all of the Offered New Securities are elected to be purchased or acquired
      as provided in Section 5.2, the Company may, during the thirty (30) day period
      following the expiration of the 10-day period provided in Section 5.2, offer
      and
      sell the remaining unsubscribed portion of such securities to the proposed
      third
      party purchaser in the Issuance Notice at a price not less than, and upon terms
      no more favorable to the proposed third party purchaser than, those specified
      in
      the Issuance Notice. If the Company does not enter into an agreement for the
      sale of such securities within such period, or if such agreement is not
      consummated within thirty (30) days after the execution thereof, the right
      of
      first refusal provided hereunder shall be deemed to be revived and such
      securities shall not be offered to a third party unless first reoffered to
      the
      Investors in accordance with this Section.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    5.3 Capitalization
      upon Closing.
       The
      capitalization of the Company upon the Closing is set forth in Exhibit D annexed
      hereto. The Company shall not take any action which would or might change the
      capitalization without the prior written approval of Chinamerica Fund,
      L.P.

    

    5.4. Independent
      Directors, Public Relations and Executive Searches.
      The
      Company agrees to deliver $5,500,000 directly into escrow on Closing Date for
      the purposes of (i) ensuring the appointment of a five member board of
      directors, of which a minimum of 3 directors are independent, (ii) ensuring
      the
      appointment of a duly qualified Chief Financial Officer with a minimum two-year
      employment agreement and (iii) applying $500,000 to effect an integrated
      investor and public relations campaign. The terms of such escrow shall be
      governed by an escrow agreement by and among Tri-Sate Title & Escrow, LLC,
      as escrow agent, the Company and the Investors in the form attached as
Exhibit
      H
      (the
“Escrow
      Agreement”).
      The
      release of such portion of the escrow monies from escrow shall be effected
      in
      accordance with the terms of the Escrow Agreement. 

     

    6. Representations,
      Warranties and Covenants of the Investor.

     

    6.1 The
      Investor represents and warrants to, and covenants with, the Company that:
      (i) the Investor is either an “accredited investor” as defined in
      Regulation D under the Securities Act or a non-U.S. person as defined in
      Regulation S under the Securities Act who is acquiring the Securities in an
      offshore transaction, and the Investor is also knowledgeable, sophisticated
      and
      experienced in making, and is qualified to make decisions with respect to
      investments in shares presenting an investment decision like that involved
      in
      the purchase of the Securities, including investments in securities issued
      by
      the Company and investments in comparable companies, and has requested,
      received, reviewed and considered all information it deemed relevant in making
      an informed decision to purchase the Securities; (ii) the Investor
      understands that the Securities are “restricted securities” and have not been
      registered under the Securities Act and is acquiring the number of Securities
      set forth in paragraph 3 of the Stock Purchase Agreement in the ordinary course
      of its business and for its own account and not with a view towards, or for
      resale in connection with, the public sale or distribution thereof, except
      pursuant to sales registered or exempted under the Securities Act (including
      pursuant to the Registration Statement (as defined in Section 8.1 below), and
      has no agreement or understanding, directly or indirectly, with any person
      to
      distribute any of the Securities; (iii) the Investor will not, directly or
      indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit
      any offers to buy, purchase or otherwise acquire or take a pledge of) any of
      the
      Securities except in compliance with the Securities Act, applicable state
      securities laws and the respective rules and regulations promulgated thereunder;
      (iv) the Investor has completed or caused to be completed and delivered to
      the Company the Investor Questionnaire and has answered all questions on the
      Investor Questionnaire for use in preparation of the Registration Statement
      and
      the answers thereto are true, correct and complete in all material respects
      as
      of the date hereof and will be true, correct and complete in all material
      respects as of the Closing Date; (v) the Investor will notify the Company
      immediately of any change in any of such information until such time as the
      Investor has sold all of its Securities or until the Company is no longer
      required to keep the Registration Statement effective; (vi) the Investor has,
      in
      connection with its decision to purchase the number of Securities set forth
      in
      paragraph 3 of the Stock Purchase Agreement, relied only upon the Exchange
      Act
      Documents, the representations and warranties of the Company contained herein
      and in the Exhibits attached hereto, and written information provided by the
      Company or its counsel; and (vii) the Investor has reviewed and understood
      the
      Company’s Exchange Act Documents; (viii) the Investor has read and understands
      the risk factors of Weifang Shengtai Pharmaceutical Co., Ltd. (in Exhibit F
      hereto) and has considered those and other risks in deciding to purchase the
      Securities and (ix) the Investor is not purchasing the Securities as a result
      of
      any advertisement, article, notice or other communication regarding the
      Securities published in any newspaper, magazine or similar media or broadcast
      over television or radio or presented at any seminar or any other general
      solicitation or general advertisement. The Investor understands that its
      acquisition of the Securities has not been registered under the Securities
      Act
      or registered or qualified under any state securities law in reliance on
      specific exemptions therefrom, which exemptions may depend upon, among other
      things, the representations of the Investor, including the bona fide nature
      of
      the Investor’s investment intent, as contained herein. The Investor acknowledges
      and agrees that a restrictive legend will be included on the Securities as
      follows:

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    THE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
      OR ANY STATE IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS
      OF
      THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND, ACCORDINGLY, MAY NOT BE
      OFFERED, SOLD, TRANSFERRED, PLEDGED OR HYPOTHETICATED EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR IN ACCORDANCE WITH AN
      EXEMPTION THEREFROM, IF AVAILABLE, OR IN A TRANSACTION NOT SUBJECT TO THE
      REGISTRATION REQUIREMENTS OF THE ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS, AS EVIDENCED BY AN OPINION OF COUNSEL FOR THE TRANSFEROR
      REASONABLY SATISFACTORY TO THE COMPANY, PROVIDED THAT NO SUCH OPINION OR ANY
      CONSENT BY THE COMPANY SHALL BE REQUIRED FOR PLEDGE OF THE SECURITIES PURSUANT
      TO A BONA FIDE MARGIN OR FINANCING ARRANGEMENT. 

     

    6.2 The
      Investor acknowledges that no action has been or will be taken in any
      jurisdiction outside the United States by the Company that would permit an
      offering of the Securities, or possession or distribution of offering materials
      in connection with the issue of the Securities, in any jurisdiction outside
      the
      United States where legal action by the Company for that purpose is required.
      Each Investor outside the United States will comply with all applicable laws
      and
      regulations in each foreign jurisdiction in which it purchases, offers, sells
      or
      delivers Securities or has in its possession or distributes any offering
      material, in all cases at its own expense.

    

    6.3 The
      Investor further represents and warrants to, and covenants with, the Company
      that (i) the Investor has full right, power, authority and capacity to
      enter into this Agreement and to consummate the transactions contemplated hereby
      and has taken all necessary action to authorize the execution, delivery and
      performance of this Agreement; and (ii) this Agreement constitutes a valid
      and binding obligation of the Investor enforceable against the Investor in
      accordance with its terms, except as enforceability may be limited by applicable
      bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
      creditors’ and contracting parties’ rights generally and except as
      enforceability may be subject to general principles of equity (regardless of
      whether such enforceability is considered in a proceeding in equity or at law)
      and except as the indemnification agreements of the Investors herein may be
      legally unenforceable.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    6.4 Investor
      will not, prior to the effectiveness of the Registration Statement, directly
      or
      indirectly, sell, offer to sell, solicit offers to buy, dispose of, loan, pledge
      or grant any right with respect to (collectively, a "Disposition") the
      Securities in violation of the Securities Act. The Investor has not, during
      the
      15 days prior to the date of this Agreement, directly or indirectly, traded
      in
      the Securities or established any hedge or other position in the Securities
      that
      is outstanding on the Closing Date and that is designed to or expected to lead
      to or result in a Disposition by the Investor or any other person or entity,
      nor
      will Investor engage in any hedging or other transaction which is designed
      to or
      could reasonably be expected to lead to or result in a Disposition of Securities
      by the Investor or any other person or entity in violation of the Securities
      Act. For purposes of the preceding sentence, “hedging or other transactions”
would include without limitation effecting any short sale or having in effect
      any short position (whether or not such sale or position is against the box
      and
      regardless of when such position was entered into) or any purchase, sale or
      grant of any right (including without limitation any put or call option) with
      respect to the Securities of the Company or with respect to any security (other
      than a broad-based market basket or index) that includes, relates to or derives
      any significant part of its value from the Securities. 

     

    6.5 The
      Investor understands that nothing in the Exchange Act Documents, this Agreement
      or any other materials presented to the Investor in connection with the purchase
      and sale of the Securities constitutes legal, tax or investment advice. The
      Investor has consulted such legal, tax and investment advisors as it, in its
      sole discretion, has deemed necessary or appropriate in connection with its
      purchase of Securities.

     

    6.6 The
      Investor represents to the Company that, at all time during the Offering, the
      Investor has maintained in confidence all material non-public information
      relating to the Company received by the Investor from the Company or the
      Placement Agents, and covenants that from the date hereof it will maintain
      in
      confidence all material non-public information regarding the Offering and the
      Corporate Presentation received by the Investor from the Company or the
      Placement Agents until such information (a) is disclosed by the Company pursuant
      to Section 10 below or otherwise, (b) becomes generally publicly available
      other
      than through a violation of this provision by the Investor or its agents, or
      (c)
      is required to be disclosed in legal, regulatory or administrative proceedings
      or similar process; provided, however, that before making any disclosure in
      reliance on this Section 6.6, the Investor will give the Company at least
      fifteen (15) days prior written notice ( or such shorter period as may be
      required by law) specifying the circumstances giving rise thereto and will
      furnish only that portion of the non-public information which is legally
      required and will exercise its commercially reasonable efforts to ensure that
      confidential treatment will be accorded any non-public information so furnished.
      

     

    6.7 The
      Investor acknowledges that it has independently evaluated the merits of the
      transaction contemplated by this Agreement, that it has independently determined
      to enter into the transaction contemplated hereby, that it is not relying on
      any
      advice from or evaluation by any Other Investor, and that it is not acting
      in
      concert with any Other Investor in making its purchase of the Securities
      hereunder. The Investor acknowledges that the Investors have not taken any
      actions that would deem the Investors to be members of a “group” for purposes of
      Section 13(d) of the Exchange Act.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    6.8 The
      Investor agrees to comply with the requirements of Regulation M, if applicable,
      with respect to the sale of the Securities by the Investor. The Investor hereby
      confirms its understanding that it may not cover short sales made prior to
      the
      effective date of the Registration Statement with Securities registered for
      resale thereon. The Investor acknowledges that it does not intend to cover
      short
      positions made by it before the effective date with Securities held by it and
      registered on the Registration Statement.

     

    7. Survival
      of Representations, Warranties and Agreements.
      Notwithstanding any investigation made by any party to this Agreement, all
      covenants, agreements, representations and warranties made by the Company and
      the Investor herein shall survive the execution of this Agreement, the delivery
      to the Investor of the Securities being purchased and the payment
      therefor.

     

    8. Registration
      of the Securities; Compliance with the Securities Act.

     

    8.1 Registration
      Requirement.
      The
      Company shall file a Registration Statement on 

    Form
      S-1
      (or any other applicable form to this offering) (the “Initial Registration
      Statement”) within 45 days of the Closing of this transaction covering 100% of
      the Common Stock purchased and the Common Stock underlying the Warrants with
      the
      SEC (the “Registrable Securities”). If the Initial Registration Statement is not
      filed within 45 days of the Closing Date (the “Relevant Filing Date”), damages
      shall be paid to each Investor in cash in an amount equal to 1.0% of the
      purchase amount subscribed for by such the Investor. Such 1.0% damage amount
      shall e paid each month (or part thereof) after the Relevant Filing Date and
      before the date of the Initial Registration Statement is filed. Such 1.0% damage
      amount shall be paid on the first business day after the Relevant Filing Date
      and on each monthly anniversary of said date until the Initial Registration
      Statement is filed. 

    

    If
      the
      Initial Registration Statement is not declared effective within 200 days of
      the
      Closing date (the “Relevant Effective Date”),
      the
      Company shall pay liquidated damages to the Investors. Such damages shall be
      paid in cash to each Investor in the amount equal to 0.50% of the purchase
      amount subscribed for by such Investor. Such 0.5% damage amount shall be paid
      each month (or part thereof) after the Relevant Effective Date and before the
      date the Initial Registration Statement is declared effective. Such 0.5% damage
      amount shall be paid on the first business day after the Relevant Effective
      Date
      and on each monthly anniversary of said date (applied on a daily pro-rata basis)
      until the Initial Registration Statement is declared effective, provided,
      however, that the Company shall not have any obligation to pay liquidated
      damages pursuant to this provision for any delay arising from (i) issues raised
      by the SEC relating to Rule 415 of the Securities Act, as amended, or to the
      structure of the sale and resale of the Securities, (ii) information required
      from person or entities other than the Company or its subsidiary, or (iii)
      issues resulting from or relating to acts or omissions of persons or entities
      other than the Company or its subsidiary. Such liquidated damages (including
      any
      damages under Section 8.8(f)) shall be capped at 10% of the principal amount
      subscribed for by the Investors (the “Registration Damages Cap”). 

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    If
      necessary, the Company shall file subsequent Registration Statements until
      all
      of the Registrable Securities have been registered for resale (each a
“Subsequent Registration Statement”). The Subsequent Registration Statements
      will be filed at the earliest date permissible under then current SEC guidance,
      which is at least 180 days from the effective date of the last Registration
      Statement (each such date referred to as “Subsequent Relevant Filing Date”).
      Each Investor’s Registrable Securities in this transaction will participate in
      the subsequent registrations on a pro rata basis. If any Subsequent Registration
      Statement is not filed on time, liquidated damages equal to the amount of 1.0%
      of the purchase amount of the remaining unregistered Registrable Securities
      shall be paid pro-rata in cash to the Investors on the first business day after
      the Subsequent Relevant Filing Date, and on each monthly anniversary of said
      date (applied on a daily pro rata basis) until the Subsequent Registration
      Statement is filed, provided, however, that the Company shall not have any
      obligation to pay liquidated damages pursuant to this provision for any delay
      arising from (i) issues raised by the SEC relating to Rule 415 of the Securities
      Act, as amended, or to the structure of the sale and resale of the Registrable
      Securities, (ii) information required from person or entities other than the
      Company or its subsidiary, or (iii) issues resulting from or relating to acts
      or
      omissions of persons or entities other than the Company or its subsidiary.
      Such
      liquidated damages shall be subject to and included in the Registration Damages
      Cap.

    

    If
      the
      Subsequent Registration Statement is not declared effective within 200 days
      of
      the Subsequent Relevant Filing Date (each referred to as the “Subsequent
      Relevant Effective Date”), liquidated damages shall be paid in cash pro-rata to
      Investors holding unregistered Registrable Securities in the amount equal to
      0.50% of the purchase amount of the remaining unregistered Registrable
      Securities subscribed for by the Investors per month (applied on a daily pro
      rata basis) after the Subsequent Relevant Effective Date to be paid on the
      first
      business day after the Subsequent Relevant Effective Date and on each monthly
      anniversary of said date until the Registration Statement is declared effective,
      provided, however, that the Company shall not have any obligation to pay
      liquidated damages pursuant to this provision for any delay arising from (i)
      issues raised by the SEC relating to Rule 415 of the Securities Act, as amended,
      or to the structure of the sale and resale of the Securities, (ii) information
      required from person or entities other than the Company or its subsidiary,
      or
      (iii) issues resulting from or relating to acts or omissions of persons or
      entities other than the Company or its subsidiary. Such liquidated damages
      shall
      be subject to and included in the Registration Damages Cap.

    

    8.2 Rule
      415; Cutback.
      Notwithstanding the registration obligations set forth in Section 8.1, in the
      event the SEC informs the Company that all of the Registrable Securities cannot,
      as a result of the application of Rule 415, be registered for resale on a single
      registration statement, the Company agrees to promptly (i) inform each of the
      holders thereof and use its reasonable best efforts to file amendments to the
      Initial Registration Statement as required by the SEC and/or (ii) withdraw
      the
      Initial Registration Statement and file a new registration statement (a “New
      Registration Statement”), in either case covering the maximum number of
      Registrable Securities permitted to be registered by the SEC on Form S-1 or
      such
      other form available to register for resale the Registrable Securities.  
In the event the Company amends the Initial Registration Statement or files
      a
      New Registration Statement, as the case may be, under clauses (i) or (ii) above,
      the Company will use its reasonable best efforts to file with the SEC, as
      promptly as allowed by SEC or staff guidance provided to the Company or to
      registrants of securities in general, one or more registration statements on
      Form S-1 or such other form available to register for resale those Registrable
      Securities that were not registered for resale on the Initial Registration
      Statement, as amended, or the New Registration Statement (the “Remainder
      Registration Statements”).

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    8.3 Limitation
      to Registration Requirement.
      The
      Company shall not be obligated to effect any registration of the Registrable
      Securities or take any other action pursuant to this Section 8 or any subsection
      thereof (i) in any particular jurisdiction in which the Company would be
      required to execute a general consent to service of process in effecting such
      registration, qualification or compliance unless the Company is already subject
      to service in such jurisdiction and except as may be required by the Securities
      Act, or (ii) during any period in which the Company suspends the rights of
      an
      Investor after giving the Investor a Suspension Notice (defined below) pursuant
      to Section 8.8 hereof. 

     

    8.4 Expenses
      of Registration.
      Except
      as otherwise expressly set forth, the Company shall bear all expenses incurred
      by the Company in compliance with the registration obligation of the Company,
      including, without limitation, all registration and filing fees, printing
      expenses, fees and disbursements of counsel for the Company incurred in
      connection with any registration, qualification or compliance pursuant to the
      Agreements. All underwriting discounts, selling commissions and expense
      allowances applicable to the sale by the Investor of Registrable Securities
      and
      all fees and disbursements of counsel for the Investor shall be borne by the
      Investor.

     

    8.5 Registration
      Procedures.
      The
      Company shall:

     

    (a)  Subject
      to the prompt receipt of necessary information from the Investors, prepare
      and
      file with the SEC such amendments and supplements to the Registration Statement
      and the prospectus used in connection with the Registration Statement as may
      be
      necessary to comply with the provisions of the Securities Act with respect
      to
      the disposition of securities covered by the Registration
      Statement;

     

    (b)  Respond
      as promptly as reasonably practicable to any comments received from the SEC
      with
      respect to the Registration Statement or any amendment thereto.

     

    (c)  Notify
      the Investor as promptly as reasonably practicable and (if requested by any
      such
      person) confirm such notice in writing no later than one trading day following
      the day (A) when a prospectus or any prospectus supplement or post-effective
      amendment to the Registration Statement is proposed to be filed and (B) with
      respect to the Registration Statement or any post-effective amendment, when
      the
      same has become effective; 

     

    (d)  Furnish
      such number of prospectuses and other documents incident thereto, including
      supplements and amendments, as the Investor may reasonably request, together
      with a copy of a letter from the Company substantially in the form attached
      hereto as Exhibit C; 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (e)  Use
      its
      reasonable best efforts to avoid the issuance of, or, if issued, obtain the
      withdrawal of (i) any order suspending the effectiveness of the Registration
      Statement, or (ii) any suspension of the qualification (or exemption from
      qualification) of any of the Registrable Securities for sale in any
      jurisdiction, at the earliest practicable moment; 

     

    (f)  Use
      its
      reasonable best efforts to comply with all applicable rules and regulations
      of
      the U.S. federal and state securities laws applicable to the Registration
      Statement; and

     

    (g)  Take
      such
      action, consistent with Section 11 below, as is necessary to cause the Company’s
      transfer agent promptly after the effective date of the Registration Statement,
      to effect the removal of the legend set forth in Section 6.1 above.

    

    8.6 Statement
      of Beneficial Ownership.
      The
      Company may require the Investor to furnish to the Company a certified statement
      as to the number of shares of Common Stock beneficially owned by such Investor
      and the controlling person thereof and any other such information regarding
      the
      Investor, the Registrable Securities held by the Investor and the intended
      method of disposition of such securities as shall be reasonably required with
      respect to the registration of the Investor’s Registrable Securities. The
      Investor hereby understands and agrees that the Company may, in its sole
      discretion, exclude the Investor’s shares of Common Stock from the Registration
      Statement in the event that the Investor fails to provide such information
      requested by the Company within the time period reasonably specified by the
      Company.

     

    8.7 Compliance.
      The
      Investor covenants and agrees that it will comply with the prospectus delivery
      requirements of the Securities Act as applicable to such Investor in connection
      with sales of Registrable Securities pursuant to the registration statement
      required hereunder.

     

    8.8 Transfer
      of Securities After Registration; Suspension.

     

    (a) The
      Investor agrees that it will not effect any disposition of the Securities or
      its
      right to purchase the Securities that would constitute a sale within the meaning
      of the Securities Act except as contemplated in the Registration Statement
      referred to in Section 8.1 and as described below or as otherwise permitted
      by law, and that it will promptly notify the Company of any changes in the
      information set forth in the Registration Statement regarding the Investor
      or
      its plan of distribution.

    

    (b) Except
      in
      the event that paragraph (c) below applies, the Company shall (i) if deemed
      necessary by the Company, prepare and file from time to time with the SEC a
      post-effective amendment to the Registration Statement or a supplement to the
      related Prospectus or a supplement or amendment to any document incorporated
      therein by reference or file any other required document so that such
      Registration Statement will not contain an untrue statement of a material fact
      or omit to state a material fact required to be stated therein or necessary
      to
      make the statements therein not misleading, and so that, as thereafter made
      available to or, if required, delivered to purchasers of the Securities being
      sold thereunder in accordance with the Securities Act, such Prospectus will
      not
      contain an untrue statement of a material fact or omit to state a material
      fact
      required to be stated therein or necessary to make the statements therein,
      in
      light of the circumstances under which they were made, not misleading;
      (ii) to the extent required under the Securities Act, provide the Investor
      copies of any documents filed pursuant to Section 8.8(b)(i); and
      (iii) inform each Investor that the Company has complied with its
      obligations in Section 8.8(b)(i) (or that, if the Company has filed a
      post-effective amendment to the Registration Statement which has not yet been
      declared effective, the Company will notify the Investor to that effect, will
      use its commercially reasonable efforts to secure the effectiveness of such
      post-effective amendment as promptly as possible and will promptly notify the
      Investor when the amendment has become effective).

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (c) Subject
      to paragraph (d) below, in the event (i) of any request by the SEC or any
      other federal or state governmental authority during the period of effectiveness
      of the Registration Statement for amendments or supplements to a Registration
      Statement or related Prospectus or for additional information, (ii) of the
      issuance by the SEC or any other federal or state governmental authority of
      any
      stop order suspending the effectiveness of a Registration Statement or the
      initiation of any proceedings for that purpose, (iii) of the receipt by the
      Company of any notification with respect to the suspension of the qualification
      or exemption from qualification of any of the Securities for sale in any
      jurisdiction or the initiation or threatening of any proceeding for such
      purpose, or (iv) of any event or circumstance which, upon the advice of its
      counsel, necessitates the making of any changes in the Registration Statement
      or
      Prospectus, or any document incorporated or deemed to be incorporated therein
      by
      reference, so that, in the case of the Registration Statement, it will not
      contain any untrue statement of a material fact or any omission to state a
      material fact required to be stated therein or necessary to make the statements
      therein not misleading, and that in the case of the Prospectus, it will not
      contain any untrue statement of a material fact or any omission to state a
      material fact required to be stated therein or necessary to make the statements
      therein, in the light of the circumstances under which they were made, not
      misleading, then the Company shall deliver a certificate in writing to the
      Investor (the “Suspension Notice”) to the effect of the foregoing and, upon
      receipt of such Suspension Notice, the Investor will refrain from selling any
      Securities pursuant to the Registration Statement (a “Suspension”) until the
      Investor’s receipt of notice from the Company that a supplemented or amended
      Prospectus has been prepared and filed by the Company with the SEC and is
      available electronically, or, if required in accordance with the Securities
      Act,
      until it is advised in writing by the Company that the current Prospectus may
      be
      used, and has received copies of any additional or supplemental filings that
      are
      incorporated or deemed incorporated by reference in any such Prospectus. In
      the
      event of any Suspension, the Company will use its commercially reasonable
      efforts to cause the use of the Prospectus so suspended to be resumed as soon
      as
      reasonably practicable after the delivery of a Suspension Notice to the
      Investor. 

    

    (d) Provided
      that a Suspension is not then in effect, the Investor may sell Securities under
      the Registration Statement. Upon receipt of a request therefor, the Company
      has
      agreed, if required under applicable law, to provide an adequate number of
      current Prospectuses to the Investor and to supply copies to any other parties
      requiring such Prospectuses.

     

    (e) In
      the
      event of a sale of Registrable Securities by the Investor pursuant to the
      Registration Statement, the Investor must also deliver to the Company’s transfer
      agent, with a copy to the Company, a certificate of subsequent sale
      substantially in the form included in Exhibit C attached hereto, so that
      the Registrable Securities may be properly transferred.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (f)
       on
      any
      day after the Relevant Effective Date or the Subsequent Relevant Effective
      Date
      (as the case may be), sales of all of the Registrable Securities required to
      be
      included in the Initial Registration Statement or Subsequent Registration
      Statement, as applicable, cannot be made, other than during any period in which
      the Company is diligently pursuing the effectiveness under the 1933 Act of
      any
      amendment to such Registration Statement or Subsequent Registration Statement
      (including, without limitation, because of a failure to (a) keep such
      Registration Statement or Subsequent Registration Statement effective or (b)
      disclose such information as is necessary for sales to be made pursuant to
      such
      Registration Statement or Subsequent Registration Statement, as applicable
      (a
      "Maintenance Failure");

     

    then,
      as
      the sole and exclusive relief to any Investor by reason of any such delay in
      or
      reduction of its ability to sell the Registrable Securities, the Company shall
      pay to each holder of Registrable Securities required under this Agreement
      to
      be, or remain (as applicable), registered under such Initial Registration
      Statement, or Subsequent Registration Statement, as applicable (the “Subject
      Securities”), an amount in cash, 

     

    (A) equal
      to
      one half of one percent (0.5%) of the aggregate Purchase Price (as such term
      is
      defined above) of such Investor's Subject Securities that corresponds to the
      number of such Investor’s Subject Securities permitted to be registered by the
      SEC in such Registration Statement pursuant to Rule 415, such 0.5% amount
      payable on every thirtieth (30th)
      day
      (prorated for periods totaling less than thirty (30) days) after the occurrence
      of any Maintenance Failure if such Maintenance Failure has not been cured on
      or
      before the ninetieth (90th)
      day
      after such Maintenance Failure, and 

     

    (B)
       equal
      to
      one percent (1.0%) of the aggregate Purchase Price of such Investor's Subject
      Securities that corresponds to the number of such Investor’s Subject Securities
      permitted to be registered by the SEC in such Registration Statement pursuant
      to
      Rule 415, such 1.0% amount payable on every thirtieth (30th)
      day
      (prorated for periods totaling less than thirty (30) days) starting with the
      ninety-first (91st)
      day
      after the occurrence of a Maintenance Failure until such Maintenance Failure
      is
      cured. 

     

    The
      payments to which a holder shall be entitled pursuant to this Section 8.8(f)
      are
      referred to herein as "Registration Delay Payments." In the event the Company
      fails to make Registration Delay Payments in a timely manner, such Registration
      Delay Payments shall bear interest at the rate of one and one-half percent
      (1.5%) per month (prorated for partial months) until paid in full. 

     

    Notwithstanding
      anything herein to the contrary, (i) in no event shall the aggregate amount
      of
      Registration Delay Payments payable to any Investor exceed, in the aggregate,
      the limits set out in Section 8.1 above , (ii) in no case shall Registration
      Delay Payments be payable from and after the date the Registrable Securities
      are
      eligible for sale pursuant to Rule 144(k) under the 1933 Act, and (iii) the
      Company shall have no obligation to pay any such Registration Delay Payments
      to
      the Investor during an Maintenance Failure for any delay substantially due
      to
      information required from the Investor not being provided or being inaccurate
      or
      incomplete. For the avoidance of doubt, any right to receive such Registration
      Delay Payments shall be the Investor’s sole and exclusive remedy at law or in
      equity for a Maintenance Failure.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    8.9 Indemnification.
      For the
      purpose of this Section 8.9:

     

    (i) the
      term
“Selling Holder” shall include the Investor and any affiliate of such
      Investor;

    

    (ii) the
      term
“Registration Statement” shall include the Prospectus in the form first filed
      with the SEC pursuant to Rule 424(b) of the Securities Act or filed as part
      of the Registration Statement at the time of effectiveness if no
      Rule 424(b) filing is required, together with any exhibit, supplement or
      amendment included in or relating to the Registration Statement referred to
      in
      Section 8.5; and

    

    (iii) the
      term
“untrue statement” shall include any untrue statement or alleged untrue
      statement, or any omission or alleged omission to state in the Registration
      Statement a material fact required to be stated therein or necessary to make
      the
      statements therein, in the light of the circumstances under which they were
      made, not misleading.

    

    (a) The
      Company agrees to indemnify and hold harmless each Selling Holder from and
      against any losses, claims, damages or liabilities to which such Selling Holder
      may become subject (under the Securities Act or otherwise) insofar as such
      losses, claims, damages or liabilities (or actions or proceedings in respect
      thereof) arise out of, or are based upon (i) any material breach of the
      representations or warranties of the Company contained herein or failure to
      comply materially with the covenants and agreements of the Company contained
      herein, (ii) any untrue statement of a material fact contained in the
      Registration Statement as amended at the time of effectiveness or any omission
      of a material fact required to be stated therein or necessary to make the
      statements therein not misleading, or (iii) any failure by the Company to
      fulfill any material undertaking included in the Registration Statement as
      amended at the time of effectiveness, and the Company will reimburse such
      Selling Holder for any reasonable legal or other expenses reasonably incurred
      in
      investigating, defending or preparing to defend any such action, proceeding
      or
      claim, provided,
      however,
      that
      the Company shall not be liable in any such case to the extent that such loss,
      claim, damage or liability arises out of, or is based upon, an untrue statement
      made in such Registration Statement or any omission of a material fact required
      to be stated therein or necessary to make the statements therein not misleading
      in reliance upon and in conformity with written information furnished to the
      Company by or on behalf of such Selling Holder specifically for use in
      preparation of the Registration Statement or the failure of such Selling Holder
      to comply with its covenants and agreements contained in Section 8.8 hereof
      respecting sale of the Securities or any statement or omission in any Prospectus
      that is corrected in any subsequent Prospectus prior to the time of any sale
      giving rise to the obligations to indemnify. The Company shall reimburse each
      Selling Holder for the amounts provided for herein on demand as such expenses
      are incurred.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) The
      Investor agrees to indemnify and hold harmless the Company and each person,
      if
      any, who controls the Company within the meaning of Section 15 of the
      Securities Act, each officer of the Company who signs the Registration Statement
      and each director of the Company from and against any losses, claims, damages
      or
      liabilities to which the Company (or any such officer, director or controlling
      person) may become subject (under the Securities Act or otherwise), insofar
      as
      such losses, claims, damages or liabilities (or actions or proceedings in
      respect thereof) arise out of, or are based upon, (i) any failure to comply
      with
      the covenants and agreements contained in Section 8.8 hereof respecting
      sale of the Securities, or (ii) any untrue statement of a material fact
      contained in the Registration Statement or any omission of a material fact
      required to be stated therein or necessary to make the statements therein not
      misleading if such untrue statement or omission was made in reliance upon and
      in
      conformity with written information furnished by or on behalf of the Investor
      specifically for use in preparation of the Registration Statement, and the
      Investor will reimburse the Company (or such officer, director or controlling
      person), as the case may be, for any legal or other expenses reasonably incurred
      in investigating, defending or preparing to defend any such action, proceeding
      or claim; provided
      that the
      Investor’s obligation to indemnify the Company shall be limited to the net
      amount received by the Investor from the sale of the Securities.

    

    (c) Promptly
      after receipt by any indemnified person of a notice of a claim or the beginning
      of any action in respect of which indemnity is to be sought against an
      indemnifying person pursuant to this Section 8.9, such indemnified person
      shall notify the indemnifying person in writing of such claim or of the
      commencement of such action, but the omission to so notify the indemnifying
      person will not relieve it from any liability which it may have to any
      indemnified person under this Section 8.9 (except to the extent that such
      omission materially and adversely affects the indemnifying person’s ability to
      defend such action) or from any liability otherwise than under this
      Section 8.9. Subject to the provisions hereinafter stated, in case any such
      action shall be brought against an indemnified person, the indemnifying person
      shall be entitled to participate therein, and, to the extent that it shall
      elect
      by written notice delivered to the indemnified person promptly after receiving
      the aforesaid notice from such indemnified person, shall be entitled to assume
      the defense thereof, with counsel reasonably satisfactory to such indemnified
      person. After notice from the indemnifying person to such indemnified person
      of
      its election to assume the defense thereof, such indemnifying person shall
      not
      be liable to such indemnified person for any legal expenses subsequently
      incurred by such indemnified person in connection with the defense thereof,
      provided,
      however,
      that if
      there exists or shall exist a conflict of interest that would make it
      inappropriate, in the opinion of counsel to the indemnified person, for the
      same
      counsel to represent both the indemnified person and such indemnifying person
      or
      any affiliate or associate thereof, the indemnified person shall be entitled
      to
      retain its own counsel at the expense of such indemnifying person; provided,
      however, that no indemnifying person shall be responsible for the fees and
      expenses of more than one separate counsel (together with appropriate local
      counsel) for all indemnified parties. In no event shall any indemnifying person
      be liable in respect of any amounts paid in settlement of any action unless
      the
      indemnifying person shall have approved the terms of such settlement;
provided
      that
      such consent shall not be unreasonably withheld. No indemnifying person shall,
      without the prior written consent of the indemnified person, effect any
      settlement of any pending or threatened proceeding in respect of which any
      indemnified person is or could have been a party and indemnification could
      have
      been sought hereunder by such indemnified person, unless such settlement
      includes an unconditional release of such indemnified person from all liability
      on claims that are the subject matter of such proceeding.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    (d) If
      the
      indemnification provided for in this Section 8.9 is unavailable to or
      insufficient to hold harmless an indemnified person under subsection (a) or
      (b)
      above in respect of any losses, claims, damages or liabilities (or actions
      or
      proceedings in respect thereof) referred to therein, then each indemnifying
      person shall contribute to the amount paid or payable by such indemnified person
      as a result of such losses, claims, damages or liabilities (or actions in
      respect thereof) in such proportion as is appropriate to reflect the relative
      fault of the Company on the one hand and the Investor, on the other hand in
      connection with the statements or omissions or other matters which resulted
      in
      such losses, claims, damages or liabilities (or actions in respect thereof),
      as
      well as any other relevant equitable considerations. The relative fault shall
      be
      determined by reference to, among other things, in the case of an untrue
      statement, whether the untrue statement relates to information supplied by
      the
      Company on the one hand or an Investor or other Investors on the other and
      the
      parties’ relative intent, knowledge, access to information and opportunity to
      correct or prevent such untrue statement. The Company and the Investor agree
      that it would not be just and equitable if contribution pursuant to this
      subsection (d) were determined by pro rata allocation (even if the Investor
      and
      Other Investors were treated as one entity for such purpose) or by any other
      method of allocation which does not take into account the equitable
      considerations referred to above in this subsection (d). The amount paid or
      payable by an indemnified person as a result of the losses, claims, damages
      or
      liabilities (or actions in respect thereof) referred to above in this subsection
      (d) shall be deemed to include any legal or other expenses reasonably incurred
      by such indemnified person in connection with investigating or defending any
      such action or claim. Notwithstanding the provisions of this subsection (d),
      the
      Investor shall not be required to contribute any amount in excess of the amount
      by which the net amount received by the Investor from the sale of the Securities
      to which such loss relates exceeds the amount of any damages which such Investor
      has otherwise been required to pay by reason of such untrue statement. No person
      guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
      of the Securities Act) shall be entitled to contribution from any person who
      was
      not guilty of such fraudulent misrepresentation. The Investor’s obligations in
      this subsection to contribute shall be in proportion to such Investor’s sale of
      Securities to which such loss relates and shall not be joint with any Other
      Investors.

    

    (e) The
      parties to this Agreement hereby acknowledge that they are sophisticated
      business persons who were represented by counsel during the negotiations
      regarding the provisions hereof including, without limitation, the provisions
      of
      this Section 8.9, and are fully informed regarding said provisions. They
      further acknowledge that the provisions of this Section 8.9 fairly allocate
      the risks in light of the ability of the parties to investigate the Company
      and
      its business in order to assure that adequate disclosure is made in the
      Registration Statement as required by the Securities Act and the Exchange Act.
      The parties are advised that federal or state public policy as interpreted
      by
      the courts in certain jurisdictions may be contrary to certain of the provisions
      of this Section 8.9, and the parties hereto hereby expressly waive and
      relinquish any right or ability to assert such public policy as a defense to
      a
      claim under this Section 8.9 and further agree not to attempt to assert any
      such defense.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    8.10 Termination
      of Conditions and Obligations.
      The
      conditions precedent imposed by Section 6 or this Section 8 upon the
      transferability of the Securities shall cease and terminate as to any particular
      number of the Securities when such Securities shall have been effectively
      registered under the Securities Act and sold or otherwise disposed of in
      accordance with the intended method of disposition set forth in the Registration
      Statement covering such Securities or at such time as an opinion of counsel
      reasonably satisfactory to the Company shall have been rendered to the effect
      that such conditions are not necessary in order to comply with the Securities
      Act.

     

    8.11 Information
      Available.
      So long
      as the Registration Statement is effective covering the resale of Securities
      owned by the Investor, the Company will furnish or otherwise make available
      to
      the Investor:

     

    (a) as
      soon
      as practicable after it is available, one copy (excluding exhibits) of its
      Annual Report on Form 10-K, which Annual Report on Form 10-K shall contain
      financial statements audited in accordance with generally accepted accounting
      principles by a national firm of certified public accountants;

    

    (b) upon
      the
      reasonable request of the Investor, all exhibits excluded by the parenthetical
      to subparagraph (a) of this Section 8.11 as filed with the SEC and all
      other information that is made available to stockholders; and

    

    (c) upon
      the
      reasonable request of the Investor, an adequate number of copies of the
      Prospectuses to supply to any other party requiring such Prospectuses; and,
      upon
      the reasonable request of the Investor, the President or the Chief Financial
      Officer of the Company (or an appropriate designee thereof) will meet with
      the
      Investor or a representative thereof at the Company’s headquarters to discuss
      all information relevant for disclosure in the Registration Statement covering
      the Securities and will otherwise cooperate with any Investor conducting an
      investigation for the purpose of reducing or eliminating such Investor’s
      exposure to liability under the Securities Act, including the reasonable
      production of information at the Company’s headquarters; provided, that the
      Company shall not be required to disclose any confidential information to or
      meet at its headquarters with any Investor until and unless the Investor shall
      have entered into a confidentiality agreement in form and substance reasonably
      satisfactory to the Company with the Company with respect thereto.

    

    9. Rule
      144.
      The
      Company covenants that it will timely file the reports required to be filed
      by
      it under the Securities Act and the Exchange Act and the rules and regulations
      adopted by the SEC thereunder, and it will take such further action as any
      such
      Investor may reasonably request, all to the extent required from time to time
      to
      enable such Investor to sell Securities purchased hereunder without registration
      under the Securities Act within the limitation of the exemptions provided by
      (a)
      Rule 144 under the Securities Act, as such Rule may be amended from time to
      time, or (b) any similar rule or regulation hereafter adopted by the SEC.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    10.
       Public
      Statements. 
      The Company shall, on or before 8:30 a.m., New York time, on the first Business
      Day following execution of the Agreements, issue a press release disclosing
      all
      material terms of the Offering, including the financial projections contained
      in
      the Corporate Presentation.  Within four (4) Business Days after the
      Closing Date, the Company shall file a Current Report on Form 8-K with the
      SEC
      (the “8-K Filing”) describing the terms of the Offering and including as
      exhibits to the 8-K Filing this Agreement in the form required by the Exchange
      Act.  Thereafter, the Company shall timely file any filings and notices
      required by the SEC or applicable law with respect to the Offering. The Company
      shall not include the name of any Investor in any press release without the
      prior written consent of such Investor.

     

    11. Removal
      of Legends.
      Certificates evidencing the Securities shall not contain any legend (including
      the legend set forth in Section 6.1 above) (i) while the Registration Statement
      covering the resale of the Securities is effective under the Securities Act;
      (ii) if such Securities are sold pursuant to Rule 144 (assuming the transferor
      is not an affiliate of the Company); (iii) if such Securities are eligible
      for
      resale under Rule 144(k); or (iv) if such legend is not otherwise required
      under
      applicable requirements of the Securities Act. After the effective date of
      the
      Registration Statement or at such earlier time as a legend is no longer required
      for the Securities, the Company shall, no later than five business days
      following the delivery by an Investor to the Company or the Company’s transfer
      agent (with notice to the Company) of a legended certificate representing such
      Securities (endorsed or with stock powers attached, signatures guaranteed,
      and
      otherwise in form necessary to effect the re-issuance and/or transfer), take
      all
      action as is necessary for a certificate representing such Securities to be
      delivered to such Investor that is free from all restrictive and other legends.
      The Company shall cause its counsel to issue a legal opinion to the transfer
      agent with respect to such matters on the effective date. Any fees incurred
      by
      the transfer agent, counsel to the Company or otherwise associated with the
      issuance of such opinion, the removal of the legend, and the re-issuance of
      the
      certificates representing the Securities shall be borne by the Company. The
      Company may not make any notation on its records or give instructions to the
      transfer agent that enlarge the restrictions on transfer set forth in this
      Section 11 with respect to the Securities.

     

    12. Notices.
      All
      notices, requests, consents and other communications hereunder shall be in
      writing, and shall be deemed given (i) if deposited in the U.S. mail, on
      the business day actually received, (ii) if delivered by overnight courier,
      on the next business day after delivery to such courier, (iii) if delivered
      by facsimile, upon electronic confirmation of receipt and shall be delivered
      as
      addressed as follows:

     

    (a) if
      to the
      Company, to:

    

    Shengtai
      Holding Inc. 

    c/o
      Weifang Shengtai Pharmaceutical Co., Ltd. 

    Hi-Tech
      Industrial Park of Changle County,

    Shandong
      Province,

    People’s
      Republic of China 262400

    Attn:
      Mr.
      Qingtai Liu

    Phone:
      +1-86-536-6281018, 6289669

    Fax:
      +1-86-536-6289982

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) with
      a
      copy to:

    

    Guzov
      Ofsink LLC

    600
      Madison Avenue, 14th
      Floor

    New
      York,
      NY 10022

    Fax:
      (212) 688 7273

    Attn:
      Darren Ofsink, Esq.

    

    (c) if
      to the
      Investor, at its address on the signature page hereto, or at such other address
      or addresses as may have been furnished to the Company in writing.

    

    13. Changes.
      This
      Agreement may not be modified or amended except pursuant to an instrument in
      writing signed by the Company and the Investor.

     

    14. Headings.
      The
      headings of the various sections of this Agreement have been inserted for
      convenience of reference only and shall not be deemed to be part of this
      Agreement.

     

    15. Severability.
      In case
      any provision contained in this Agreement should be invalid, illegal or
      unenforceable in any respect, the validity, legality and enforceability of
      the
      remaining provisions contained herein shall not in any way be affected or
      impaired thereby.

     

    16. Governing
      Law.
      This
      Agreement shall be governed by, and construed in accordance with, the internal
      laws of the State of New York.

     

    17. Counterparts.
      This
      Agreement may be executed in two or more counterparts, each of which shall
      constitute an original, but all of which, when taken together, shall constitute
      but one instrument, and shall become effective when one or more counterparts
      have been signed by each party hereto and delivered to the other
      parties.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    ANNEX
      II

    

    WEST
      COAST CAR COMPANY

    

    INVESTOR
      QUESTIONNAIRE

    

    (ALL
      INFORMATION WILL BE TREATED CONFIDENTIALLY)

    

    
      	To:	
              West
                Coast Car Company 

              
                c/o
                  Weifang Shengtai Pharmaceutical Co., Ltd. 

                Hi-Tech
                  Industrial Park of Changle County,

                Shandong
                  Province,

                People’s
                  Republic of China 262400

                Attn:
                  Mr. Qingtai Liu

              

            

    

    
    

     

    This
      Investor Questionnaire (“Questionnaire”) must be completed by each potential
      investor in connection with the offer and sale of the shares of the common
      stock, $0.001 par value per share (the “Securities), of West Coast Car Company
      (“WCSC”). The Securities are being offered and sold by WCSC without registration
      under the Securities Act of 1933, as amended (the “Act”), and the securities
      laws of certain states, in reliance on the exemptions contained in
      Section 4(2) of the Act and on Regulation D and Regulation S promulgated
      thereunder and in reliance on similar exemptions under applicable state laws.
      WCSC must determine that a potential investor meets certain suitability
      requirements before offering or selling Securities to such investor. The purpose
      of this Questionnaire is to assure WCSC that each investor will meet the
      applicable suitability requirements. The information supplied by you will be
      used in determining whether you meet such criteria, and reliance upon the
      private offering exemption from registration is based in part on the information
      herein supplied.

    

    This
      Questionnaire does not constitute an offer to sell or a solicitation of an
      offer
      to buy any security. Your answers will be kept strictly confidential. However,
      by signing this Questionnaire you will be authorizing WCSC to provide a
      completed copy of this Questionnaire to such parties as WCSC deems appropriate
      in order to ensure that the offer and sale of the Securities will not result
      in
      a violation of the Act or the securities laws of any state and that you
      otherwise satisfy the suitability standards applicable to purchasers of the
      Securities. All potential investors must answer all applicable questions and
      complete, date and sign this Questionnaire. Please print or type your responses
      and attach additional sheets of paper if necessary to complete your answers
      to
      any item.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    A. BACKGROUND
      INFORMATION

    

      Name:
        ____________________________________________________________________________________

      

      Business
        Address: __________________________________________________________________________

      (Number
        and Street)

       

      _________________________________________________________________________________________

      (City)            (State)            (Zip
        Code)

      

      Telephone
        Number: (___) _____________________________________________________________________

      

      Residence
        Address: __________________________________________________________________________

      (Number
        and Street)

       

      
        _________________________________________________________________________________________

        (City)            (State)            (Zip
          Code)

      

       

      Telephone
        Number: (___) _____________________________________________________________________

      

      If
        an
        individual:

       

      Age:
        ____________ Citizenship: ____________ Where registered to vote:
        _______________

      

      If
        a
        corporation, partnership, limited liability company, trust or other
        entity:

       

      Type
        of
        entity:
        ____________________________________________________________________

       

      State
        of
        formation: _______________ Date of formation: _______________

      

      Social
        Security or Taxpayer Identification No.
        ________________________________________

      

      Send
        all
        correspondence to (check one): ______________ Residence Address ____________
        Business Address

      

      Current
        ownership of securities of CPSL: __________ shares of common stock, $0.001
        value
        per share (the “Common Stock”); ___________ options to purchase __________
        shares of Common Stock

    

    

    B. STATUS
      AS ACCREDITED INVESTOR

    

    The
      undersigned is an “accredited investor” as such term is defined in Regulation D
      under the Act, as at the time of the sale of the Securities the undersigned
      falls within one or more of the following categories (Please
      initial one or more, as applicable):1 

     

    ____
      (1) a
      bank as
      defined in Section 3(a)(2) of the Act, or a savings and loan association or
      other institution as defined in Section 3(a)(5)(A) of the Act whether
      acting in its individual or fiduciary capacity; a broker or dealer registered
      pursuant to Section 15 of the Securities Exchange Act of 1934; an insurance
      company as defined in Section 2(13) of the Act; an investment company
      registered under the Investment Corporation Act of 1940 or a business
      development company as defined in Section 2(a)(48) of that Act; a Small
      Business Investment Corporation licensed by the U.S. Small Business
      Administration under Section 301(c) or (d) of the Small Business Investment
      Act of 1958; a plan established and maintained by a state, its political
      subdivisions, or any agency or instrumentality of a state or its political
      subdivisions for the benefit of its employees, if such plan has total assets
      in
      excess of $5,000,000; an employee benefit plan within the meaning of the
      Employee Retirement Income Security Act of 1974 if the investment decision
      is
      made by a plan fiduciary, as defined in Section 3(21) of such Act, which is
      either a bank, savings and loan association, insurance company, or registered
      investment adviser, or if the employee benefit plan has total assets in excess
      of $5,000,000 or, if a self-directed plan, with the investment decisions made
      solely by persons that are accredited investors;

     

      
        

      

    

    
      1
        As
        used in this Questionnaire, the term “net worth” means the excess of total
        assets over total liabilities. In computing net worth for the purpose of
        subsection (4), the principal residence of the investor must be valued at
        cost,
        including cost of improvements, or at recently appraised value by an
        institutional lender making a secured loan, net of encumbrances. In determining
        income, the investor should add to the investor’s adjusted gross income any
        amounts attributable to tax exempt income received, losses claimed as a limited
        partner in any limited partnership, deductions claimed for depiction,
        contributions to an IRA or KEOGH retirement plan, alimony payments, and any
        amount by which income from long-term capital gains has been reduced in arriving
        at adjusted gross income.

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

       

    

    ____
      (2) a
      private
      business development company as defined in Section 202(a)(22) of the
      Investment Adviser Act of 1940;

    

    ____
      (3) an
      organization described in Section 501(c)(3) of the Internal Revenue Code of
      1986, as amended, corporation, Massachusetts or similar business trust, or
      partnership, not formed for the specific purpose of acquiring the Securities
      offered, with total assets in excess of $5,000,000;

    

    ____
      (4) a
      natural
      person whose individual net worth, or joint net worth with that person’s spouse,
      at the time of such person’s purchase of the Securities exceeds
      $1,000,000;

    

    ____
      (5) a
      natural
      person who had an individual income in excess of $200,000 in each of the two
      most recent years or joint income with that person’s spouse in excess of
      $300,000 in each of those years and has a reasonable expectation of reaching
      the
      same income level in the current year;

    

    ____
      (6) a
      trust,
      with total assets in excess of $5,000,000, not formed for the specific purpose
      of acquiring the Securities offered, whose purchase is directed by a
      sophisticated person as described in Rule 506(b)(2)(ii) of Regulation D;
      and

    

    ____
      (7) an
      entity
      in which all of the equity owners are accredited investors (as defined
      above).

    
      

      
        	
                C.

              	
                FOR
                  NON-U.S. PERSONS ACQUIRING IN RELIANCE UPON REGULATION S ONLY.
                  PLEASE
                  CHECK ALL BOXES THAT APPLY.

              

      

       

      
        	1.	
                The
                  undersigned has checked the following box as
                  appropriate:

              

      

       

      
        	 	
                o

              	
                The
                  undersigned is an “accredited investor” (as defined above in Part
                  B).

              

      

       

      
        	 	
                o

              	
                The
                  undersigned is not an accredited investor.

              

      

       

      
        	2.	
                o          
                  The undersigned is not a “U.S. person” as defined in Rule 902 of
                  Regulation S under the Act. Specifically, the undersigned is not:

              

      

       

      
        	 	
                ·

              	
                A
                  natural person resident in the United
                  States;

              

      

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      
        	 	
                ·

              	
                A
                  partnership or corporation organized or incorporated under the
                  laws of the
                  United States;

              

      

       

      
        	 	
                ·

              	
                An
                  estate of which any executor or administrator is a U.S.
                  person;

              

      

       

      
        	 	
                ·

              	
                A
                  trust of which any trustee is a U.S.
                  person;

              

      

       

      
        	 	
                ·

              	
                An
                  agency or branch of a foreign entity located in the United
                  States;

              

      

       

      
        	 	
                ·

              	
                A
                  non-discretionary account or similar account (other than an estate
                  or
                  trust) held by a dealer or other fiduciary for the benefit or account
                  of a
                  U.S. person;

              

      

       

      
        	 	
                ·

              	
                A
                  discretionary account or similar account (other than an estate
                  or trust)
                  held by a dealer or other fiduciary organized, incorporated, or
                  (if an
                  individual) resident in the United States;
                  and

              

      

       

      
        	 	
                ·

              	
                A
                  partnership or corporation if:

              

      

       

      Organized
        or incorporated under the laws of any foreign jurisdiction; and

       

      Formed
        by
        a U.S. person principally for the purpose of investing in securities not
        registered under the Act, unless it is organized or incorporated, and owned,
        by
        accredited investors (as defined in Rule
        501(a))
        who are
        not natural persons, estates or trusts.

      
         

        
          	3.	
                  o          
                    The Securities were not offered to the undersigned in the United
                    States.

                

        

      
        
           

          
            	4.	
                    o          
                      The undersigned was physically outside the United States when
                      the
                      agreement to acquire the Securities was made. No documents
                      relating to the
                      acquisition of the Securities were executed by the undersigned
                      in the
                      United States.

                  

          

        
          
             

            
              	5.	
                      o          
                        The undersigned acknowledges that the Securities were not
                        offered by means
                        of any general solicitation or advertising. 

                    

            

          
            
               

              
                	6.	
                        o          
                          The undersigned is purchasing the Securities for its own
                          account for
                          investment and not on behalf of or for the benefit of any
                          U.S.
                          person.

                      

              

            
              
                 

                
                  	7.	
                          o          
                            The undersigned has not prearranged the sale of the Securities
                            to any
                            buyer in the United States and has no present plan or
                            intention to engage
                            in a distribution of the Securities in the United
                            States.

                        

                

              
                
                   

                  
                    	8.	
                            o          
                              The undersigned agrees that, prior to the expiration
                              of a period
                              commencing on the closing of the Stock Purchase Agreement
                              and ending
                              one-year thereafter (the “Restricted Period”), no offers and sales of the
                              Securities shall be made to U.S. persons or for the
                              account or benefit of
                              U.S. persons except in compliance with U.S. federal
                              and state securities
                              laws. 

                          

                  

                
                  
                     

                    
                      
                        
                        

                      

                      
                        
                        

                        
                          

                        

                      

                      
                        
                        

                      

                    

                     

                    
                      
                        	9.	
                                o          
                                  If the undersigned is a distributor or dealer with
                                  respect to the
                                  Offering, the undersigned acknowledges and agrees
                                  that it is subject to
                                  the same restrictions as each other Investor.

                              

                      

                    
                      
                         

                        
                          
                            	10.	
                                    o          
                                      The undersigned has not engaged in and is not
                                      aware of any other person
                                      having engaged in any “directed selling efforts,” as that term is defined
                                      in Rule 902 of Regulation S, in connection
                                      with the acquisition of the
                                      Securities.

                                  

                          

                        
                          
                             

                            
                              
                                	11.	
                                        o          
                                          The undersigned will not make any sale,
                                          transfer or other disposition of
                                          the Securities in violation of the Act,
                                          the Securities and Exchange Act of
                                          1934, as amended (the “Exchange Act”), or the rules and regulations of the
                                          Securities and Exchange Commission (the
“Commission”) promulgated
                                          thereunder.

                                      

                              

                            
                              
                                 

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

      Note:
        Each equity owner must submit an individual investor
        questionnaire.

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      

      IN
        WITNESS WHEREOF, the undersigned has executed this Questionnaire this _____
        day
        of____________, 2007, and declares under oath that it is truthful and
        correct.

       

      
        	 	 	 
	 	
                
                  

                

                Print
                  Name

              
	 
 	 
 	 
 
	
              	By:  	
              
	 	 	
                

                Signature

              
	 	 	 
	 	Title: 	 
	 	
                

                (required
                  for any purchaser that is a corporation, 

                partnership,
                  trust or other entity)

              

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      EXHIBIT
        A

      

      INSTRUCTIONS
        TO TRANSFER MAKE GOOD SHARES

       

      Pursuant
        to Section 5.1 of the Stock Purchase Agreement, dated as of May
        [           ], 2007, among West
        Coast Car Company (the “Company”) and the Investors named therein, the Company
        hereby instructs [ 
],
        as the
        Company’s share registrar and transfer agent, as follows:

      

      These
        instructions are made pursuant to Section 5.1 [(a)] [(b)] [insert
        applicable section reference]
        of the
        Stock Purchase Agreement, dated May _____, 2007.

      

      The
        Company hereby certifies that the condition for transfer of the Make Good
        Shares
        as set forth such Section 5.1 [(a)] [(b)] [insert
        applicable section reference]
        [has]
        [has not] been satisfied as evidenced in the Company’s audited financial
        statements for the fiscal year ended June 31, 200[7] [8] [insert
        applicable year]
        and
        filed with the U.S. Securities Exchange Commission in the Company’s Annual
        Report on Form 10-K for such fiscal year on [insert
        date of SEC filing].

      

      Make
        Good
        Shares should be transferred from escrow to the Investors pro-rata [insert
        as appropriate]
        as set
        forth below:

      

      Amount
        of
        Make Good Shares

      to
        be
        transferred:  ________________________________

      

      Transferor:
         ________________________________

      

      Transferees: [Include
        names of all Investors]

       

      Name:   ________________________________

       

      Address:          ________________________________

       

      City/State:     
         ________________________________

       

      Zip:                 
         ________________________________

       

      Number
        of
        Shares:         ________________________________

       

       

      
        	 	 	 
	 	
                WEST
                  COAST CAR COMPANY 

              
	 
 	 
 	 
 
	Date:
                _________________	By:  	 
	 	
                
Name:
	 	Title:

      

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      EXHIBIT
        B

      

      LIMITED
        STANDSTILL AGREEMENT

      

      This
        AGREEMENT (the “Agreement”) is made as of the ___ day of May, 2007, by the
        signatories hereto (each a “Holder”), in connection with their respective
        ownership of shares of West Coast Car Company, a Delaware corporation (the
        “Company”). Terms not otherwise defined herein are defined in the Stock Purchase
        Agreement among the Company and the Investors named therein; dated as of
        May __,
        2007 (the “Stock Purchase Agreement”).

       

      NOW
        THEREFORE, for good and valuable consideration, the sufficiency and receipt
        of
        which consideration are hereby acknowledged, Holder agrees as
        follows:

       

      1. General.

      

      (a) Holder
        is
        a director or executive officer of the Company and the beneficial owner of
        the
        amount of shares of the Common Stock, $0.001 par value, of the Company (“Common
        Stock”) and rights to purchase Common Stock as designated on the signature page
        hereto (collectively, the “Shares”). 

      

      (b) Holder
        acknowledges that the Company has entered into or will enter into an agreement
        with each Investor (a “Stock Purchase Agreement”) for the sale to the Investors
        of an aggregate of at least $15,000,000 but no more than $17,500,000 principal
        amount of Common Stock (the “Offering”). Holder understands that, as a condition
        to Closing, the Investors have required, and the Company has agreed to obtain,
        an agreement from the Holder to refrain from selling any securities of the
        Company in accordance with the terms and conditions set forth
        herein.

       

      2. Share
        Restriction.

       

      (a) Holder
        hereby agrees that during the period commencing on the Closing Date under
        the
        Stock Purchase Agreement, continuing through the effective date of the
        Registration Statement filed pursuant to Section 8 of the Stock Purchase
        Agreement and ending on the date that is twelve (12) months thereafter (the
        “Restriction Period”), the Holder will not offer, sell, contract to sell, sell
        any option or contract to purchase, purchase any option or contract to sell,
        sell short, grant any option, right or warrant to purchase, lend or otherwise
        transfer or dispose of any Shares or enter into any swap or other arrangement
        that transfers any economic consequences of ownership of Shares other than
        any
        transfer of Make Good Shares to an Investor and a transfer of 600,000 shares
        to
        Chinamerica Fund L.P. on Closing Date; provided, however, that 20% of the
        Holder’s Shares shall be released from and no longer subject to the foregoing
        restrictions after ninety (90) calendar days following the effective date
        of
        such Registration Statement, and further, provided, that such 20% may, at
        Holder’s option, be registered for resale under the Securities Act of 1933, as
        amended, on the Registration Statement to be filed pursuant to Section 8
        of the
        Stock Purchase Agreement. The foregoing sentence shall not apply with respect
        to
        an offer made to all shareholders of the Company in connection with any merger,
        consolidation or similar transaction involving the Company. Holder further
        agrees that the Company is authorized to and the Company agrees to place
“stop
        orders” on its books to prevent any transfer of Shares held by Holder in
        violation of this Agreement.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      (b) Any
        subsequent issuance to and/or acquisition of Common Stock or the right to
        acquire Common Stock by Holder will be subject to the provisions of this
        Agreement; provided, however, that the Restriction Period shall not be extended
        hereby with respect thereto.

       

      (c) Notwithstanding
        the foregoing restrictions on transfer, the Holder may, at any time and from
        time to time during the Restriction Period, transfer the Common Stock (i)
        as
        bona fide gifts or transfers by will or intestacy, (ii) to any trust for
        the
        direct or indirect benefit of the undersigned or the immediate family of
        the
        Holder, provided that any such transfer shall not involve a disposition for
        value, (iii) to a partnership which is the general partner of a partnership
        of
        which the Holder is a general partner, provided, that, in the case of any
        gift
        or transfer described in clauses (i), (ii) or (iii), each donee or transferee
        agrees in writing to be bound by the terms and conditions contained herein
        in
        the same manner as such terms and conditions apply to the undersigned. For
        purposes hereof, “immediate family” means any relationship by blood, marriage or
        adoption, not more remote than first cousin.

       

      3. Miscellaneous.

       

      (a) At
        any
        time, and from time to time, after the signing of this Agreement Holder will
        execute such additional instruments and take such action as may be reasonably
        requested by the Investors to carry out the intent and purposes of this
        Agreement. The Company agrees not to take any action or allow any act to
        be
        taken which would be inconsistent with this Agreement.

       

      (b) This
        Agreement shall be governed, construed and enforced in accordance with the
        laws
        of the State of New York without regard to conflicts of laws principles that
        would result in the application of the substantive laws of another jurisdiction,
        except to the extent that the securities laws of the state in which Holder
        resides and federal securities laws may apply. Any proceeding brought to
        enforce
        this Agreement may be brought exclusively in courts sitting in New York County,
        New York.

       

      (c) This
        Agreement contains the entire agreement of the Holder with respect to the
        subject matter hereof. This Agreement shall be binding upon Holder, its legal
        representatives, successors, heirs and assigns.

       

      (d) This
        Agreement may be signed in counterpart and delivered by facsimile or electronic
        transmission and such facsimile or electronic transmission signed and delivered
        shall be enforceable.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

      IN
        WITNESS WHEREOF, and intending to be legally bound hereby, Holder has executed
        this Agreement as of the day and year first above written.

       

      
        	 	 	HOLDER:
	 	 	 	 
	
              	 	 	
              
	
              	 	
                
(Signature
                of Holder)
	
              	 	 	
              
	 	 	 	 
	 	 	
                
(Print
                name of Holder)
	 	 	 	 
	 	 	 	 
	 	 	
                
                  

                

                Number
                  of shares of Common Stock 

                Beneficially
                  Owned

              
	 	 	 	 
	 	 	 	 
	 	 	
                
                  

                

                Number
                  of options, warrants or other rights to

                acquire
                  Common Stock

              
	 	 	 	 
	 	 	COMPANY:
	 	 	 	 
	 	 	
                WEST
                  COAST CAR COMPANY

              
	 	 	 	 
	 	 	By:  	 
	 	 	 	
                

                Name:
                  Qingtai Liu

              
	 	 	 	
                Title:
                  President and Chief Executive
                  Officer

              

      

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

       

    

    EXHIBIT
      C

     

    WEST
      COAST CAR COMPANY

    

    ___________________,
      2007

     

    Re:
      West
      Coast Car Company.; Registration Statement on Form S-1

    

    Dear
      Investor:

    

    Please
      be
      advised that the Company’s Registration Statement on Form S-1 (Registration No.
      333- ) (the “Registration
      Statement”)
      relating to the resale of your shares of common stock, $0.001 par value (the
      “Securities”),
      of
      the Company has been declared effective by the Securities and Exchange
      Commission and the prospectus dated ______________, 2007 (the “Prospectus”)
      is now
      available for use in connection therewith. As
      an Investor under the Registration Statement, you may have an obligation to
      deliver a copy of the Prospectus to each purchaser of your Securities, either
      directly or through the broker-dealer who executes the sale of your
      Securities.

    

    The
      Company is obligated to notify you in the event that it suspends trading under
      the Registration Statement in accordance with the terms of the Stock Purchase
      Agreement between the Company and you. During the period that the Registration
      Statement remains effective and trading thereunder has not been suspended,
      you
      will be permitted to sell your Securities which are included in the Prospectus
      under the Registration Statement. Upon a sale of any Securities under the
      Registration Statement, you or your broker will be required to deliver to the
      Transfer Agent, Corporate Stock Transfer, Inc. (1) your restricted stock
      certificate(s) representing the Securities, (2) instructions for transfer of
      the
      Securities sold, and (3) a representation letter from your broker, or from
      you
      if you are selling in a privately negotiated transaction, or from such other
      appropriate party, in the form of Exhibit 1
      attached
      hereto (the “Representation Letter”). The Representation Letter confirms that
      the Securities have been sold pursuant to the Registration Statement and in a
      manner described under the caption “Plan of Distribution” in the Prospectus and
      that such sale was made in accordance with all applicable securities laws,
      including any applicable prospectus delivery requirements.

    

    Please
      note that you are under no obligation to sell your Securities during the
      registration period. However, if you do decide to sell, you must comply with
      the
      requirements described in this letter or otherwise applicable to such sale.
      Your
      failure to do so may result in liability under the Securities Act of 1933,
      as
      amended, and the Securities Exchange Act of 1934, as amended. Please remember
      that all sales of your Securities must be carried out in the manner set forth
      under the caption “Plan of Distribution” in the Prospectus if you sell under the
      Registration Statement. The Company may require an opinion of counsel reasonably
      satisfactory to the Company if you choose another method of sale. You
      should consult with your own legal advisor(s) on an ongoing basis to ensure
      your
      compliance with the relevant securities laws and
      regulations.

    

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

       

    

    In
      order to maintain the accuracy of the Prospectus, you must notify the
      undersigned upon the sale, gift, or other transfer of any Securities by you,
      including the number of Securities being transferred, and in the event of any
      other change in the information regarding you which is contained in the
      Prospectus. For example, you must notify the undersigned if you enter into
      any
      arrangement with a broker-dealer for the sale of shares through a block trade,
      special offering, exchange distribution or secondary distribution or a purchase
      by a broker-dealer. Depending on the circumstances, such transactions may
      require the filing of a supplement to the prospectus in order to update the
      information set forth under the caption “Plan of Distribution” in the
      Prospectus.

    

    Should
      you need any copies of the Prospectus, or if you have any questions concerning
      the foregoing, please write to me at West Coast Car Company c/o Weifang Shengtai
      Pharmaceutical Co., Ltd., Hi-Tech Industrial Park of Changle County, Shandong
      Province, People’s Republic of China 262400 Attn: Mr. Qingtai Liu. Thank
      you.

     

    
      	 	 	 
	 	Sincerely,
	 	 
	 	WEST COAST CAR COMPANY
	 
 	 
 	 
 
	
            	By:  	
            
	 	
              
Qingtai
              Liu, President and
              CEO

    

    

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    Exhibit
      1

     

    CERTIFICATE
      OF SUBSEQUENT SALE

    

    Name
      and
      Address of Transfer Agent

    

    
      	 	
              RE:

            	
              Sale
                of Shares of Common Stock of West Coast Car Company (the “Company”)
                pursuant to the Company’s Prospectus dated _____________, 2007 (the
                “Prospectus”)

            

    

    

    Dear
      Sir/Madam:

    

    The
      undersigned hereby certifies, in connection with the sale of shares of Common
      Stock of the Company included in the table of Investors in the Prospectus,
      that
      the undersigned has sold the shares pursuant to the Prospectus and in a manner
      described under the caption “Plan of Distribution” in the Prospectus and that
      such sale complies with all securities laws applicable to the undersigned,
      including, without limitation, applicable Prospectus delivery requirements
      of
      the Securities Act of 1933, as amended.

     

    
 

    
      	
              Investor
                (the beneficial
                owner): _______________________________________________________

            
	 
	
              Record
                Holder (e.g., if held in name of
                nominee): ___________________________________________

            
	 
	
              Restricted
                Stock Certificate
                No.(s): _______________________________________________________

            
	 
	
              Number
                of Shares
                Sold: _______________________________________________________________

            
	 
	
              Date
                of
                Sale: ______________________________________________________________________

            

    

    

    In
      the
      event that you receive a stock certificate(s) representing more shares of Common
      Stock than have been sold by the undersigned, then you should return to the
      undersigned a newly issued certificate for such excess shares in the name of
      the
      Record Holder. Further, you should place a stop transfer on your records with
      regard to such certificate.

     

    

      
        	 	 	 	
                Very
                  truly yours,

              
	 	 	 	 	 
	Dated:	    
	 	
                By:

              	 
	 	 	 	 	 
	 	 	 	
                Print
                  Name:

              	 
	 	 	 	 	 
	 	 	 	
                Title: 

              	 

      

    

    

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    EXHIBIT
      D

    

    Capitalization
      Table

    

    Pre-Money
      Valuation: US$20.25 million

    Post-Money
      Valuation (in the event US$15 million is raised *): US$35.25 million

    Post-Money
      Valuation (in the event US$17.5 million is raised **): US$37.75
      million

    

    
      	
               

              Name
                of Shareholder

            	 	
               

              No.
                of Shares
                *

            	 	
               

              Percentage *

            	 	
               

              No.
                of Shares
                **

            	 	
               

              Percentage **

            	 
	
              Qingtai
                Liu

            	 	 	
              
              

              7,840,600

            	 	 	
              
              

              44.49

            	
              
              

              %

            	 	
              
              

              7,840,600

            	 	 	
              
              

              41.54

            	
              
              

              %

            
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Investors

            	 	 	
              7,500,000

            	 	 	
              42.55

            	
              %

            	 	
              8,750,000

            	 	 	
              46.36

            	
              %

            
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Others

            	 	 	
              
              

              2,284,400

            	 	 	
              
              

              12.96

            	
              
              

              %

            	 	
              
              

              2,284,400

            	 	 	
              
              

              12.10

            	
              
              

              %

            
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
              Total

            	 	 	
              17,625,000

            	 	 	
              100

            	
              %

            	 	
              18,875,000

            	 	 	
              100

            	
              %

            

    

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    EXHIBIT
      E

    

    Financials
      of Weifang Shengtai Pharmaceutical Co., Ltd.

    

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      F

    

    Weifang
      Shengtai Pharmaceutical Co., Ltd’s Risk Factors 

    

    For
      the purposes of this Exhibit F, references to “we” and “our” refer to Weifang
      Shengtai Pharmaceutical Co. Ltd.

    

    Risks
      related to doing business in the People’s Republic of China

    

    Our
      business operations take place primarily in the People’s Republic of China
      (“PRC”). Because Chinese laws, regulations and policies are continually
      changing, our Chinese operations will face several risks summarized
      below.

    

    Laws
      and Regulations

    

    Our
      offices and manufacturing plants are located in the PRC and the production,
      sale
      and distribution of your products are subject to Chinese rules and regulations.
      

    

    The
      PRC
      only recently has permitted provincial and local economic autonomy and private
      economic activities. Chinese government has exercised and continues to exercise
      substantial control over virtually every sector of the Chinese economy through
      regulation and state ownership. 

    

    Our
      ability to operate in the PRC may be harmed by changes in its laws and
      regulations, including those relating to taxation, import and export tariffs,
      environmental regulations, land use rights, property and other
      matters.

    

    Also,
      we
      are a state-licensed corporation and production and manufacturing facility
      and
      subject to Chinese regulation and environmental laws. The Chinese government
      has
      been active in regulating the pharmaceutical and medicinal goods industry.
      Our
      business and products are subject to government regulations mandating the use
      of
      good manufacturing practices. Changes in such laws or regulations in the PRC,
      or
      other countries we sell into, that govern or apply to our operations could
      have
      a materially adverse effect on our business. For example, the law could change
      so as to prohibit the use of certain chemical agents in our products. If such
      chemical agents are found in our products, then such a change would reduce
      our
      productivity of that product. 

    

    If
      we
      were to lose our state-licensed status, we would no longer be able to
      manufacture our products in the PRC, which is our sole operation. 

    

    Economic
      Reforms

    

    Although
      the Chinese government owns the majority of productive assets in the PRC, in
      the
      past several years the government has implemented economic reform measures
      that
      emphasize decentralization and encourage private economic activity.

    

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

       

    

    Because
      these economic reform measures may be inconsistent or ineffectual, there are
      no
      assurances that:

     

    
      	 	
              -

            	We will be able to capitalize on economic
              reforms;

      	 	 	 

      	 	
              -

            	
              The
                Chinese government will continue its pursuit of economic reform policies;
                

            

      	 	 	 

      	 	
              -

            	The economic policies, even if pursued, will be
              successful;

      	 	 	 

      	 	
              -

            	Economic policies will not be significantly altered
              from
              time to time; and 

    

     

    
      	 	
              -
                

            	
              Business
                operations in the PRC will not become subject to the risk of
                nationalization. 

            

    

    

    Since
      1979, the Chinese government has reformed its economic systems. Because many
      reforms are unprecedented or experimental, they are expected to be refined
      and
      improved. Other political, economic and social factors, such as political
      changes, changes in the rates of economic growth, unemployment or inflation,
      or
      in the disparities in per capita wealth between regions within the PRC, could
      lead to further readjustment of the reform measures. This refining and
      readjustment process may negatively affect our operations.

    

    Over
      the
      last few years, the PRC's economy has registered a high growth rate. During
      the
      past ten years, the rate of inflation in the PRC has been as high as 20.7%
      and
      as low as -2.2%. Recently, there have been indications that rates of inflation
      have increased. In response, the Chinese government recently has taken measures
      to curb this excessively expansive economy. These corrective measures were
      designed to restrict the availability of credit or regulate growth and contain
      inflation. These measures have included devaluations of the Chinese currency,
      the Renminbi (RMB), restrictions on the availability of domestic credit,
      reducing the purchasing capability of certain of its customers, and limited
      re-centralization of the approval process for purchases of some foreign
      products. These austerity measures alone may not succeed in slowing down the
      economy's excessive expansion or control inflation, and may result in severe
      dislocations in the Chinese economy. The Chinese government may adopt additional
      measures to further combat inflation, including the establishment of freezes
      or
      restraints on certain projects or markets.

    

    While
      inflation has been more moderate since 1995, high inflation may in the future
      cause Chinese government to impose controls on credit and/or prices, or to
      take
      other action, which could inhibit economic activity in China, and thereby harm
      the market for our products. Future inflation in China may inhibit our activity
      to conduct business in China.

    

    To
      date
      reforms to the PRC's economic system have not adversely impacted our operations
      and are not expected to adversely impact operations in the foreseeable future;
      however, there can be no assurance that the reforms to the PRC's economic system
      will continue or that we will not be adversely affected by changes in the PRC's
      political, economic, and social conditions and by changes in policies of the
      Chinese government, such as changes in laws and regulations, measures which
      may
      be introduced to control inflation, changes in the rate or method of taxation,
      imposition of additional restrictions on currency conversion and remittance
      abroad, and reduction in tariff protection and other import
      restrictions.

    

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

       

    

    Accordingly,
      government actions in the future, including any decision not to continue to
      support recent economic reforms and to return to a more centrally planned
      economy or regional or local variations in the implementation of economic
      policies, could have a significant effect on economic conditions in the PRC
      or
      particular regions thereof, and could require us to divest ourselves of any
      interest we then hold in Chinese properties or businesses.

    

    Limitations
      on Chinese economic market reforms may discourage foreign investment in Chinese
      businesses. The value of investments in Chinese businesses could be adversely
      affected by political, economic and social uncertainties in the PRC. The
      economic reforms in the PRC in recent years are regarded by the PRC's central
      government as a way to introduce economic market forces into the PRC. Given
      the
      overriding desire of the central government leadership to maintain stability
      in
      the PRC amid rapid social and economic changes in the country, the economic
      market reforms of recent years could be slowed, or even reversed.

    

    Any
      change in policy by the Chinese government could adversely affect investments
      in
      Chinese businesses. Changes in policy could result in imposition of restrictions
      on currency conversion, imports or the source of suppliers, as well as new
      laws
      affecting joint ventures and foreign-owned enterprises doing business in the
      PRC. Although the PRC has been pursuing economic reforms for the past two
      decades, events such as a change in leadership or social disruptions that may
      occur upon the proposed privatization of certain state-owned industries could
      significantly affect the government's ability to continue with its
      reform.

    

    We
      face
      economic risks in doing business in the PRC. As a developing nation, the PRC's
      economy is more volatile than that of developed Western industrial economies.
      It
      differs significantly from that of the U.S. or a Western European Country in
      such respects as structure, level of development, capital reinvestment, resource
      allocation and self-sufficiency. Only in recent years has the Chinese economy
      moved from what had been a command economy through the 1970s to one that during
      the 1990s encouraged substantial private economic activity. In 1993, the
      Constitution of the PRC was amended to reinforce such economic reforms. The
      trends of the 1990s indicate that future policies of the Chinese government
      will
      emphasize greater utilization of market forces. The PRC government has confirmed
      that economic development will follow the model of a market economy. For
      example, in 1999 the Government announced plans to amend the Chinese
      Constitution to recognize private property, although private business will
      officially remain subordinated to the state-owned companies, which are the
      mainstay of the Chinese economy. However, there can be no assurance that, under
      some circumstances, the government's pursuit of economic reforms will not be
      restrained or curtailed. Actions by the central government of the PRC could
      have
      a significant adverse effect on economic conditions in the country as a whole
      and on the economic prospects for our Chinese operations. Economic reforms
      could
      either benefit or damage our operations and profitability. Some of the things
      that could have this effect are: i) level of government involvement in the
      economy; ii) control of foreign exchange; methods of allocating resources;
      iv)
      international trade restrictions; and v) international conflict. 

    

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

       

    

    Under
      the
      present direction, we believe that the PRC will continue to strengthen its
      economic and trading relationships with foreign countries and business
      development in the PRC will follow market forces. While we believe that this
      trend will continue, there can be no assurance that this will be the case.
      A
      change in policies by the PRC government could adversely affect our interests
      by, among other factors: changes in laws, regulations or the interpretation
      thereof, confiscatory taxation, restrictions on currency conversion, imports
      or
      sources of supplies, or the expropriation or nationalization of private
      enterprises. Although the PRC government has been pursuing economic reform
      policies for more than two decades, there is no assurance that the government
      will continue to pursue such policies or that such policies may not be
      significantly altered, especially in the event of a change in leadership, social
      or political disruption, or other circumstances affecting the PRC's political,
      economic and social life.

    

    Legal
      and Judicial System

    

    The
      Chinese legal and judicial system may negatively impact foreign investors.
      In
      1982, the National People's Congress amended the Constitution of China to
      authorize foreign investment and guarantee the "lawful rights and interests"
      of
      foreign investors in the PRC. However, the PRC's system of laws is not yet
      comprehensive. The legal and judicial systems in the PRC are still rudimentary,
      and enforcement of existing laws is inconsistent. Many judges in the PRC lack
      the depth of legal training and experience that would be expected of a judge
      in
      a more developed country. Because the Chinese judiciary is relatively
      inexperienced in enforcing the laws that do exist, anticipation of judicial
      decision-making is more uncertain than would be expected in a more developed
      country. It may be impossible to obtain swift and equitable enforcement of
      laws
      that do exist, or to obtain enforcement of the judgment of one court by a court
      of another jurisdiction. The PRC's legal system is based on written statutes;
      a
      decision by one judge does not set a legal precedent that is required to be
      followed by judges in other cases. In addition, the interpretation of Chinese
      laws may be varied to reflect domestic political changes.

    

    The
      promulgation of new laws, changes to existing laws and the pre-emption of local
      regulations by national laws may adversely affect foreign investors. However,
      the trend of legislation over the last 20 years has significantly enhanced
      the
      protection of foreign investment and allowed for more control by foreign parties
      of their investments in Chinese enterprises. There can be no assurance that
      a
      change in leadership, social or political disruption, or unforeseen
      circumstances affecting the PRC's political, economic or social life, will
      not
      affect the Chinese government's ability to continue to support and pursue these
      reforms. Such a shift could have a material adverse effect on our business
      and
      prospects.

    

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

       

    

    The
      practical effect of the PRC legal system on our business operations in the
      PRC
      can be viewed from two separate but intertwined considerations. First, as a
      matter of substantive law, the Foreign Invested Enterprise laws provide
      significant protection from government interference. In addition, these laws
      guarantee the full enjoyment of the benefits of corporate Articles and contracts
      to Foreign Invested Enterprise participants. These laws, however, do impose
      standards concerning corporate formation and governance, which are not
      qualitatively different from the general corporation laws of the several states.
      Similarly, the PRC accounting laws mandate accounting practices, which are
      not
      consistent with U.S. Generally Accepted Accounting Principles. PRC’s accounting
      laws require that an annual "statutory audit" be performed in accordance with
      PRC accounting standards and that the books of account of Foreign Invested
      Enterprises are maintained in accordance with Chinese accounting laws. Article
      14 of the People's Republic of China Wholly Foreign-Owned Enterprise Law
      requires a Wholly Foreign-Owned Enterprise to submit certain periodic fiscal
      reports and statements to designated financial and tax authorities, at the
      risk
      of business license revocation. Second, while the enforcement of substantive
      rights may appear less clear than United States procedures, the Foreign Invested
      Enterprises and Wholly Foreign- Owned Enterprises are Chinese registered
      companies, which enjoy the same status as other Chinese registered companies
      in
      business-to-business dispute resolution. 

    

    Since
      our
      Articles of Association do not provide for the resolution of disputes business,
      the parties are free to proceed to either the Chinese courts or if they are
      in
      agreement, to arbitration. 

    

    Any
      award
      rendered by an arbitration tribunal is enforceable in accordance with the United
      Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards
      (1958). Therefore, as a practical matter, although no assurances can be given,
      the Chinese legal infrastructure, while different in operation from its United
      States counterpart, should not present any significant impediment to the
      operation of Foreign Invested Enterprises.

    

    The
      Chinese legal system is a civil law system based on written statutes. Unlike
      common law systems, it is a system in which precedents set in earlier legal
      cases are not generally used. The overall effect of legislation enacted over
      the
      past 20 years has been to enhance the protections afforded to foreign invested
      enterprises in China. However, these laws, regulations and legal requirements
      are relatively recent and are evolving rapidly, and their interpretation and
      enforcement involve uncertainties. These uncertainties could limit the legal
      protections available to foreign investors, such as the right of foreign
      invested enterprises to hold licenses and permits such as requisite business
      licenses. 

    

    In
      addition, our executive officers and our directors, most notably, Mr. Qingtai
      Liu, are residents of the PRC and not of the United States, and substantially
      all the assets of these persons are located outside the United States. As a
      result, it could be difficult for investors to affect service of process in
      the
      United States, or to enforce a judgment obtained in the United States against
      us
      or any of these persons.

    

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

       

    

    The
      PRC
      laws and regulations governing our current business operations are sometimes
      vague and uncertain. There are substantial uncertainties regarding the
      interpretation and application of PRC laws and regulations, including but not
      limited to the laws and regulations governing our business, or the enforcement
      and performance of our arrangements with customers in the event of the
      imposition of statutory liens, death, bankruptcy and criminal proceedings.
      These
      laws and regulations are sometimes vague and may be subject to future changes,
      and their official interpretation and enforcement may involve substantial
      uncertainty. The effectiveness of newly enacted laws, regulations or amendments
      may be delayed, resulting in detrimental reliance by foreign investors. New
      laws
      and regulations that affect existing and proposed future businesses may also
      be
      applied retroactively. We cannot predict what effect the interpretation of
      existing or new PRC laws or regulations may have on our business.

    

    Foreign
      Currency

    

    The
      majority of our revenues will be settled in Renminbi and U.S. Dollars, and
      any
      future restrictions on currency exchanges may limit our ability to use revenue
      generated in Renminbi to fund any future business activities outside the PRC
      or
      to make payments in U.S. dollars. Although the Chinese government introduced
      regulations in 1996 to allow greater convertibility of the Renminbi for current
      account transactions, significant restrictions still remain, including primarily
      the restriction that foreign-invested enterprises may only buy, sell or remit
      foreign currencies after providing valid commercial documents, at those banks
      in
      the PRC authorized to conduct foreign exchange business. 

    

    In
      addition, conversion of Renminbi for capital account items, including direct
      investment and loans, is subject to governmental approval in the PRC, and
      companies are required to open and maintain separate foreign exchange accounts
      for capital account items. We cannot be certain that the Chinese regulatory
      authorities will not impose more stringent restrictions on the convertibility
      of
      the Renminbi.

    

    The
      value
      of our common stock will be affected by the foreign exchange rate between U.S.
      dollars and Renminbi, and between those currencies and other currencies in
      which
      our sales may be denominated. For example, to the extent that we need to convert
      U.S. dollars into Renminbi for our operational needs and should the Renminbi
      appreciate against the U.S. dollar at that time, our financial position, the
      business of the Company, and the price of our common stock may be harmed.
      Conversely, if we decide to convert our Renminbi into U.S. dollars for the
      purpose of declaring dividends on our common stock or for other business
      purposes and the U.S. dollar appreciates against the Renminbi, our earnings
      will
      be reduced.

    

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

       

    

    The
      PRC
      government imposes controls on the convertibility of Renminbi ("RMB") into
      foreign currencies and, in certain cases, the remittance of currency out of
      the
      PRC. We receive substantially all of our revenues in RMB, which is currently
      not
      a freely convertible currency. Shortages in the availability of foreign currency
      may restrict our ability to remit sufficient foreign currency to pay dividends,
      or otherwise satisfy foreign currency dominated obligations. Under existing
      PRC
      foreign exchange regulations, payments of current account items, including
      profit distributions, interest payments and expenditures from the transaction,
      can be made in foreign currencies without prior approval from the PRC State
      Administration of Foreign Exchange by complying
      with certain procedural requirements. However, approval from appropriate
      governmental authorities is required where RMB is to be converted into foreign
      currency and remitted out of the PRC to pay capital expenses, such as the
      repayment of bank loans denominated in foreign currencies.

    

    The
      PRC
      government may also at its discretion restrict access in the future to foreign
      currencies for current account transactions. If the foreign exchange control
      system prevents us from obtaining sufficient foreign currency to satisfy our
      currency demands, we may not be able to pay certain expenses as they come
      due.

    

    On
      July
      21, 2005, the PRC government changed its decade-old policy of pegging the value
      of the RMB to the U.S. Dollar. Under the new policy, the RMB is permitted to
      fluctuate within a narrow and managed band against a basket of certain foreign
      currencies. This change in policy has resulted in an approximately 2.0%
      appreciation of the RMB against the U.S. Dollar. While the international
      reaction to the RMB revaluation has generally been positive, there remains
      significant international pressure on the PRC government to adopt an even more
      flexible currency policy, which could result in a further and more significant
      appreciation of the RMB against the U.S. Dollar.

    

    Recent
      PRC State Administration of Foreign Exchange ("SAFE") Regulations regarding
      offshore financing activities by PRC residents have undergone a number of
      changes which may increase the administrative burden we face. The failure by
      shareholders of foreign holding corporations who are PRC residents to make
      any
      required applications and filings pursuant to such regulations may prevent
      the
      foreign holding corporation from being able to distribute profits and could
      expose the foreign holding corporation and its PRC resident shareholders to
      liability under PRC law.

    

    SAFE
      issued a public notice ("October Notice") effective from November 1, 2005,
      which
      requires registration with SAFE by the PRC resident shareholders of any foreign
      holding company of a PRC entity. Without registration, the PRC entity cannot
      remit any of its profits out of the PRC as dividends or otherwise; however,
      it
      is uncertain how the October Notice will be interpreted or implemented. In
      addition, the October Notice requires that any monies remitted to PRC residents
      outside of the PRC be returned within 180 days; however, there is no indication
      of what the penalty will be for failure to comply or if shareholder
      non-compliance will be considered to be a violation of the October Notice by
      us
      or otherwise affect us.

    

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

       

    

    In
      the
      event that the proper procedures are not followed under the SAFE October Notice,
      our holding company could lose the ability to remit monies outside of the PRC
      and would therefore be unable to pay dividends or make other distributions.
      

    

    Risks
      related to our business 

    

    We
      give
      no assurances that any plans for future expansion will be
      implemented.

    

    We
      have a
      limited operating history and limited historical financial information upon
      which you may evaluate our performance.

    

    We
      are in
      our early stages of development and face risks associated with a new company
      in
      a growth industry. We may not successfully address these risks and uncertainties
      or successfully implement our operating strategies. If we fail to do so, it
      could materially harm our business to the point of having to cease operations
      and could impair the value of our common stock to the point investors may lose
      their entire investment. Even if we accomplish these objectives, we may not
      generate positive cash flows or the profits we anticipate in the
      future.

    

    Although
      our revenues have grown rapidly since our inception, we cannot assure you that
      we will maintain our profitability or that we will not incur net losses in
      the
      future. We expect that our operating expenses will increase as we expand. Any
      significant failure to realize anticipated revenue growth could result in
      significant operating losses. We will continue to encounter risks and
      difficulties frequently experienced by companies at a similar stage of
      development, including our potential failure to:

    

    
      	 	
              -
                

            	
              expand
                our product offerings and maintain the high quality of our
                products;

            

    

    

    
      	 	
              -
                

            	
              manage
                our expanding operations, including the integration of any future
                acquisitions;

            

    

    

    
      	 	
              -
                

            	
              obtain
                sufficient working capital to support our expansion and to fill customers'
                orders in time;

            

    

    

    
      	 	
              -
                

            	
              maintain
                adequate control of our expenses;

            

    

    

    
      	 	
              -
                

            	
              implement
                our product development, marketing, sales, and acquisition strategies
                and
                adapt and modify them as needed;

            

    

    

    
      	 	
              -
                

            	
              anticipate
                and adapt to changing conditions in the dextrose monohydrate and
                glucose
                products markets in which we operate as well as the impact of any
                changes
                in government regulation, mergers and acquisitions involving our
                competitors, technological developments and other significant competitive
                and market dynamics.

            

    

    

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

       

    

    If
      we are
      not successful in addressing any or all of these risks, our business may be
      materially and adversely affected.

    

    We
      will
      face a lot of competition, some of which may be better capitalized and more
      experienced than us. 

    

    We
      face
      competition in the pharmaceutical grade dextrose monohydrate and glucose
      industries. Although we view ourselves in a favorable position vis-à-vis our
      competition, some of the other companies that sell into our markets may be
      more
      successful than us and/or have more experience and money that we do. This
      additional experience and money may enable our competitors to produce more
      cost-effective products and market their products with more success than we
      are
      able to, which would decrease our sales. We expect that we will be required
      to
      continue to invest in product development and productivity improvements to
      compete effectively in our markets. However, we cannot give you assurance that
      we can successfully remain competitive. If our competitors could develop a
      more
      efficient product or undertake more aggressive and costly marketing campaigns
      than us, which may adversely affect our marketing strategies and could have
      a
      material adverse effect on our business, results of operations or financial
      condition.

    

    Our
      business is largely subject to the uncertain legal environment in the PRC and
      your legal protection could be limited.

    

    A
      slowdown or other adverse developments in the PRC economy may materially and
      adversely affect our customers, demand for our products and our
      business.

    

       All
      of
      our operations are conducted in the PRC and most of all of our revenues are
      generated from sales in the PRC. Although the PRC economy has grown
      significantly in recent years, we cannot assure you that such growth will
      continue. Also, while we believe the demand for our products are independent
      of
      the health of the economy, we do not know how sensitive we are to a slowdown
      in
      economic growth or other adverse changes in the PRC economy. A slowdown in
      overall economic growth, an economic downturn or recession or other adverse
      economic developments in the PRC may materially reduce the demand for our
      products and materially and adversely affect our business.

    

    Conversely,
      our major competitors may be better able than us to successfully endure
      downturns in our sector. In periods of reduced demand for our products, we
      can
      either choose to maintain market share by reducing our selling prices to meet
      competition or maintain selling prices, which would likely sacrifice market
      share. Sales and overall profitability would be reduced under either scenario.
      In addition, we cannot assure you that additional competitors will not enter
      our
      existing markets, or that we will be able to compete successfully against
      existing or new competition.

    

    Inflation
      in the PRC could negatively affect our profitability and growth.

    

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

       

    

    While
      the
      PRC economy has experienced rapid growth, such growth has been uneven
      among various sectors of the economy and in different geographical areas of
      the
      country. Rapid economic growth can lead to growth in the money supply and rising
      inflation. If prices for our products rise at a rate that is insufficient to
      compensate for the rise in the costs of supplies, it may have an adverse effect
      on profitability. In order to control inflation in the past, the PRC government
      has imposed controls on bank credits, limits on loans for fixed assets and
      restrictions on state bank lending. Such an austere policy can lead to a slowing
      of economic growth. In October 2004, the People's Bank of China, the PRC's
      central bank, raised interest rates for the first time in nearly a decade and
      indicated in a statement that the measure was prompted by inflationary concerns
      in the Chinese economy. Repeated rises in interest rates by the central bank
      would likely slow economic activity in China which could, in turn, materially
      increase our costs and also reduce demand for our products. 

    

    A
      renewed
      outbreak of SARS or another widespread public health problem in the
      PRC,
      such as bird flu where all of the Company's revenue is derived, could have
      an
      adverse effect on our operations. Our operations may be impacted by a number
      of
      health-related factors, including quarantines or closures of some offices that
      would adversely disrupt our operations.

    

    Any
      of
      the foregoing events or other unforeseen consequences of public health problems
      could adversely affect our operations.

    

    Because
      our principal assets are located outside of the U.S. and all of our directors
      and all our officers reside outside of the U.S., it may be difficult for you
      to
      enforce your rights based on U.S. Federal Securities Laws against us and our
      officers and some directors in the U.S. or to enforce a U.S. court judgment
      against us or them in the PRC.

    

    Further,
      it is unclear if extradition treaties now in effect between the U.S. and the
      PRC
      would permit effective enforcement against us or our officers and directors
      of
      criminal penalties under the U.S. Federal securities laws or
      otherwise.

    

    We
      may
      have difficulty establishing adequate management, legal and financial
controls
      in the PRC.

    

    The
      PRC
      historically has not adopted a western style of management and financial
      reporting concepts and practices, as well as in modern banking, computer and
      other control systems. We may have difficulty in hiring and retaining a
      sufficient number of qualified employees to work in the PRC. As a result of
      these factors, we may experience difficulty in establishing management, legal
      and financial controls, collecting financial data and preparing financial
      statements, books of account and corporate records and instituting business
      practices that meet Western standards.

    

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

       

    

    Our
      inability to fund our capital expenditure requirements may adversely affect
      our
      growth and profitability. Our continued growth is dependent upon our ability
      to
      raise capital from outside sources. Our ability to obtain financing will depend
      upon a number of factors, including:

    

    -
       our
      financial condition and results of operations,

    

    -
       the
      condition of the PRC economy and the healthcare sector in the PRC,
      and

    

    -
       conditions
      in relevant financial markets.

    

    If
      we are
      unable to obtain financing, as needed, on a timely basis and on acceptable
      terms, our financial position, competitive position, growth and profitability
      may be adversely affected.

    

    We
      may
      not be able to effectively control and manage our growth.

    

    If
      our
      business and markets grow and develop, it will be necessary for us to finance
      and manage expansion in an orderly fashion. In addition, we may face challenges
      in managing expanding product offerings and in integrating acquired businesses
      with our own. Such eventualities will increase demands on our existing
      management, workforce and facilities. Failure to satisfy such increased demands
      could interrupt or adversely affect our operations and cause production
      backlogs, longer product development time frames and administrative
      inefficiencies.

    

    We
      do not
      have any long-term supply contracts with our raw materials suppliers as the
      market price for the raw materials has been fairly stable. Any significant
      fluctuation in price of our raw materials may have a material adverse effect
      on
      the manufacturing cost of our products. We are subject to market conditions
      and
      although these raw materials are generally available and we have not experienced
      any raw material shortage in the past, we cannot assure you that the necessary
      materials will continue to be available to us at prices currently in effect
      or
      acceptable to us.

    

    We
      may
      have limited options in the short-term for alternative supply if our suppliers
      fail for any reason, including their business failure or financial difficulties,
      to continue the supply of materials or components. Moreover, identifying and
      accessing alternative sources may increase our costs.

    

    Although
      we are in the corn-producing region in the Shandong province, there is no
      guarantee that we will not face a shortage of corn because of some natural
      calamity or other reason. We have also mitigated the risks of a shortage in
      cornstarch by managing a cornstarch-producing company, Shouguang Shengtai Starch
      Company, and implemented a vertical integration manufacturing program, which
      includes building our own cornstarch processing plant. This will not only lower
      productions costs and improve profit margins, it will also allow Weifang
      Shengtai to produce higher quality, lower-cost cornstarch. We cannot guarantee
      such measures will be effective in eradicating all risks attendant to the supply
      of raw materials. In the event our cost of materials is increased, we may have
      to raise the prices of our products, making us less competitive
      price-wise.

    

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

       

    

    We
      may
      not be able to adjust our product prices, especially in the short-term, to
      recover the costs of any increases in raw materials. Our future profitability
      may be adversely affected to the extent we are unable to pass on higher raw
      material costs to our customers.

    

    We
      depend
      on a concentration of customers.

    

    Our
      revenue is dependent, in large part, on significant orders from certain
      customers. We believe that revenue derived from current and future large
      customers will continue to represent a significant portion of our total revenue
      although we plan to diversity our customer base by, among other things,
      expanding our international sales. Our inability to continue to secure and
      maintain a sufficient number of large customers or increase our customer base
      would have a material adverse effect on our business, operating results and
      financial condition. Moreover, our success will depend in part upon our ability
      to obtain orders from new customers, as well as the financial condition and
      success of our customers and general economic conditions.

    

    We
      usually enter into annual contracts with our domestic customers and long term
      contracts with our international customers. If there is an unforeseen
      circumstance e.g. in the dramatic increase of the costs of our raw materials,
      we
      may have to honor these contracts and suffer a loss if we are unable to
      renegotiate the terms.

    

    We
      may be
      exposed to intellectual property infringement and other claims by third parties,
      which, if successful, could cause us to pay significant damage awards and incur
      other costs.

    

    Our
      success also depends in large part on our ability to use and develop our
      technology and know-how without infringing the intellectual property rights
      of
      third parties. As litigation becomes more common in the PRC in resolving
      commercial disputes, we face a higher risk of being the subject of intellectual
      property infringement claims. The validity and scope of claims relating to
      manufacturing of pharmaceuticals involve complex technical, legal and factual
      questions and analysis and, therefore, may be highly uncertain. The defense
      and
      prosecution of intellectual property suits, patent opposition proceedings and
      related legal and administrative proceedings can be both costly and time
      consuming and may significantly divert the efforts and resources of our
      technical and management personnel. An adverse determination in any such
      litigation or proceedings to which we may become a party could subject us to
      significant liability, including damage awards, to third parties, require us
      to
      seek licenses from third parties, to pay ongoing royalties, or to redesign
      our
      products or subject us to injunctions preventing the manufacture and sale of
      our
      products. Protracted litigation could also result in our customers or potential
      customers deferring or limiting their purchase or use of our products until
      resolution of such litigation.

    

    Potential
      environmental liability could have a material adverse effect on our operations
      and financial condition.

    

    
      
        
        

      

      
        17

        
          

        

      

      
        
        

      

       

    

    To
      the
      knowledge of our management team, neither the production nor the sale of our
      products constitute activities, or generate materials in a material manner,
      that
      requires our operation to comply with the PRC environmental laws. Although
      it
      has not been alleged by PRC government officials that we have violated any
      current environmental regulations, we cannot assure you that the PRC government
      will not amend the current PRC environmental protection laws and regulations.
      Our business and operating results may be materially and adversely affected
      if
      we were to be held liable for violating existing environmental regulations
      or if
      we were to increase expenditures to comply with environmental regulations
      affecting our operations.

    

    We
      rely
      on Mr. Qingtai Liu, our chairman and president, for the management of our
      business, and the loss of his services may significantly harm our business
      and
      prospects.

    

    We
      depend, to a large extent, on the abilities and participation of our current
      management team, but have a particular reliance upon Mr. Qingtai Liu for the
      direction of our business. The loss of the services of Mr. Liu, for any reason,
      may have a material adverse effect on our business and prospects. We cannot
      assure you that the services of Mr. Liu will continue to be available to us,
      or
      that we will be able to find a suitable replacement for Mr. Liu.

    

    We
      do not
      have key man insurance on Mr. Qingtai Liu, our chairman and president, upon
      whom
      we rely primarily for the direction of our business. If Mr. Liu dies and we
      are
      unable to replace Mr. Liu for a prolonged period of time, we may be unable
      to
      carry out our long term business plan and our future prospect for growth, and
      our business, may be harmed.

    

    We
      may
      not be able to hire and retain qualified personnel to support our growth and
      if
      we are unable to retain or hire such personnel in the future, our ability to
      improve our products and implement our business objectives could be adversely
      affected.

    

    Our
      future success depends heavily upon the continuing services of the members
      of
      our senior management team, in particular our chairman and president, Mr.
      Qingtai Liu. If one or more of our senior executives or other key personnel
      are
      unable or unwilling to continue in their present positions, we may not be able
      to replace them easily or at all, and our business may be disrupted and our
      financial condition and results of operations may be materially and adversely
      affected. Competition for senior management and personnel is intense, the pool
      of qualified candidates is very limited, and we may not be able to retain the
      services of our senior executives or senior personnel, or attract and retain
      high-quality senior executives or senior personnel in the future. Such failure
      could materially and adversely affect our future growth and financial
      condition.

     

    We
      may
      not have adequate internal accounting controls. While we have certain internal
      procedures in our budgeting, forecasting and in the management and allocation
      of
      funds, such controls may not be adequate.

     

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

    

     

    We
      presently do not have an experienced Chief Financial Officer who is conversant
      with U.S. Generally Accepted Accounting Principles and knowledgeable in our
      industry but we intend to search for a suitably qualified person to fill this
      position. There is no guarantee that we would be successful in our search or
      would be successful in retaining such a person. If we are unable to find a
      suitable candidate or unable to retain his services, we may not be able to
      comply with our continuing financial reporting obligations and our financial
      condition and results of operations may be materially and adversely
      affected,

    

    We
      do not
      presently maintain product liability insurance, and our property and equipment
      insurance does not cover the full value of our property and equipment, which
      leaves us with exposure in the event of loss or damage to our properties or
      claims filed against us.

    

    We
      currently do not carry any product liability or other similar insurance. We
      cannot assure you that we would not face liability in the event of the failure
      of any of our products. This is particularly true given our plan to
      significantly expand our sales into international markets, like the United
      States, where product liability claims are more prevalent.

    

    Except
      for property and automobile insurance, we do not have other insurance such
      as
      business liability or disruption insurance coverage for our operations in the
      PRC.

    

    We
      do not
      maintain a reserve fund for warranty or defective products claims. Our costs
      could substantially increase if we experience a significant number of warranty
      claims. We have not established any reserve funds for potential warranty claims
      since historically we have experienced few warranty claims for our products
      so
      that the costs associated with our warranty claims have been low. If we
      experience an increase in warranty claims or if our repair and replacement
      costs
      associated with warranty claims increase significantly, it would have a material
      adverse effect on our financial condition and results of
      operations.

    

    
      
        
        

      

      
        19

        
          

        

      

      
        
        

      

    

    EXHIBIT
      G

     

     

    FORM
      OF WARRANT

     

    NEITHER
      THIS WARRANT NOR ANY SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THIS
      WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
      AND
      THE RULES AND REGULATIONS PROMULGATED THEREUNDER (THE “SECURITIES
      ACT”).
      THIS
      WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT
      BE
      OFFERED, SOLD, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF REGISTRATION UNDER
      THE
      SECURITIES ACT OR UNLESS SUCH OFFER, SALE OR TRANSFER IS EXEMPT FROM SUCH
      REGISTRATION.

    

    WEST
      COAST CAR COMPANY

     

    COMMON
      STOCK WARRANT

     

    
      	No.
              __________	 	 	May __,
              2007

    

     

    WEST
      COAST CAR COMPANY,
      a
      Delaware corporation (the “Company”),
      hereby certifies that ______________________________________, its permissible
      transferees, designees, successors and assigns (collectively, the “Holder”), for
      value received, is entitled to purchase from the Company at any time commencing
      on the effective date (the “Effective Date”), and terminating on the fifth
      anniversary of the date of issuance of this Warrant (the “Termination Date”)
      _____________ shares (each, a “Share” and collectively the “Shares”) of the
      Company’s common stock, $.001 par value per Share (the “Common Stock”), at an
      exercise price $2.60 per Share (the “Exercise Price”). The number of Shares
      purchasable hereunder and the Exercise Price are subject to adjustment as
      provided in Section 4 hereof. 

     

    1. Exercise
      of Warrant.

     

    (a) The
      purchase right represented by this Common Stock Warrant (this "Warrant") is
      exercisable, in whole or in part, at any time and from time to time from and
      after the Effective Date through and including the Termination
      Date.

     

    (b) Upon
      presentation and surrender of this Warrant, accompanied by a completed Election
      to Purchase in the form attached hereto as Exhibit
      A
      (the
“Election
      to Purchase”)
      duly
      executed, at the principal office of the Company currently located at 45 Old
      Millstone Drive, Unit #6, East Windsor, NJ 08520 (or
      such
      other office or agency of the Company as the Company may designate to the
      Holder) together with a check payable to, or wire transfer to, the Company
      in
      the amount of the Exercise Price multiplied by the number of Shares being
      purchased, the Company or the Company’s transfer agent, as the case may be,
      shall within three (3) business days deliver to the Holder hereof certificates
      of fully paid and non-assessable Common Stock which in the aggregate represent
      the number of Shares being purchased. The certificates so delivered shall be
      in
      such denominations as may be requested by the Holder and shall be registered
      in
      the name of the Holder or such other name as shall be designated by the Holder.
      All or less than all of the purchase rights represented by this Warrant may
      be
      exercised and, in case of the exercise of less than all, the Company, upon
      surrender hereof, will at the Company’s expense deliver to the Holder a new
      warrant entitling said holder to purchase the number of Shares represented
      by
      this Warrant which have not been exercised. This Warrant may only be exercised
      to the extent the Company has a sufficient number of Shares of Common Stock
      available for issuance at the time of any exercise. The Company convenants
      that
      it will maintain a sufficient number of authorized and unissued shares of Common
      stock, available for issuance, to satisfy the Company’s obligations under all
      outstanding Warrants.

     

    
      
        
        

      

      
        20

        
          

        

      

      
        
        

      

    

     

    
      	2.	
              Warrant.

            

    

     

    (a) Exchange,
      Transfer and Replacement.
      At any
      time prior to the exercise hereof, this Warrant may be exchanged upon
      presentation and surrender to the Company, alone or with other warrants of
      like
      tenor of different denominations registered in the name of the same Holder,
      for
      another warrant or warrants of like tenor in the name of such Holder exercisable
      for the aggregate number of Shares as the warrant or warrants
      surrendered.

     

    (b) Replacement
      of Warrant.
      Upon
      receipt of evidence reasonably satisfactory to the Company of the loss, theft,
      destruction, or mutilation of this Warrant and, in the case of any such loss,
      theft, or destruction, upon delivery of an indemnity agreement reasonably
      satisfactory in form and amount to the Company, or, in the case of any such
      mutilation, upon surrender and cancellation of this Warrant, the Company, at
      its
      expense, will execute and deliver in lieu thereof, a new Warrant of like
      tenor.

     

    (c)
      Cancellation;
      Payment of Expenses.
      Upon
      the surrender of this Warrant in connection with any transfer, exchange or
      replacement as provided in this Section 2, this Warrant shall be promptly
      canceled by the Company. The Holder shall pay all taxes and all other expenses
      (including legal expenses, if any, incurred by the Holder or transferees) and
      charges payable in connection with the preparation, execution and delivery
      of
      Warrants pursuant to this Section 2. 

     

    (d)
      Warrant
      Register.
      The
      Company shall maintain, at its principal executive offices (or at the offices
      of
      the transfer agent for the Warrant or such other office or agency of the Company
      as it may designate by notice to the holder hereof), a register for this Warrant
      (the “Warrant Register”), in which the Company shall record the name and address
      of the person in whose name this Warrant has been issued, as well as the name
      and address of each transferee and each prior owner of this
      Warrant.

     

    
      
        
        

      

      
        21

        
          

        

      

      
        
        

      

    

     

    
      	3.	
              Rights
                and Obligations of Holders of this Warrant.
                The Holder of this Warrant shall not, by virtue hereof, be entitled
                to any
                rights of a stockholder in the Company, either at law or in equity;
                provided,
                however,
                that in the event any certificate representing shares of Common Stock
                or
                other securities is issued to the holder hereof upon exercise of
                this
                Warrant, such holder shall, for all purposes, be deemed to have become
                the
                holder of record of such Common Stock on the date on which this Warrant,
                together with a duly executed Election to Purchase, was surrendered
                and
                payment of the aggregate Exercise Price was made, irrespective of
                the date
                of delivery of such Common Stock
                certificate.

            

    

     

    
      	4.	
              Adjustments.
                

            

    

     

    (a) Stock
      Dividends, Reclassifications, Recapitalizations, Etc.
      In the
      event that after the Effective Date the Company: (i) pays a dividend in
      Common Stock or makes a distribution in Common Stock, (ii) subdivides its
      outstanding Common Stock into a greater number of shares, (iii) combines
      its outstanding Common Stock into a smaller number of shares or
      (iv) increases or decreases the number of shares of Common Stock
      outstanding by reclassification of its Common Stock (including a
      recapitalization in connection with a consolidation or merger in which the
      Company is the continuing corporation), then (1) the Exercise Price on the
      record date of such division or distribution or the effective date of such
      action shall be adjusted by multiplying such Exercise Price by a fraction,
      the
      numerator of which is the number of shares of Common Stock outstanding
      immediately before such event and the denominator of which is the number of
      shares of Common Stock outstanding immediately after such event, and
      (2) the number of shares of Common Stock for which this Warrant may be
      exercised immediately before such event shall be adjusted by multiplying such
      number by a fraction, the numerator of which is the Exercise Price immediately
      before such event and the denominator of which is the Exercise Price immediately
      after such event.

     

    (b) Subject
      to Sections 4(f) and (g), in the event the Company issues, during the period
      of
      eighteen (18) months after the Effective Date, any additional shares of Common
      Stock at a price per share less than $2.60 or without consideration, then the
      Warrant price upon each such issuance shall be adjusted to the price equal
      to
      the consideration per share paid for such additional shares of Common
      Stock.

     

    (c) In
      the
      event the Company shall at any time within eighteen (18) months following the
      original issuance of this Warrant take a record of the holders of its Common
      Stock for the purpose of entitling them to receive a distribution of, or shall
      in any manner (whether directly or by assumption in a merger in which the
      Company is the surviving corporation) issue or sell, any Common Stock
      equivalents, whether or not the rights to exchange or convert thereunder are
      immediately exercisable, and the price per share for which Common Stock is
      issuable upon such conversion or exchange shall be less than $2.60 immediately
      prior to the time of such issue or sale, or if, after any such issuance of
      Common Stock Equivalents, the price per share for which additional shares of
      Common Stock may be issuable thereafter is amended or adjusted, and such price
      as so amended shall be less than $2.60 at the time of such amendment or
      adjustment, then the Warrant price then in effect shall be adjusted as provided
      in Section 4(b). No further adjustments of the number of shares of Common Stock
      for which this Warrant is exercisable and the Warrant price then in effect
      shall
      be made upon the actual issue of such Common Stock upon conversion or exchange
      of such Common Stock equivalents.

     

    
      
        
        

      

      
        22

        
          

        

      

      
        
        

      

    

     

    (d) Other
      Provisions Applicable to Adjustments under this Section.
      The
      following provisions shall be ap-plicable to the making of adjustments of the
      number of shares of Common Stock for which this Warrant is exercisable and
      the
      Warrant price then in effect provided for in this Section 4:

    

    (i) Computation
      of Consideration.
      To the
      extent that any additional shares of Common Stock or any Common Stock
      equivalents (or any warrants or other rights therefor) shall be issued for
      cash
      consideration, the consideration received by the Company therefor shall be
      the
      amount of the cash received by the Company therefor, or, if such additional
      shares of Common Stock or Common Stock equivalents are offered by the Company
      for subscription, the subscription price, or, if such additional shares of
      Common Stock or Common Stock equivalents are sold to underwriters or dealers
      for
      public offering without a subscription offering, the initial public offering
      price (in any such case subtracting any amounts paid or receivable for accrued
      interest or accrued dividends and without taking into account any compensation,
      discounts or expenses paid or incurred by the Company for and in the
      underwriting of, or otherwise in connection with, the issuance thereof). In
      connection with any merger or consolidation in which the Company is the
      surviving corporation (other than any consolidation or merger in which the
      previously outstanding shares of Common Stock of the Company shall be changed
      to
      or exchanged for the stock or other securities of another corporation), the
      amount of consideration therefore shall be, deemed to be the fair value, as
      determined reasonably and in good faith by the Board and acceptable to the
      Holder, of such portion of the assets and business of the nonsurviving
      corporation as the Board may determine to be attributable to such shares of
      Common Stock or Common Stock equivalents, as the case may be. The consideration
      for any additional shares of Common Stock issuable pursuant to any Warrants
      or
      other rights to subscribe for or purchase the same shall be the consideration
      received by the Company for issuing such Warrants or other rights plus the
      additional con-sideration payable to the Company upon exercise of such Warrants
      or other rights. The consideration for any additional shares of Common Stock
      issuable pursuant to the terms of any Common Stock equivalents shall be the
      consideration received by the Company for issuing War-rants or other rights
      to
      subscribe for or purchase such Common Stock equivalents, plus the consideration
      paid or payable to the Company in respect of the subscription for or purchase
      of
      such Common Stock equivalents, plus the additional consideration, if any,
      payable to the Company upon the exercise of the right of conversion or exchange
      in such Common Stock equivalents. In the event of any consolidation or merger
      of
      the Company in which the Company is not the surviving corporation or in which
      the previously outstanding shares of Common Stock of the Company shall be
      changed into or exchanged for the stock or other securities of another
      corporation, or in the event of any sale of all or substantially all of the
      assets of the Company for stock or other securities of any corporation, the
      Company shall be deemed to have issued a number of shares of its Common Stock
      for stock or securities or other property of the other corporation computed
      on
      the basis of the actual exchange ratio on which the transaction was predicated,
      and for a consideration equal to the fair market value on the date of such
      transaction of all such stock or securities or other property of the other
      corporation. In the event any consideration received by the Company for any
      securities consists of property other than cash, the fair market value thereof
      at the time of issuance or as otherwise applicable shall be as determined in
      good faith by the Board. In the event Common Stock is issued with other shares
      or securities or other assets of the Issuer for consideration which covers
      both,
      the consideration computed as provided in this Section 4(d)(i) shall be
      allocated among such securities and assets as determined in good faith by the
      Board.

     

    
      
        
        

      

      
        23

        
          

        

      

      
        
        

      

    

     

    (ii) When
      Adjustments to Be Made.
      The
      adjustments required by this Section 4 shall be made whenever and as often
      as
      any specified event requiring an adjustment shall occur, except that any
      adjustment of the number of shares of Common Stock for which this Warrant is
      exercisable that would otherwise be required may be postponed (except in the
      case of a subdivision or combination of shares of the Common Stock, but not
      beyond the date of exercise if such adjustment either by itself or with other
      adjustments not previously made adds or subtracts less than one percent (1%)
      of
      the shares of Common Stock for which this Warrant is exercisable immediately
      prior to the making of such adjustment. Any adjustment representing a change
      of
      less than such minimum amount (except as aforesaid) which is postponed shall
      be
      carried forward and made as soon as such adjustment, together with other
      adjustments required by this Section 4 and not previously made, would result
      in
      a minimum adjustment or on the date of exercise. For the purpose of any
      adjustment, any specified event shall be deemed to have occurred at the close
      of
      business on the date of its occurrence.

    

    (iii) Fractional
      Interests.
      In
      computing ad-justments under this Section 4, fractional interests in Common
      Stock shall be taken into account to the near-est one one-hundredth
      (1/100th)
      of a
      share.

    

    (iv) When
      Adjustment Not Required.
      If the
      Company shall take a record of the holders of its Common Stock for the purpose
      of entitling them to receive a dividend or distribution or subscription or
      purchase rights and shall, thereafter and before the distribution to
      stockholders thereof, legally abandon its plan to pay or deliver such dividend,
      distribution, subscription or purchase rights, then thereafter no adjustment
      shall be required by reason of the taking of such record and any such adjustment
      previously made in respect thereof shall be rescinded and annulled.

     

    
      
        
        

      

      
        24

        
          

        

      

      
        
        

      

    

     

    (e) Form
      of Warrant after Adjustments.
      The
      form of this Warrant need not be changed because of any adjustments in the
      Warrant Price or the number and kind of Securities purchasable upon the exercise
      of this Warrant.

    

    (f) Cash
      Dividends and Other Distributions.
      In the
      event that at any time or from time to time the Company shall distribute to
      all
      holders of Common Stock (i) any dividend or other distribution of cash,
      evidences of its indebtedness, shares of its capital stock or any other
      properties or securities or (ii) any options, warrants or other rights to
      subscribe for or purchase any of the foregoing (other than in each case,
      (w) the issuance of any rights under a shareholder rights plan,
      (x) any dividend or distribution described in Section 4(a) and (y) any
      rights, options, warrants or securities described in Section 4(c)), then the
      number of shares of Common Stock issuable upon the exercise of this Warrant
      shall be increased to a number determined by multiplying the number of shares
      of
      Common Stock issuable upon the exercise of this Warrant immediately prior to
      the
      record date for any such dividend or distribution by a fraction, the numerator
      of which shall be such Current Market Value (as hereinafter defined) per share
      of Common Stock on the record date for such dividend or distribution, and the
      denominator of which shall be such Current Market Value per share of Common
      Stock on the record date for such dividend or distribution less the sum of
      (x)
      the amount of cash, if any, distributed per share of Common Stock and (y) the
      fair value (as determined in good faith by the Board of Directors of the
      Company, whose determination shall be evidenced by a board resolution, a copy
      of
      which will be sent to the Holders upon request) of the portion, if any, of
      the
      distribution applicable to one share of Common Stock consisting of evidences
      of
      indebtedness, shares of stock, securities, other property, warrants, options
      or
      subscription or purchase rights; and the Exercise Price shall be adjusted to
      a
      number determined by dividing the Exercise Price immediately prior to such
      record date by the above fraction. Such adjustments shall be made whenever
      any
      distribution is made and shall become effective as of the date of distribution,
      retroactive to the record date for any such distribution. No adjustment shall
      be
      made pursuant to this Section 4(b) which shall have the effect of decreasing
      the
      number of shares of Common Stock issuable upon exercise of this Warrant or
      increasing the Exercise Price. 

     

    (g) Combination;
      Liquidation.
      (i) In the event of a Combination (as defined below), each Holder shall
      have the right to receive upon exercise of the Warrant the kind and amount
      of
      shares of capital stock or other securities or property which such Holder would
      have been entitled to receive upon or as a result of such Combination had such
      Warrant been exercised immediately prior to such event (subject to further
      adjustment in accordance with the terms hereof). Unless paragraph (ii) is
      applicable to a Combination, the Company shall provide that the surviving or
      acquiring Person (the “Successor Company”) in such Combination will assume by
      written instrument the obligations under this Section 4 and the obligations
      to deliver to the Holder such shares of stock, securities or assets as, in
      accordance with the foregoing provisions, the Holder may be entitled to acquire.
      “Combination” means an event in which the Company consolidates with, mergers
      with or into, or sells all or substantially all of its assets to another Person,
      where “Person” means any individual, corporation, partnership, joint venture,
      limited liability company, association, joint-stock company, trust,
      unincorporated organization, government or any agency or political subdivision
      thereof or any other entity; (ii) In the event of (x) a Combination where
      consideration to the holders of Common Stock in exchange for their shares is
      payable solely in cash or (y) the dissolution, liquidation or winding-up of
      the
      Company, the Holders shall be entitled to receive, upon surrender of their
      Warrant, distributions on an equal basis with the holders of Common Stock or
      other securities issuable upon exercise of the Warrant, as if the Warrant had
      been exercised immediately prior to such event, less the Exercise Price. In
      case
      of any Combination described in this Section 4, the surviving or acquiring
      Person and, in the event of any dissolution, liquidation or winding-up of the
      Company, the Company, shall deposit promptly with an agent or trustee for the
      benefit of the Holders all the funds, if any, necessary to pay to the Holders
      the amounts to which they are entitled as described above. As each Warrant
      is
      received, the Company is required to deliver a check in such amount as is
      appropriate (or, in the case of consideration other than cash, such other
      consideration as is appropriate) to the Holders surrendering such
      Warrant.

     

    
      
        
        

      

      
        25

        
          

        

      

      
        
        

      

    

     

    a. Notice
      of Adjustment.
      Whenever the Exercise Price or the number of shares of Common Stock and other
      property, if any, issuable upon exercise of the Warrant is adjusted, as herein
      provided, the Company shall deliver to the Holders of the Warrants in accordance
      with Section 10 a certificate of the Company’s Chief Financial Officer
      setting forth, in reasonable detail, the event requiring the adjustment and
      the
      method by which such adjustment was calculated (including a description of
      the
      basis on which (i) the Board of Directors determined the fair value of any
      evidences of indebtedness, other securities or property or warrants, options
      or
      other subscription or purchase rights and (ii) the Current Market Value of
      the
      Common Stock was determined, if either of such determinations were required),
      and specifying the Exercise Price and number of shares of Common Stock issuable
      upon exercise of Warrant after giving effect to such adjustment.

     

    b.Notice
      of Certain Transactions.
      In the
      event that the Company shall propose (a) to pay any dividend payable in
      securities of any class to the holders of its Common Stock or to make any other
      non-cash dividend or distribution to the holders of its Common Stock,
      (b) to offer the holders of its Common Stock rights to subscribe for or to
      purchase any securities convertible into shares of Common Stock or shares of
      stock of any class or any other securities, rights or options, (c) to
      effect any capital reorganization, reclassification, consolidation or merger
      affecting the class of Common Stock, as a whole, or (d) to effect the
      voluntary or involuntary dissolution, liquidation or winding-up of the Company,
      the Company shall, within the time limits specified below, send to each Holder
      a
      notice of such proposed action or offer. Such notice shall be mailed to the
      Holders at their addresses as they appear in the Warrant Register (as defined
      in
      Section 2(d)),
      which
      shall specify the record date for the purposes of such dividend, distribution
      or
      rights, or the date such issuance or event is to take place and the date of
      participation therein by the holders of Common Stock, if any such date is to
      be
      fixed, and shall briefly indicate the effect of such action on the Common Stock
      and on the number and kind of any other shares of stock and on other property,
      if any, and the number of shares of Common Stock and other property, if any,
      issuable upon exercise of each Warrant and the Exercise Price after giving
      effect to any adjustment pursuant to Section 4 which will be required as a
      result of such action. Such notice shall be given as promptly as possible and
      (x) in the case of any action covered by clause (a) or (b) above, at least
      ten
      (10) days prior to the record date for determining holders of the Common Stock
      for purposes of such action or (y) in the case of any other such action, at
      least twenty (20) days prior to the date of the taking of such proposed action
      or the date of participation therein by the holders of Common Stock, whichever
      shall be the earlier.

     

    
      
        
        

      

      
        26

        
          

        

      

      
        
        

      

    

     

    c. Current
      Market Value.“Current
      Market Value” per share of Common Stock or any other security at any date means
      (i) if the security is not registered under the Securities Exchange Act of
      1934
      and/or traded on a national securities exchange, quotation system or bulletin
      board, as amended (the “Exchange Act”), (a) the value of the security,
      determined in good faith by the Board of Directors of the Company and certified
      in a board resolution, based on the most recently completed arm’s-length
      transaction between the Company and a Person other than an affiliate of the
      Company or between any two such Persons and the closing of which occurs on
      such
      date or shall have occurred within the six-month period preceding such date,
      or
      (b) if no such transaction shall have occurred within the six-month period,
      the
      value of the security as determined by an independent financial expert or an
      agreed upon financial valuation model or (ii) if the security is registered
      under the Exchange Act and/or traded on a national securities exchange,
      quotation system or bulletin board, the average of the daily closing bid prices
      (or the equivalent in an over-the-counter market) for each day on which the
      Common Stock is traded for any period on the principal securities exchange
      or
      other securities market on which the common Stock is being traded (each, a
      “Trading Day”) during the period commencing thirty (30) days before such date
      and ending on the date one day prior to such date.

     

    
      	
              5.

            	
              Fractional
                Shares.
                In lieu of issuance of a fractional share upon any exercise hereunder,
                the
                Company will pay the cash value of that fractional share, calculated
                on
                the basis of the Exercise Price. 

            

    

     

    
      	
              6.

            	
              Legends.
                Prior to issuance of the shares of Common Stock underlying this Warrant,
                all such certificates representing such shares shall bear a restrictive
                legend to the effect that the Shares represented by such certificate
                have
                not been registered under the 1933 Act, and that the Shares may not
                be
                sold or transferred in the absence of such registration or an exemption
                therefrom, such legend to be substantially in the form of the bold-face
                language appearing at the top of Page 1 of this Warrant.
                

            

    

     

    
      
        
        

      

      
        27

        
          

        

      

      
        
        

      

    

     

    
      	7.	
              Call
                Rights.
                The Company shall have the right to call the
                exercise of all, or the remaining portion of this Warrant outstanding
                and
                unexercised
                at
                the Exercise Price in the event (i) the Volume Weighted Average Price
                (“VWAP”) of the Company’s Common Stock equals or exceeds $8.00 per share
                during any twenty (20) consecutive trading days and (ii) all Shares
                for
                which this Warrant is exercisable are registered for resale by the
                Holder
                (the “Call Conditions”). For the purposes of this Warrant, the VWAP shall
                be the volume weighted average price reported by Bloomberg for the
                Common
                Stock. Within ten (10) business days of the Call Conditions, the
                Company
                shall deliver a notice to each registered Holder of the Warrants
                setting
                for the number of Warrants held and the dollar amount due to exercise
                the
                Warrants (the “Call Notice”). Each Holder shall have thirty (30) calendar
                days from the receipt of the Call Notice to exercise the remaining
                balance
                of the Warrant (the “Call Period”). Upon the expiration of the Call
                Period, any unexercised Warrant shall automatically expire.
                

            

    

    

     

    
      	8.	
              Disposition
                of Warrants or Shares; Lockup.
                

            

    

     

    The
      Holder of this Warrant, each transferee hereof and any holder and transferee
      of
      any Shares, by his or its acceptance thereof, agrees that no public distribution
      of Warrants or Shares will be made in violation of the provisions of the
      Securities Act of 1933, as amended. Furthermore, it shall be a condition to
      the
      transfer of this Warrant that any transferee thereof deliver to the Company
      his
      or its written agreement to accept and be bound by all of the terms and
      conditions contained in this Warrant. 

     

    
      	9.	
              Merger
                or Consolidation.
                The Company will not merge or consolidate with or into any other
                corporation, or sell or otherwise transfer its property, assets and
                business substantially as an entirety to another corporation, unless
                the
                corporation resulting from such merger or consolidation (if not the
                Company), or such transferee corporation, as the case may be, shall
                expressly assume, by supplemental agreement reasonably satisfactory
                in
                form and substance to the Holder, the due and punctual performance
                and
                observance of each and every covenant and condition of this Warrant
                to be
                performed and observed by the
                Company.

            

    

     

    
      	10.	
              Notices.
                Except as otherwise specified herein to the contrary, all notices,
                requests, demands and other communications required or desired to
                be given
                hereunder shall only be effective if given in writing by certified
                or
                registered U.S. mail with return receipt requested and postage prepaid;
                by
                private overnight delivery service (e.g. Federal Express); by facsimile
                transmission (if no original documents or instruments must accompany
                the
                notice); or by personal delivery. Any such notice shall be deemed
                to have
                been given (a) three business days immediately following the mailing
                thereof, if mailed by certified or registered U.S. mail as specified
                above; (b) on the business day immediately following deposit with
                a
                private overnight delivery service if sent by said service; (c) upon
                receipt of confirmation of transmission if sent by facsimile transmission;
                or (d) upon personal delivery of the notice. All such notices shall
                be
                sent to the following addresses (or to such other address or addresses
                as
                a party may have advised the other in the manner provided in this
                Section 10):

            

    

     

    
      
        
        

      

      
        28

        
          

        

      

      
        
        

      

    

     

    if
      to the Company:

     

    West
      Coast Car Company

    45
      Old
      Millstone Drive, Unit #6, East Windsor, NJ 08520

    Attention:
      David Du

    Facsimile:
      (609) 4268996

     

    If
      to the Holder:

    

    ____________________

    ____________________

    ____________________

    ____________________

    

    Notwithstanding
      the time of effectiveness of notices set forth in this Section, an Election
      to
      Purchase shall not be deemed effectively given until it has been duly completed
      and submitted to the Company together with this original Warrant and payment
      of
      the Exercise Price in a manner set forth in this Section.

     

    
      	11.	
              Governing
                Law.
                This Warrant shall be governed by and construed in accordance with
                the
                laws of the State of Delaware applicable to contracts made and to
                be
                performed in the State of Delaware.

            

    

     

    
      	12.	
              Successors
                and Assigns.
                This Warrant shall be binding upon and shall inure to the benefit
                of the
                parties hereto and their respective successors and
                assigns.

            

    

     

    
      	13.	
              Headings.
                The headings of various sections of this Warrant have been inserted
                for
                reference only and shall not affect the meaning or construction of
                any of
                the provisions hereof.

            

    

     

    
      	14.	
              Severability.
                If any provision of this Warrant is held to be unenforceable under
                applicable law, such provision shall be deemed automatically modified
                only
                to the extent necessary to make such provision enforceable, and the
                balance hereof shall be interpreted as if such provision were so
                modified.

            

    

     

    
      	15.	
              Modification
                and Waiver.
                This Warrant and any provision hereof may be amended, waived, discharged
                or terminated only by an instrument in writing signed by the Company
                and
                the Holder, except as provided in Section 14.

            

    

     

    
      	16.	
              Specific
                Enforcement.
                The Company and the Holder acknowledge and agree that irreparable
                damage
                would occur in the event that any of the provisions of this Warrant
                were
                not performed in accordance with their specific terms or were otherwise
                breached. It is accordingly agreed that the parties shall be entitled
                to
                an injunction or injunctions to prevent or cure breaches of the provisions
                of this Warrant and to enforce specifically the terms and provisions
                hereof, this being in addition to any other remedy to which either
                of them
                may be entitled by law or equity.

            

    

     

    
      
        
        

      

      
        29

        
          

        

      

      
        
        

      

    

     

    
      	17.	
              Assignment.
                Subject to prior written approval by the Company, this Warrant may
                be
                transferred or assigned, in whole or in part, at any time and from
                time to
                time by the then Holder by submitting this Warrant to the Company
                together
                with a duly executed Assignment in substantially the form and substance
                of
                the Form of Assignment which accompanies this Warrant, as Exhibit B
                hereto, and, upon the Company’s receipt hereof, and in any event, within
                three (3) business days thereafter, the Company shall issue a warrant
                to
                the Holder to evidence that portion of this Warrant, if any as shall
                not
                have been so transferred or assigned.

            

    

     

    (signature
      page immediately follows)

     

    
      
        
        

      

      
        30

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be duly executed,
      manually or by facsimile, by one of its officers thereunto duly
      authorized.

    
      	 	 	 
	 	
              WEST
                COAST CAR COMPANY

            
	 
 	 
 	 
 
	
              Date:
                __________, 2007

            	By:  	
            
	 	
              

              Name: Qingtai
                Liu

            
	 	
              Title: President
                

            

    

     

    
      
        
        

      

      
        31

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      A

     

    TO

     

    WARRANT
      CERTIFICATE

     

    ELECTION
      TO PURCHASE

     

    To
      Be
      Executed by the Holder

    in
      Order
      to Exercise the Warrant

     

    The
      undersigned Holder hereby elects to purchase _______ shares pursuant to the
      attached Warrant, and requests that certificates for securities be issued in
      the
      name of: 

     

    __________________________________________________________

    (Please
      type or print name and address)

     

    __________________________________________________________

     

    __________________________________________________________

     

    __________________________________________________________

    (Social
      Security or Tax Identification Number)

     

    and
      delivered to:_____________________________________________________

     

    ___________________________________________________________________.

     

    (Please
      type or print name and address if different from above)

     

    If
      such
      number of Shares being purchased hereby shall not be all the Shares that may
      be
      purchased pursuant to the attached Warrant, a new Warrant for the balance of
      such Shares shall be registered in the name of, and delivered to, the Holder
      at
      the address set forth below.

     

    In
      full
      payment of the purchase price with respect to the Shares purchased and transfer
      taxes, if any, the undersigned hereby tenders payment of $__________ by check,
      money order or wire transfer payable in United States currency to the order
      of
      WEST COAST CAR COMPANY.

    
      	 	 	 
	 	
              HOLDER:

            
	 
 	 
 	 
 
	
            	By:  	
            
	 	
              

              Name:

            
	 	Title:
	 	
              Address:

            
	 	 
	 	 
	
              Dated:
                _______________________ 

            	 

    

     

    
      
        
        

      

      
        32

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      B

    TO

    WARRANT

     

    FORM
      OF
      ASSIGNMENT

    (To
      be
      signed only on transfer of Warrant)

     

    For
      value
      received, the undersigned hereby sells, assigns, and transfers unto
      _____________ the right represented by the within Warrant to purchase ______
      shares of Common Stock of West Coast Car Company, a Delaware corporation, to
      which the within Warrant relates, and appoints ____________________ Attorney
      to
      transfer such right on the books of West Coast Car Company, a Delaware
      Corporation, with full power of substitution of premises.

    
      	 	 	 
	 	 	 
	
              Dated:

            	By:  	
            
	 	
              

              Name:

            
	 	
              Title:

            
	 	
              (signature
                must conform to name of
                holder as specified on 

              the
                fact of
                the Warrant) 

            
	 	 
	 	
              Address: 

            

    

     

    Signed
      in
      the presence of:

     

    Dated:

     

    
      
        
        

      

      
        33

        
          

        

      

      
        
        

      

    

    EXHIBIT
      H

    

    ESCROW
      AGREEMENT

    (See
      attached)

     

    
      
        
        

      

      
        34

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00123-of-00352.parquet"}]]